<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Balloon angioplasty, with and without stenting, versus medical therapy for hypertensive patients with renal artery stenosis - Jenks, S - 2014 | Cochrane Library</title> <meta content="Balloon angioplasty, with and without stenting, versus medical therapy for hypertensive patients with renal artery stenosis - Jenks, S - 2014 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD002944.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Balloon angioplasty, with and without stenting, versus medical therapy for hypertensive patients with renal artery stenosis - Jenks, S - 2014 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD002944.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD002944.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Balloon angioplasty, with and without stenting, versus medical therapy for hypertensive patients with renal artery stenosis" name="citation_title"/> <meta content="Sara Jenks" name="citation_author"/> <meta content="University of Edinburgh" name="citation_author_institution"/> <meta content="sjenks@doctors.org.uk" name="citation_author_email"/> <meta content="Su Ern Yeoh" name="citation_author"/> <meta content="University of Edinburgh" name="citation_author_institution"/> <meta content="Bryan R Conway" name="citation_author"/> <meta content="Queens Medical Research Institute, University of Edinburgh" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="12" name="citation_issue"/> <meta content="10.1002/14651858.CD002944.pub2" name="citation_doi"/> <meta content="2014" name="citation_date"/> <meta content="2014/12/05" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD002944.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD002944.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD002944.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Angioplasty, Balloon; *Stents; Antihypertensive Agents [*therapeutic use]; Combined Modality Therapy [methods]; Hypertension [*therapy]; Randomized Controlled Trials as Topic; Renal Artery Obstruction [*therapy]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002944.pub2&amp;doi=10.1002/14651858.CD002944.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002944.pub2&amp;doi=10.1002/14651858.CD002944.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002944.pub2&amp;doi=10.1002/14651858.CD002944.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002944.pub2&amp;doi=10.1002/14651858.CD002944.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002944.pub2&amp;doi=10.1002/14651858.CD002944.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002944.pub2&amp;doi=10.1002/14651858.CD002944.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002944.pub2&amp;doi=10.1002/14651858.CD002944.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002944.pub2&amp;doi=10.1002/14651858.CD002944.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002944.pub2&amp;doi=10.1002/14651858.CD002944.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002944.pub2&amp;doi=10.1002/14651858.CD002944.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002944.pub2&amp;doi=10.1002/14651858.CD002944.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002944.pub2&amp;doi=10.1002/14651858.CD002944.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002944.pub2&amp;doi=10.1002/14651858.CD002944.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002944.pub2&amp;doi=10.1002/14651858.CD002944.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002944.pub2&amp;doi=10.1002/14651858.CD002944.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002944.pub2&amp;doi=10.1002/14651858.CD002944.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002944.pub2&amp;doi=10.1002/14651858.CD002944.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002944.pub2&amp;doi=10.1002/14651858.CD002944.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002944.pub2&amp;doi=10.1002/14651858.CD002944.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002944.pub2&amp;doi=10.1002/14651858.CD002944.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002944.pub2&amp;doi=10.1002/14651858.CD002944.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002944.pub2&amp;doi=10.1002/14651858.CD002944.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002944.pub2&amp;doi=10.1002/14651858.CD002944.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="BqmVIxTs";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD002944\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD002944\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD002944\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD002944\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","ru","hr","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD002944.pub2",title:"Balloon angioplasty, with and without stenting, versus medical therapy for hypertensive patients with renal artery stenosis",firstPublishedDate:"Dec 5, 2014 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Vascular Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=BqmVIxTs&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD002944.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD002944.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD002944.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD002944.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD002944.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD002944.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD002944.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD002944.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD002944.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD002944.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD002944.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD002944.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD002944.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD002944.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>2750 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD002944.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002944.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002944.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002944.pub2/full#CD002944-abs-0003"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002944.pub2/full#CD002944-sec-0069"> Authors' conclusions </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002944.pub2/full#CD002944-sec-0015"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002944.pub2/full#CD002944-sec-0020"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002944.pub2/full#CD002944-sec-0021"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002944.pub2/full#CD002944-sec-0044"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002944.pub2/full#CD002944-sec-0063"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD002944.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002944.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002944.pub2/appendices#CD002944-sec-0074"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002944.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002944.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD002944.pub2/media/CDSR/CD002944/table_n/CD002944StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD002944.pub2/media/CDSR/CD002944/table_n/CD002944StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002944.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002944.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002944.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD002944.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD002944.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD002944.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2014 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD002944.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Balloon angioplasty, with and without stenting, versus medical therapy for hypertensive patients with renal artery stenosis </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD002944.pub2/information#CD002944-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Sara Jenks</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD002944.pub2/information#CD002944-cr-0003">Su Ern Yeoh</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD002944.pub2/information#CD002944-cr-0004">Bryan R Conway</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD002944.pub2/information/en#CD002944-sec-0079">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 05 December 2014 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD002944.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD002944.pub2">https://doi.org/10.1002/14651858.CD002944.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD002944-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD002944-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD002944-abs-0002">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD002944-abs-0007">فارسی</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD002944-abs-0001" lang="en"> <section id="CD002944-sec-0001"> <h3 class="title" id="CD002944-sec-0001">Background</h3> <p>Atherosclerotic renal artery stenosis is the most common cause of secondary hypertension. Balloon angioplasty with stenting is widely used for the treatment of hypertensive patients with renal artery stenosis but the effectiveness of this procedure in treating hypertension, improving renal function and preventing adverse cardiovascular and renal events remains uncertain. This is an update, to include the results of recent, important large trials, of a review first published in 2003. </p> </section> <section id="CD002944-sec-0002"> <h3 class="title" id="CD002944-sec-0002">Objectives</h3> <p>To compare the effectiveness of balloon angioplasty (with and without stenting) with medical therapy for the treatment of atherosclerotic renal artery stenosis in patients with hypertension. The following outcomes were compared: blood pressure control, renal function, frequency of cardiovascular and renal adverse events, presence or absence of restenosis of the renal artery, side effects of medical therapy, numbers and defined daily doses of antihypertensive drugs. </p> </section> <section id="CD002944-sec-0003"> <h3 class="title" id="CD002944-sec-0003">Search methods</h3> <p>For this update the Cochrane Peripheral Vascular Diseases Group Trials Search Co‐ordinator searched the Specialised Register (last searched May 2014) and CENTRAL (2014, Issue 4). Bibliographies were also reviewed and trial authors were contacted for more information. </p> </section> <section id="CD002944-sec-0004"> <h3 class="title" id="CD002944-sec-0004">Selection criteria</h3> <p>Randomised controlled trials (RCTs) comparing balloon angioplasty with medical therapy in hypertensive patients with haemodynamically significant renal artery stenosis (greater than 50% reduction in luminal diameter) and with a minimum follow‐up of six months. </p> </section> <section id="CD002944-sec-0005"> <h3 class="title" id="CD002944-sec-0005">Data collection and analysis</h3> <p>Data were extracted independently on trial design, participants, interventions and outcome measures. A formal meta‐analysis was completed to assess the effect on blood pressure, renal function and cardiovascular and renal adverse events. Peto's odds ratios (ORs) and corresponding 95% confidence intervals (CI) for dichotomous outcomes and mean differences (MD) and corresponding 95% CIs for continuous variables were calculated. </p> </section> <section id="CD002944-sec-0006"> <h3 class="title" id="CD002944-sec-0006">Main results</h3> <p>Eight RCTs involving 2222 participants with renal artery stenosis were included in the review. The overall quality of evidence included in this review was moderate. Limited pooling of results was possible due to the variable presentation of some of the trial outcomes. Meta‐analysis of the four studies reporting change in diastolic blood pressure (BP) found a small improvement in diastolic BP in the angioplasty group (MD ‐2.00 mmHg; 95% CI ‐3.72 to ‐0.27) whilst the meta‐analysis of the five studies reporting change in systolic BP did not find any evidence of significant improvement (MD ‐1.07 mmHg; 95% CI ‐3.45 to 1.30). There was no significant effect on renal function as measured by serum creatinine (MD ‐7.99 µmol/L; 95% CI ‐22.6 to 6.62). Meta‐analysis of the three studies that reported the mean number of antihypertensive drugs found a small decrease in antihypertensive drug requirements for the angioplasty group (MD ‐0.18; 95% CI ‐0.34 to ‐0.03). Repeat angiography was only performed on a small number of participants in a single trial and it was therefore not possible to comment on restenosis of the renal artery following balloon angioplasty. Based on the results of the seven studies that reported cardiovascular and renal clinical outcomes there were no differences in cardiovascular (OR 0.91; 95% CI 0.75 to 1.11) or renal adverse events (OR 1.02; 95% CI 0.75 to 1.38) between the angioplasty and medical treatment groups. A small number of procedural complications of balloon angioplasty were reported (haematoma at the site of catheter insertion (6.5%), femoral artery pseudoaneurysm (0.7%), renal artery or kidney perforation or dissection (2.5%) as well as peri‐procedural deaths (0.4%)). No side effects of medical therapy were reported. </p> </section> <section id="CD002944-sec-0007"> <h3 class="title" id="CD002944-sec-0007">Authors' conclusions</h3> <p>The available data are insufficient to conclude that revascularisation in the form of balloon angioplasty, with or without stenting, is superior to medical therapy for the treatment of atherosclerotic renal artery stenosis in patients with hypertension. However, balloon angioplasty results in a small improvement in diastolic blood pressure and a small reduction in antihypertensive drug requirements. Balloon angioplasty appears safe and results in similar numbers of cardiovascular and renal adverse events to medical therapy. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD002944-abs-0003" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD002944-abs-0003">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD002944-abs-0006">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD002944-abs-0008">فارسی</a> </li> <li class="section-language"> <a class="" href="full/hr#CD002944-abs-0005">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/ru#CD002944-abs-0004">Русский</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD002944-abs-0003" lang="en"> <h3>Balloon angioplasty versus medical therapy for patients with renal artery obstruction and high blood pressure </h3> <p>Atherosclerosis can cause narrowing and hardening of the main blood vessel supplying the kidneys (renal artery stenosis) resulting in high blood pressure. Even using drugs that lower blood pressure (antihypertensives) atherosclerotic renal artery narrowing tends to progress. Poor blood flow results in a lack of oxygen (renal ischaemia) and loss of kidney function, causing kidney failure. Currently, possible treatments are medical treatment with blood pressure lowering drugs, balloon angioplasty with stent insertion (insertion of a balloon‐like tube which is inflated to open up the artery followed by insertion of a metal tube which remains in place to try and keep the artery open), and surgery to reconstruct the artery. The review authors identified eight controlled trials in which a total of 2222 adults were randomised to have balloon angioplasty or drug treatment only. The overall quality of the evidence was considered to be moderate because the methodological quality of the studies varied substantially and two of the studies had not provided sufficient data to be able to assess their risk of bias. Overall, the data were insufficient to show that one treatment was better than the other for preventing loss of kidney function or restenosis of the renal artery. Those treated with balloon angioplasty may require fewer antihypertensive drugs or lower doses and experience a slight improvement in diastolic but not systolic blood pressure. Balloon angioplasty appears to be safe and there were similar numbers of renal and cardiovascular adverse events in participants treated with either approach. A small number of procedural complications of balloon angioplasty were reported (collection of blood outside the blood vessel at the site of catheter insertion (6.5%), dilated groin artery (0.7%), renal artery or kidney perforation or tear (2.5%) as well as deaths shortly before, during or after the procedure (0.4%)). No side effects of medical therapy were reported. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD002944-sec-0069" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD002944-sec-0069"></div> <h3 class="title" id="CD002944-sec-0070">Implications for practice</h3> <section id="CD002944-sec-0070"> <p>The available data does not allow us to conclude that balloon angioplasty is superior to medical therapy in lowering the blood pressure of patients with renal artery stenosis in whom blood pressure can be controlled with medical therapy. However, angioplasty does appear to be safe and there is no evidence of increased complications relative to medical therapy. </p> <p>Overall, the data does not provide any evidence that angioplasty reduces the incidence of cardiovascular or renal adverse events when compared to the best available medical therapy. Angioplasty does seem to have a small drug‐saving effect and may result in a small improvement in diastolic blood pressure, but the clinical importance of these benefits is unclear as there is no evidence that these improvements translate into improved cardiovascular and renal outcomes. </p> </section> <h3 class="title" id="CD002944-sec-0071">Implications for research</h3> <section id="CD002944-sec-0071"> <p>Further well‐conducted randomised controlled trials comparing the effect of medical therapy and balloon angioplasty in patients with atherosclerotic renal artery stenosis should be performed to overcome methodological errors evident in the published literature. These trials should ensure a sufficient number of participants are included to provide statistical power, unambiguous participant selection criteria, blinded outcome assessment, and follow‐up of three or more years in order to evaluate the long‐term effect of the interventions on the preservation of renal function. Studies specifically designed to investigate whether certain patients (for example those with renal artery stenosis &gt; 70% or severe bilateral stenosis, rapidly deteriorating renal function, or flash pulmonary oedema) may be more likely to benefit clinically from angioplasty would also be useful. Additional studies should be carried out to determine whether investigations, such as Doppler ultrasound waveform analysis, may aid in the identification of patients with true reno‐vascular hypertension who may be more likely to benefit from revascularisation. The following outcome parameters should be considered for any future study: 1) serum creatinine, creatinine clearance or estimated glomerular filtration rate; 2) systolic and diastolic blood pressure; 3) cardiovascular and renal adverse events; 4) numbers of antihypertensive medications; and 5) peri‐procedural complications. A cost‐effectiveness analysis, taking into account patient preference, would also be desirable. </p> </section> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD002944-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD002944-sec-0015"></div> <section id="CD002944-sec-0016"> <h3 class="title" id="CD002944-sec-0016">Description of the condition</h3> <p>Atherosclerotic renal artery stenosis (progressive narrowing and hardening of the main blood vessel supplying the kidneys) is the most common cause of secondary hypertension (high blood pressure) and accounts for 1% to 5% of all cases of hypertension (<a href="./references#CD002944-bbs2-0015" title="DerkxFH , SchalenkampMA . Renal artery stenosis and hypertension. Lancet1994;344:3287‐9. ">Derkx 1994</a>). Prospective studies on renal angiography in patients starting dialysis identified atherosclerotic renal artery stenosis as the underlying cause of end stage renal failure in up to 20% of cases (<a href="./references#CD002944-bbs2-0019" title="NovickA , ScobleJE , HamiltonG . Renal vascular disease. London: WB Saunders, 1996. ">Novick 1996</a>). With increasing population age and widespread use of noninvasive screening tests, the frequency of documented renal artery stenosis will probably increase (<a href="./references#CD002944-bbs2-0013" title="AndersonGHJr , BlakemanN , StreetenDHP . The effect of age on the prevalence of secondary forms of hypertension in 4429 consecutively referred patients. Journal of Hypertension1994;12:609‐15. ">Anderson 1994</a>; <a href="./references#CD002944-bbs2-0014" title="DavidsonRA , WilcoxCS . Newer tests for the diagnosis of renovascular disease. JAMA1992;268:3353‐8. ">Davidson 1992</a>). </p> <p>Despite antihypertensive drug therapy, atherosclerotic renal artery stenosis tends to progress, leading to renal ischaemia (poor blood flow resulting in a lack of oxygen) and loss of renal (kidney) function (<a href="./references#CD002944-bbs2-0025" title="ZierlerRE , BergelinRO , DavidsonRC , Cantwell‐GabK , PolissarNL , StrandessDE . A prospective study of disease progression in patients with atherosclerotic renal artery stenosis. American Journal of Hypertension1997;9(11):1055‐61. ">Zierler 1997</a>). The rate of progression has been reported to be 4% to 12% per year (<a href="./references#CD002944-bbs2-0022" title="SchreiberMJ , PohlMA , NovickAI . The natural history of atherosclerotic and fibrous renal artery disease. Urologic Clinics of North America1984;11(3):383‐92. ">Schreiber 1984</a>; <a href="./references#CD002944-bbs2-0023" title="TollefsonDFJ , ErnstCB . Natural history of atherosclerotic renal artery stenosis associated with aortic disease. Journal of Vascular Surgery1991;14:327‐33. ">Tollefson 1991</a>). The probability of survival in patients with renal artery stenosis depends on the severity of the impairment of renal function. In a cohort study of patients treated with stent revascularisation (insertion of a tube (stent) to keep the artery open and allow blood to flow through) three‐year survival was 92% for patients with normal renal function, 74% for patients with mild renal failure and 52% for patients with more severe renal failure (<a href="./references#CD002944-bbs2-0016" title="DorrosG , JaffM , MathiakL , DorrosII , LoweA , MurphyK , et al. Four year follow up of Palmaz‐Schatz stent revascularization as treatment for atherosclerotic renal artery stenosis. Circulation1998;98:642‐7. ">Dorros 1998</a>). </p> </section> <section id="CD002944-sec-0017"> <h3 class="title" id="CD002944-sec-0017">Description of the intervention</h3> <p>Currently, there are three possible therapeutic options for patients with atherosclerotic renal artery stenosis (ARAS). These are medical treatment with antihypertensive drugs, balloon angioplasty with or without stent insertion, and surgery to reconstruct the artery. In a trial comparing balloon angioplasty with surgical reconstruction for the treatment of renal artery stenosis, the interventions were equally effective in restoring patency of the obstructed vessel but balloon angioplasty was associated with fewer major complications (<a href="./references#CD002944-bbs2-0024" title="WeibullH , BergqvistD , BergentzSE , JonssonK , HulthénUL , ManhmeP . Percutaneous transluminal renal angioplasty versus surgical reconstruction of atherosclerotic renal artery stenosis: a prospective randomized study. Journal of Vascular Surgery1993;18:841‐52. ">Weibull 1993</a>). Surgical reconstruction does not therefore seem to offer any clinical benefit over balloon angioplasty in patients with ARAS. For that reason, this review focuses on the relative benefits of balloon angioplasty, with or without stenting, in comparison to medical treatment. </p> </section> <section id="CD002944-sec-0018"> <h3 class="title" id="CD002944-sec-0018">How the intervention might work</h3> <p>It is generally regarded that restoring renal artery patency may reduce blood pressure and prevent decline in renal function by improving renal blood flow. This prevents any further ischaemic damage to the renal parenchyma from subsequent progression of stenosis or catastrophic thrombosis. It also reduces stimulation of the renin‐angiotensin system with a resultant reduction in vasoconstriction and a fall in salt and water retention. Blood pressure therefore falls and the renal parenchyma is protected from hypertension‐induced damage. </p> </section> <section id="CD002944-sec-0019"> <h3 class="title" id="CD002944-sec-0019">Why it is important to do this review</h3> <p>Promising results from early observational studies suggested that balloon angioplasty was superior to medical therapy for the treatment of ARAS, with balloon angioplasty resulting in a cure from hypertension in 19% of patients and to improved blood pressure control (as measured by a reduction in the dosage of antihypertensive drugs by at least half a tablet a day) in 52% of patients (<a href="./references#CD002944-bbs2-0020" title="RamsayLE , WallerPC . Blood pressure response to percutaneous transluminal angioplasty for renovascular hypertension: an overview of published series. BMJ1990;300:569‐72. ">Ramsay 1990</a>). Based on these results balloon angioplasty continues to be widely used for the treatment of renal artery stenosis. However, these early findings have not been replicated in more recent randomised controlled trials and the optimal role for angioplasty is currently unclear. This systematic review of randomised controlled trials aimed to compare the effect of balloon angioplasty and medical treatment in hypertensive patients with atherosclerotic renal artery stenosis on blood pressure control, renal function and treatment complications. This is an update of a Cochrane Review last updated in 2008. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD002944-sec-0020" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD002944-sec-0020"></div> <p>The objective of this systematic review was to compare the effectiveness of balloon angioplasty (with and without stenting) with medical therapy for the treatment of atherosclerotic renal artery stenosis in patients with hypertension. The following outcomes were compared: </p> <p> <ul id="CD002944-list-0001"> <li> <p>blood pressure control;</p> </li> <li> <p>renal function;</p> </li> <li> <p>frequency of cardiovascular and renal adverse events;</p> </li> <li> <p>presence or absence of restenosis of the renal artery;</p> </li> <li> <p>side effects of medical therapy; and</p> </li> <li> <p>numbers and defined daily doses of antihypertensive drugs.</p> </li> </ul> </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD002944-sec-0021" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD002944-sec-0021"></div> <section id="CD002944-sec-0022"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD002944-sec-0023"> <h4 class="title">Types of studies</h4> <p>Randomised or quasi‐randomised controlled trials comparing balloon angioplasty with medical treatment in hypertensive patients with haemodynamically significant atherosclerotic renal artery stenosis (greater than 50% reduction in luminal diameter). The trials were required to have a follow‐up of at least six months. </p> </section> <section id="CD002944-sec-0024"> <h4 class="title">Types of participants</h4> <p>Only trials including adults (older than 18 years of age) with hypertension (diastolic blood pressure higher or equal to 95 mmHg) and uni‐ or bilateral atherosclerotic renal artery stenosis (stenosis greater than 50%) were included. Trials analysing the effects of the two strategies in patients with fibromuscular dysplasia, total occlusion of the renal artery, an affected kidney smaller than 8 cm, malignant hypertension or a serum creatinine of greater than 500 µmol/L were excluded. </p> </section> <section id="CD002944-sec-0025"> <h4 class="title">Types of interventions</h4> <p>All participants had to be randomised to either primary balloon angioplasty (with or without insertion of a stent) or medical therapy. Trials comparing surgical interventions with either angioplasty or medical therapy were excluded. </p> </section> <section id="CD002944-sec-0026"> <h4 class="title">Types of outcome measures</h4> <p>All trials had to report clinically relevant outcome measures after a minimum follow‐up of six months. </p> <section id="CD002944-sec-0027"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD002944-list-0002"> <li> <p>Systolic and diastolic blood pressure</p> </li> <li> <p>Renal function as assessed by serum creatinine, creatinine clearance or estimated glomerular filtration rate </p> </li> </ul> </p> </section> <section id="CD002944-sec-0028"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD002944-list-0003"> <li> <p>Numbers and defined daily doses (DDD) of antihypertensive drugs (one DDD is the average maintenance dose per day) </p> </li> <li> <p>Presence or absence of restenosis of the renal artery (defined as a stenosis of greater than 50%) </p> </li> <li> <p>Cardiovascular adverse events (myocardial infarction, angina, heart failure, stroke, non‐procedure related symptomatic hypotension, or cardiovascular death), renal adverse events (defined as an increase of serum creatinine of more than 50%, cholesterol embolisation, development of renal failure, total occlusion of the stenotic artery, dissection of the renal artery, major complication during balloon angioplasty other than haematoma at the puncture site, or need for dialysis), procedural complications (bleeding at the arterial site), and side effects of medical therapy </p> </li> </ul> </p> </section> </section> </section> <section id="CD002944-sec-0029"> <h3 class="title">Search methods for identification of studies</h3> <p>We did not apply any language restrictions on publications or any restrictions regarding publication status. </p> <section id="CD002944-sec-0030"> <h4 class="title">Electronic searches</h4> <p>For this update the Cochrane Peripheral Vascular Diseases (PVD) Group Trials Search Co‐ordinator (TSC) searched the Specialised Register (last searched May 2014) and the Cochrane Central Register of Controlled Trials (CENTRAL) (2014, Issue 4) in <i>The Cochrane Library</i> (<a href="http://www.thecochranelibrary.com" target="_blank">www.thecochranelibrary.com</a>). See <a href="./appendices#CD002944-sec-0075">Appendix 1</a> for details of the search strategy used to search CENTRAL. The Peripheral Vascular Diseases Group Specialised Register is maintained by the TSC and is constructed from weekly electronic searches of MEDLINE, EMBASE, CINAHL, AMED, and through handsearching relevant journals. The full list of the databases, journals and conference proceedings which have been searched as well as the search strategies used are described in the <a href="http://www.mrw.interscience.wiley.com/cochrane/clabout/articles/PVD/frame.html" target="_blank">Specialised Register</a> section of the Cochrane Peripheral Vascular Diseases Group module in <i>The Cochrane Library</i> (<a href="http://www.thecochranelibrary.com" target="_blank">www.thecochranelibrary.com</a>). </p> </section> <section id="CD002944-sec-0031"> <h4 class="title">Searching other resources</h4> <p>We searched the reference lists of articles retrieved by the electronic searches for additional citations. Where possible, we contacted trialists for further information in cases where there were missing data or doubts about whether to include the trials in the review. </p> </section> </section> <section id="CD002944-sec-0032"> <h3 class="title" id="CD002944-sec-0032">Data collection and analysis</h3> <section id="CD002944-sec-0033"> <h4 class="title">Selection of studies</h4> <p>For this update, two review authors (SJ and SEY) selected all trials which appeared to be relevant, on the basis of the title and abstract, for a full independent review. We then independently selected studies fulfilling the inclusion criteria for this review. Disagreements were resolved by consensus. The reason for each study’s exclusion is presented in the <a href="./references#CD002944-sec-0086" title="">Characteristics of excluded studies</a> table. </p> </section> <section id="CD002944-sec-0034"> <h4 class="title">Data extraction and management</h4> <p>Two review authors (SJ and SEY) extracted data independently. The following items were noted. </p> <p> <ul id="CD002944-list-0004"> <li> <p>Methods: allocation concealment, method of randomisation, presence or absence of run‐in period, length of follow‐up, dropouts and crossovers, co‐interventions and other potential confounders, blinding of evaluators, methods of assessment of blood pressure and renal function. </p> </li> <li> <p>Participants: age, gender, mean blood pressure, duration of hypertension, number of antihypertensive agents, grade of stenosis, renal function at the beginning of the study. </p> </li> <li> <p>Interventions: numbers and types of additional procedures such as stenting and surgery in the balloon angioplasty group, type and number of antihypertensive drugs and additional interventions in the medical treatment group. </p> </li> <li> <p>Outcomes: mean systolic and diastolic blood pressure differences at end of follow‐up or at two years if follow‐up was longer than two years, differences in renal function at two years or the end of follow‐up, angiographic assessment of vessel restenosis, cardiovascular and renal adverse events, procedural complications and drug side effects. </p> </li> </ul> </p> <p>Disagreement on data extraction was resolved by consensus.</p> <p>Authors of publications were contacted for additional details. Data were entered into Review Manager (RevMan), which is the systematic review software from The Cochrane Collaboration (<a href="./references#CD002944-bbs2-0021" title="Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan) Version 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012. ">RevMan 2012</a>). </p> </section> <section id="CD002944-sec-0035"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (SJ and SEY) independently assessed the methodological quality of included trials using the risk of bias criteria outlined in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD002944-bbs2-0017" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). We were not blinded to the authors or results of the trials. The risk of bias tool provides a protocol for the assessment of allocation (selection bias), blinding (performance bias and detection bias), incomplete outcome data (attrition bias), selective reporting (reporting bias) and other potential sources of bias. For each of the six domains, we assessed the risk of bias as 'low', 'high' or 'unclear', with unclear indicating that there was insufficient information available to permit an assessment of either low or high risk of bias. Disagreements were resolved by consensus. </p> </section> <section id="CD002944-sec-0036"> <h4 class="title">Measures of treatment effect</h4> <p>All analyses were conducted on an intention‐to‐treat basis. We set out to pool data on changes in systolic and diastolic BP, serum creatinine, and the numbers of antihypertensive drugs from each trial to arrive at an estimate of the overall effectiveness of balloon angioplasty. For continuous outcomes such as BP and creatinine we presented the statistical analysis results as mean differences (MD) with 95% confidence intervals (CI), and for dichotomous outcomes as Peto odds ratios (OR) with 95% CIs. Not all studies presented standard deviations (SD) for the change in BP or the number of antihypertensive drugs and, where necessary, these were imputed from the available data using methodology described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD002944-bbs2-0017" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). </p> <p>All the included studies had provided the SDs for serum creatinine measurements during follow‐up and serum creatinines were therefore chosen to measure treatment effect rather than changes in serum creatinine from baseline, for which no SDs were provided. However, there are limitations in presenting serum creatinine at the end of follow‐up, the main one being that this does not take into account any differences in serum creatinine between angioplasty and medical treatment groups at baseline. </p> </section> <section id="CD002944-sec-0037"> <h4 class="title">Unit of analysis issues</h4> <p>The unit of randomisation was the individual participant in all included studies. All of the included trials collected follow‐up data at different points in time, ranging from one month to five years. In order to enable pooling of the BP and creatinine results, data from either the end of follow‐up or two years into follow‐up were pooled. Two years into follow‐up was chosen as one study followed up participants for five years but by the end of the five‐year follow‐up many participants had either died or been lost to follow‐up. It was therefore felt to be more appropriate to analyse the two‐year follow‐up data for this study. </p> </section> <section id="CD002944-sec-0038"> <h4 class="title">Dealing with missing data</h4> <p>Where necessary, and wherever possible, we contacted the authors of included trials to clarify data and obtain missing data. Not all studies presented the SDs for change in BP or the number of antihypertensive drugs and, where necessary, these were imputed from the available data using methodology described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD002944-bbs2-0017" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). </p> </section> <section id="CD002944-sec-0039"> <h4 class="title">Assessment of heterogeneity</h4> <p>We assessed heterogeneity of trials with the I<sup>2</sup> statistic, using the analysis programme within RevMan, with heterogeneity being identified by I<sup>2</sup> &gt; 50%. No evidence of heterogeneity was found and therefore a fixed‐effect model was applied for each meta‐analysis. </p> </section> <section id="CD002944-sec-0040"> <h4 class="title">Assessment of reporting biases</h4> <p>Since only eight trials were included in this systematic review, no funnel plots to evaluate potential publication bias were prepared. </p> </section> <section id="CD002944-sec-0041"> <h4 class="title">Data synthesis</h4> <p>We performed a meta‐analysis where two or more studies were available. Results for serum creatinine were stated in µmol/L. Changes in BP were stated in mmHg. Continuous variables were reported as MDs with 95% CIs and dichotomous outcomes were reported as ORs with 95% CIs; a P value less than 0.05 was considered as evidence of a statistically significant difference between the balloon angioplasty and medical treatment groups. All meta‐analyses were based on a fixed‐effect model. </p> </section> <section id="CD002944-sec-0042"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>The available data did not permit the pre‐planned subgroup analyses for patients with ostial versus non‐ostial stenosis, uni‐ versus bilateral stenosis, or trials of high and low risk of bias. We performed a subgroup analysis restricting all the meta‐analyses to the five studies that carried out angioplasty with stenting rather than angioplasty alone. There was no evidence of heterogeneity (defined as I<sup>2</sup> &gt; 50%). </p> </section> <section id="CD002944-sec-0043"> <h4 class="title">Sensitivity analysis</h4> <p>The <a href="./references#CD002944-bbs2-0001" title="ASTRAL Investigators, WheatleyK , IvesN , GrayR , KalraPA , MossJG , et al. Revascularization versus medical therapy for renal‐artery stenosis. New England Journal of Medicine2009;361(20):1953‐62. ISRCTN59586944 . Angioplasty and stent for renal artery lesions. ISRCTN Register2007. [URL: http://www.controlled‐trials.com/ISRCTN59586944/Angioplasty+stent+for+renal+artery+lesions] KalraP , MossJ , IvesN , HandleyK , GrayR , WheatleyK . Outcome of patients with highly significant and clinically relevant RAS within the ASTRAL trial. Renal Week 2008, 41st Annual Meeting &amp; Scientific Exposition; 2008 Nov 4‐9; Pennsylvania,USA2008. KalraPA , MossJ , IvesN , Fitzpatrick EllisK , GrayR , WheatleyK , et al. The impact of renal artery revascularization in atherosclerotic renovascular disease: the angioplasty and stenting for renal artery lesions (ASTRAL) trial [abstract no: 090]. Nephrology2008;13 Suppl 3:A123. MistryS , IvesN , HardingJ , Fitzpatrick‐EllisK , LipkinG , KalraPA , et al. Angioplasty and STent for Renal Artery Lesions (ASTRAL trial): rationale, methods and results so far. Journal of Human Hypertension2007;21(7):511‐5. MossJG . ASTRAL trial initial results. Cardiovascular and Interventional Radiological Society of Europe Annual Meeting Abstracts; 2008 Sep 13‐17; Copenhagen, Denmark2008:309. WheatleyK , KalraPA , MossJ , IvesN , Fitzpatrick‐EllisK , GrayR , et al. Lack of benefit of renal artery revascularization in atherosclerotic renovascular disease (ARVD): results of the ASTRAL trial. Renal Week 2008, 41st Annual Meeting &amp; Scientific Exposition; 2008 Nov 4‐9; Pennsylvania,USA2008. ">ASTRAL</a> and <a href="./references#CD002944-bbs2-0002" title="CooperCJ , MurphyTP , MatsumotoA , SteffesM , CohenDJ , JaffM , et al. Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trial. American Heart Journal2006;152(1):59‐66. CooperCJM , MurphyTP , CutlipDE , JamersonK , HenrichW , ReidDM , et al. Stenting and medical therapy for atherosclerotic renal‐artery stenosis. New England Journal of Medicine2014;370:13‐22. MatsumotoA , H , CooperC , MurphyT , CutlipD , ConawayM , et al. Severity of renal artery lesions in patients enrolled into the CORAL trial. Journal of Vascular and Interventional Radiology2010;21(2 Suppl 1):S19. MatsumotoAH , CooperCJ , MurphyTP , CutlipM , ConawayMR , DworkinL . Severity of renal artery lesions in patients enrolled into the CORAL trial. Cardiovascular and Interventional Radiological Society of Europe Annual Meeting Abstracts; 2008 Sep 13‐17; Copenhagen, Denmark2008:308. MurphyTP , CooperCJ , DworkinLD , HenrichWL , RundbackJH , MatsumotoAH , et al. The Cardiovascular Outcomes with Renal Atherosclerotic Lesions (CORAL) study: rationale and methods. Journal of Vascular and Interventional Radiology2005;16(10):1295‐300. NCT00081731 . Benefits of medical therapy plus stenting for renal atherosclerotic lesions. http://clinicaltrials.gov/ct/show/NCT00081731?order=1. [URL: http://clinicaltrials.gov/ct/show/NCT00081731?order=1] ">CORAL</a> trials were much larger than any of the other included studies and a sensitivity analysis was carried out to establish whether either of these trials heavily influenced any results. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD002944-sec-0044" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD002944-sec-0044"></div> <section id="CD002944-sec-0045"> <h3 class="title">Description of studies</h3> <p>See <a href="./references#CD002944-sec-0085" title="">Characteristics of included studies</a>; <a href="./references#CD002944-sec-0086" title="">Characteristics of excluded studies</a>; <a href="./references#CD002944-sec-0087" title="">Characteristics of ongoing studies</a>. </p> <section id="CD002944-sec-0046"> <h4 class="title">Results of the search</h4> <p>See <a href="#CD002944-fig-0001">Figure 1</a>. </p> <div class="figure" id="CD002944-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD002944-fig-0001" src="/cdsr/doi/10.1002/14651858.CD002944.pub2/media/CDSR/CD002944/image_n/nCD002944-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> <p>Five additional studies (<a href="./references#CD002944-bbs2-0001" title="ASTRAL Investigators, WheatleyK , IvesN , GrayR , KalraPA , MossJG , et al. Revascularization versus medical therapy for renal‐artery stenosis. New England Journal of Medicine2009;361(20):1953‐62. ISRCTN59586944 . Angioplasty and stent for renal artery lesions. ISRCTN Register2007. [URL: http://www.controlled‐trials.com/ISRCTN59586944/Angioplasty+stent+for+renal+artery+lesions] KalraP , MossJ , IvesN , HandleyK , GrayR , WheatleyK . Outcome of patients with highly significant and clinically relevant RAS within the ASTRAL trial. Renal Week 2008, 41st Annual Meeting &amp; Scientific Exposition; 2008 Nov 4‐9; Pennsylvania,USA2008. KalraPA , MossJ , IvesN , Fitzpatrick EllisK , GrayR , WheatleyK , et al. The impact of renal artery revascularization in atherosclerotic renovascular disease: the angioplasty and stenting for renal artery lesions (ASTRAL) trial [abstract no: 090]. Nephrology2008;13 Suppl 3:A123. MistryS , IvesN , HardingJ , Fitzpatrick‐EllisK , LipkinG , KalraPA , et al. Angioplasty and STent for Renal Artery Lesions (ASTRAL trial): rationale, methods and results so far. Journal of Human Hypertension2007;21(7):511‐5. MossJG . ASTRAL trial initial results. Cardiovascular and Interventional Radiological Society of Europe Annual Meeting Abstracts; 2008 Sep 13‐17; Copenhagen, Denmark2008:309. WheatleyK , KalraPA , MossJ , IvesN , Fitzpatrick‐EllisK , GrayR , et al. Lack of benefit of renal artery revascularization in atherosclerotic renovascular disease (ARVD): results of the ASTRAL trial. Renal Week 2008, 41st Annual Meeting &amp; Scientific Exposition; 2008 Nov 4‐9; Pennsylvania,USA2008. ">ASTRAL</a>; <a href="./references#CD002944-bbs2-0002" title="CooperCJ , MurphyTP , MatsumotoA , SteffesM , CohenDJ , JaffM , et al. Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trial. American Heart Journal2006;152(1):59‐66. CooperCJM , MurphyTP , CutlipDE , JamersonK , HenrichW , ReidDM , et al. Stenting and medical therapy for atherosclerotic renal‐artery stenosis. New England Journal of Medicine2014;370:13‐22. MatsumotoA , H , CooperC , MurphyT , CutlipD , ConawayM , et al. Severity of renal artery lesions in patients enrolled into the CORAL trial. Journal of Vascular and Interventional Radiology2010;21(2 Suppl 1):S19. MatsumotoAH , CooperCJ , MurphyTP , CutlipM , ConawayMR , DworkinL . Severity of renal artery lesions in patients enrolled into the CORAL trial. Cardiovascular and Interventional Radiological Society of Europe Annual Meeting Abstracts; 2008 Sep 13‐17; Copenhagen, Denmark2008:308. MurphyTP , CooperCJ , DworkinLD , HenrichWL , RundbackJH , MatsumotoAH , et al. The Cardiovascular Outcomes with Renal Atherosclerotic Lesions (CORAL) study: rationale and methods. Journal of Vascular and Interventional Radiology2005;16(10):1295‐300. NCT00081731 . Benefits of medical therapy plus stenting for renal atherosclerotic lesions. http://clinicaltrials.gov/ct/show/NCT00081731?order=1. [URL: http://clinicaltrials.gov/ct/show/NCT00081731?order=1] ">CORAL</a>; <a href="./references#CD002944-bbs2-0005" title="ScarpioniR , MichielettiE , CristinelliL , UgolottiU , ScolariF , VenturelliC , et al. Atherosclerotic renovascular disease: medical therapy versus medical therapy plus renal artery stenting in preventing renal failure progression: the rationale and study design of a prospective, multicenter and randomized trial (NITER). Journal of Nephrology2005;18(4):423‐8. ScarpioniR , MichielettiE , PavoneL . Atherosclerotic renovascular disease (ARVD): medical therapy plus renal artery stenting (PRTS), compared with medical therapy alone, do not offer more chances in preventing C‐V events or the progression of renal failure. Preliminary results of a prospective, multicenter and randomized trial. Abstract World Congress of Nephrology; May 22, 2009; Milan, Italy2009. ">NITER</a>; <a href="./references#CD002944-bbs2-0006" title="SchwarzwalderU , HaukM , ZellerT . RADAR ‐ A randomised, multi‐centre, prospective study comparing best medical treatment versus best medical treatment plus renal artery stenting in patients with haemodynamically relevant atherosclerotic renal artery stenosis. Trials2009;10:60. [NCT00640406] ZellerT . RADAR ‐ Data of a prematurely terminated randomized, multi‐centre prospective study comparing best medical treatment versus best medical treatment plus renal artery stenting in patients with hemodynamically relevant atherosclerotic renal artery stenosis. VASA. Zeitschrift fur Gefasskrankheiten. Journal for Vascular Diseases2013;42:40. ">RADAR</a>; <a href="./references#CD002944-bbs2-0008" title="BaxL , MaliWP , BuskensE , KoomansHA , BeutlerJJ , BraamB , et al. The benefit of STent placement and blood pressure and lipid‐lowering for the prevention of progression of renal dysfunction caused by Atherosclerotic ostial stenosis of the Renal artery. The STAR‐study: rationale and study design. Journal of Nephrology2003;16(6):807‐12. BaxL , WoittiezAJ , KouwenbergHJ , MaliWP , BuskensE , BeekFJ , et al. Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial. Annals of Internal Medicine2009;150(12):840‐8. ">STAR</a>) were included in the update, making a total of eight included studies (<a href="./references#CD002944-bbs2-0001" title="ASTRAL Investigators, WheatleyK , IvesN , GrayR , KalraPA , MossJG , et al. Revascularization versus medical therapy for renal‐artery stenosis. New England Journal of Medicine2009;361(20):1953‐62. ISRCTN59586944 . Angioplasty and stent for renal artery lesions. ISRCTN Register2007. [URL: http://www.controlled‐trials.com/ISRCTN59586944/Angioplasty+stent+for+renal+artery+lesions] KalraP , MossJ , IvesN , HandleyK , GrayR , WheatleyK . Outcome of patients with highly significant and clinically relevant RAS within the ASTRAL trial. Renal Week 2008, 41st Annual Meeting &amp; Scientific Exposition; 2008 Nov 4‐9; Pennsylvania,USA2008. KalraPA , MossJ , IvesN , Fitzpatrick EllisK , GrayR , WheatleyK , et al. The impact of renal artery revascularization in atherosclerotic renovascular disease: the angioplasty and stenting for renal artery lesions (ASTRAL) trial [abstract no: 090]. Nephrology2008;13 Suppl 3:A123. MistryS , IvesN , HardingJ , Fitzpatrick‐EllisK , LipkinG , KalraPA , et al. Angioplasty and STent for Renal Artery Lesions (ASTRAL trial): rationale, methods and results so far. Journal of Human Hypertension2007;21(7):511‐5. MossJG . ASTRAL trial initial results. Cardiovascular and Interventional Radiological Society of Europe Annual Meeting Abstracts; 2008 Sep 13‐17; Copenhagen, Denmark2008:309. WheatleyK , KalraPA , MossJ , IvesN , Fitzpatrick‐EllisK , GrayR , et al. Lack of benefit of renal artery revascularization in atherosclerotic renovascular disease (ARVD): results of the ASTRAL trial. Renal Week 2008, 41st Annual Meeting &amp; Scientific Exposition; 2008 Nov 4‐9; Pennsylvania,USA2008. ">ASTRAL</a>; <a href="./references#CD002944-bbs2-0002" title="CooperCJ , MurphyTP , MatsumotoA , SteffesM , CohenDJ , JaffM , et al. Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trial. American Heart Journal2006;152(1):59‐66. CooperCJM , MurphyTP , CutlipDE , JamersonK , HenrichW , ReidDM , et al. Stenting and medical therapy for atherosclerotic renal‐artery stenosis. New England Journal of Medicine2014;370:13‐22. MatsumotoA , H , CooperC , MurphyT , CutlipD , ConawayM , et al. Severity of renal artery lesions in patients enrolled into the CORAL trial. Journal of Vascular and Interventional Radiology2010;21(2 Suppl 1):S19. MatsumotoAH , CooperCJ , MurphyTP , CutlipM , ConawayMR , DworkinL . Severity of renal artery lesions in patients enrolled into the CORAL trial. Cardiovascular and Interventional Radiological Society of Europe Annual Meeting Abstracts; 2008 Sep 13‐17; Copenhagen, Denmark2008:308. MurphyTP , CooperCJ , DworkinLD , HenrichWL , RundbackJH , MatsumotoAH , et al. The Cardiovascular Outcomes with Renal Atherosclerotic Lesions (CORAL) study: rationale and methods. Journal of Vascular and Interventional Radiology2005;16(10):1295‐300. NCT00081731 . Benefits of medical therapy plus stenting for renal atherosclerotic lesions. http://clinicaltrials.gov/ct/show/NCT00081731?order=1. [URL: http://clinicaltrials.gov/ct/show/NCT00081731?order=1] ">CORAL</a>; <a href="./references#CD002944-bbs2-0003" title="KrijnenP , vanJaarsveldBC , HuninkMG , HabbemaJD . The effect of treatment on health‐related quality of life in patients with hypertension and renal artery stenosis. Journal of Human Hypertension2005;19(6):467‐70. vanJaarsveldB , KrijnenP , BartelinkA , DeesAd , DerkxFH , Man in't VeldA , et al. The Dutch Renal Artery Stenosis Intervention Cooperative (DRASTIC) Study: rationale and inclusion data. Journal of Hypertension1998;16 Suppl 6:S21‐7. vanJaarsveldB , KrijnenP , BartelinkA , DeesAd , DerkxFH , Man in't VeldA , et al. The Dutch Renal Artery Stenosis Intervention Cooperative (DRASTIC) Study: rationale and inclusion data. Journal of Hypertension1998;16 Suppl 6:S21‐7. vanJaarsveldBC , KrijnenP . Prospective studies of diagnosis and intervention: the Dutch experience. Seminars in Nephrology2000;20(5):463‐73. vanJaarsveldBC , KrijnenP , PietermanH , DerkxF , DeinumJ , PostmaCT , et al. The effect of balloon angioplasty on hypertension in atherosclerotic renal artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group. New England Journal of Medicine2000;342(14):1007‐14. ">DRASTIC</a>; <a href="./references#CD002944-bbs2-0004" title="PlouinPF , ChatellierG , DarnéB , RaynaudA . Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis. A randomized trial. Essai Multicentrique Medicaments vs Angioplastie (EMMA) Study Group. Hypertension1998;31(3):823‐9. Scottish and Newcastle Renovascular Collaborative Group. Prospective randomized trial of interventional (angioplasty) versus medical therapy in hypertensive patients with atheromatous renal artery stenosis. Journal of Hypertension1994; Vol. 12:1312. ">EMMA</a>; <a href="./references#CD002944-bbs2-0005" title="ScarpioniR , MichielettiE , CristinelliL , UgolottiU , ScolariF , VenturelliC , et al. Atherosclerotic renovascular disease: medical therapy versus medical therapy plus renal artery stenting in preventing renal failure progression: the rationale and study design of a prospective, multicenter and randomized trial (NITER). Journal of Nephrology2005;18(4):423‐8. ScarpioniR , MichielettiE , PavoneL . Atherosclerotic renovascular disease (ARVD): medical therapy plus renal artery stenting (PRTS), compared with medical therapy alone, do not offer more chances in preventing C‐V events or the progression of renal failure. Preliminary results of a prospective, multicenter and randomized trial. Abstract World Congress of Nephrology; May 22, 2009; Milan, Italy2009. ">NITER</a>; <a href="./references#CD002944-bbs2-0006" title="SchwarzwalderU , HaukM , ZellerT . RADAR ‐ A randomised, multi‐centre, prospective study comparing best medical treatment versus best medical treatment plus renal artery stenting in patients with haemodynamically relevant atherosclerotic renal artery stenosis. Trials2009;10:60. [NCT00640406] ZellerT . RADAR ‐ Data of a prematurely terminated randomized, multi‐centre prospective study comparing best medical treatment versus best medical treatment plus renal artery stenting in patients with hemodynamically relevant atherosclerotic renal artery stenosis. VASA. Zeitschrift fur Gefasskrankheiten. Journal for Vascular Diseases2013;42:40. ">RADAR</a>; <a href="./references#CD002944-bbs2-0007" title="WebsterJ , MarshallF , AbdallaM , DominiczakA , EdwardsR , IslesCG , et al. Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. Scottish and Newcastle Renal Artery Stenosis Collaborative Group. Journal of Human Hypertension1998;12(5):329‐35. ">SNRASCG</a>; <a href="./references#CD002944-bbs2-0008" title="BaxL , MaliWP , BuskensE , KoomansHA , BeutlerJJ , BraamB , et al. The benefit of STent placement and blood pressure and lipid‐lowering for the prevention of progression of renal dysfunction caused by Atherosclerotic ostial stenosis of the Renal artery. The STAR‐study: rationale and study design. Journal of Nephrology2003;16(6):807‐12. BaxL , WoittiezAJ , KouwenbergHJ , MaliWP , BuskensE , BeekFJ , et al. Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial. Annals of Internal Medicine2009;150(12):840‐8. ">STAR</a>). Three of these studies had been ongoing studies in the previous version of the review (<a href="./references#CD002944-bbs2-0002" title="CooperCJ , MurphyTP , MatsumotoA , SteffesM , CohenDJ , JaffM , et al. Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trial. American Heart Journal2006;152(1):59‐66. CooperCJM , MurphyTP , CutlipDE , JamersonK , HenrichW , ReidDM , et al. Stenting and medical therapy for atherosclerotic renal‐artery stenosis. New England Journal of Medicine2014;370:13‐22. MatsumotoA , H , CooperC , MurphyT , CutlipD , ConawayM , et al. Severity of renal artery lesions in patients enrolled into the CORAL trial. Journal of Vascular and Interventional Radiology2010;21(2 Suppl 1):S19. MatsumotoAH , CooperCJ , MurphyTP , CutlipM , ConawayMR , DworkinL . Severity of renal artery lesions in patients enrolled into the CORAL trial. Cardiovascular and Interventional Radiological Society of Europe Annual Meeting Abstracts; 2008 Sep 13‐17; Copenhagen, Denmark2008:308. MurphyTP , CooperCJ , DworkinLD , HenrichWL , RundbackJH , MatsumotoAH , et al. The Cardiovascular Outcomes with Renal Atherosclerotic Lesions (CORAL) study: rationale and methods. Journal of Vascular and Interventional Radiology2005;16(10):1295‐300. NCT00081731 . Benefits of medical therapy plus stenting for renal atherosclerotic lesions. http://clinicaltrials.gov/ct/show/NCT00081731?order=1. [URL: http://clinicaltrials.gov/ct/show/NCT00081731?order=1] ">CORAL</a>; <a href="./references#CD002944-bbs2-0005" title="ScarpioniR , MichielettiE , CristinelliL , UgolottiU , ScolariF , VenturelliC , et al. Atherosclerotic renovascular disease: medical therapy versus medical therapy plus renal artery stenting in preventing renal failure progression: the rationale and study design of a prospective, multicenter and randomized trial (NITER). Journal of Nephrology2005;18(4):423‐8. ScarpioniR , MichielettiE , PavoneL . Atherosclerotic renovascular disease (ARVD): medical therapy plus renal artery stenting (PRTS), compared with medical therapy alone, do not offer more chances in preventing C‐V events or the progression of renal failure. Preliminary results of a prospective, multicenter and randomized trial. Abstract World Congress of Nephrology; May 22, 2009; Milan, Italy2009. ">NITER</a>; <a href="./references#CD002944-bbs2-0008" title="BaxL , MaliWP , BuskensE , KoomansHA , BeutlerJJ , BraamB , et al. The benefit of STent placement and blood pressure and lipid‐lowering for the prevention of progression of renal dysfunction caused by Atherosclerotic ostial stenosis of the Renal artery. The STAR‐study: rationale and study design. Journal of Nephrology2003;16(6):807‐12. BaxL , WoittiezAJ , KouwenbergHJ , MaliWP , BuskensE , BeekFJ , et al. Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial. Annals of Internal Medicine2009;150(12):840‐8. ">STAR</a>). </p> <p>Two additional ongoing studies were identified, METRAS (<a href="./references#CD002944-bbs2-0011" title="RossiG , P , SecciaT , M , MiottoD , ZucchettaP , et al. The Medical and Endovascular Treatment of Atherosclerotic Renal Artery Stenosis (METRAS) study: Rationale and study design. Journal of Human Hypertension2012;26(8):507‐16. [NCT01208714] ">Rossi 2012</a>) and RAVE (<a href="./references#CD002944-bbs2-0012" title="NCT00127738 . Renal Atherosclerotic Revascularization Evaluation: RAVE Study. ClinicalTrials.gov2007. [URL: http://clinicaltrials.gov/show/NCT00127738] TobeSW , AtriM , PerkinsN , PugashR , BellCM , et al. Renal atherosclerotic revascularization evaluation (RAVE study): study protocol of a randomized trial [NCT00127738]. BMC Nephrology2007;8:4. ">Tobe 2007</a>). </p> </section> <section id="CD002944-sec-0047"> <h4 class="title">Included studies</h4> <p>This review includes eight eligible trials: three from the original review (<a href="./references#CD002944-bbs2-0003" title="KrijnenP , vanJaarsveldBC , HuninkMG , HabbemaJD . The effect of treatment on health‐related quality of life in patients with hypertension and renal artery stenosis. Journal of Human Hypertension2005;19(6):467‐70. vanJaarsveldB , KrijnenP , BartelinkA , DeesAd , DerkxFH , Man in't VeldA , et al. The Dutch Renal Artery Stenosis Intervention Cooperative (DRASTIC) Study: rationale and inclusion data. Journal of Hypertension1998;16 Suppl 6:S21‐7. vanJaarsveldB , KrijnenP , BartelinkA , DeesAd , DerkxFH , Man in't VeldA , et al. The Dutch Renal Artery Stenosis Intervention Cooperative (DRASTIC) Study: rationale and inclusion data. Journal of Hypertension1998;16 Suppl 6:S21‐7. vanJaarsveldBC , KrijnenP . Prospective studies of diagnosis and intervention: the Dutch experience. Seminars in Nephrology2000;20(5):463‐73. vanJaarsveldBC , KrijnenP , PietermanH , DerkxF , DeinumJ , PostmaCT , et al. The effect of balloon angioplasty on hypertension in atherosclerotic renal artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group. New England Journal of Medicine2000;342(14):1007‐14. ">DRASTIC</a>; <a href="./references#CD002944-bbs2-0004" title="PlouinPF , ChatellierG , DarnéB , RaynaudA . Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis. A randomized trial. Essai Multicentrique Medicaments vs Angioplastie (EMMA) Study Group. Hypertension1998;31(3):823‐9. Scottish and Newcastle Renovascular Collaborative Group. Prospective randomized trial of interventional (angioplasty) versus medical therapy in hypertensive patients with atheromatous renal artery stenosis. Journal of Hypertension1994; Vol. 12:1312. ">EMMA</a>; <a href="./references#CD002944-bbs2-0007" title="WebsterJ , MarshallF , AbdallaM , DominiczakA , EdwardsR , IslesCG , et al. Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. Scottish and Newcastle Renal Artery Stenosis Collaborative Group. Journal of Human Hypertension1998;12(5):329‐35. ">SNRASCG</a>) and five from the update (<a href="./references#CD002944-bbs2-0001" title="ASTRAL Investigators, WheatleyK , IvesN , GrayR , KalraPA , MossJG , et al. Revascularization versus medical therapy for renal‐artery stenosis. New England Journal of Medicine2009;361(20):1953‐62. ISRCTN59586944 . Angioplasty and stent for renal artery lesions. ISRCTN Register2007. [URL: http://www.controlled‐trials.com/ISRCTN59586944/Angioplasty+stent+for+renal+artery+lesions] KalraP , MossJ , IvesN , HandleyK , GrayR , WheatleyK . Outcome of patients with highly significant and clinically relevant RAS within the ASTRAL trial. Renal Week 2008, 41st Annual Meeting &amp; Scientific Exposition; 2008 Nov 4‐9; Pennsylvania,USA2008. KalraPA , MossJ , IvesN , Fitzpatrick EllisK , GrayR , WheatleyK , et al. The impact of renal artery revascularization in atherosclerotic renovascular disease: the angioplasty and stenting for renal artery lesions (ASTRAL) trial [abstract no: 090]. Nephrology2008;13 Suppl 3:A123. MistryS , IvesN , HardingJ , Fitzpatrick‐EllisK , LipkinG , KalraPA , et al. Angioplasty and STent for Renal Artery Lesions (ASTRAL trial): rationale, methods and results so far. Journal of Human Hypertension2007;21(7):511‐5. MossJG . ASTRAL trial initial results. Cardiovascular and Interventional Radiological Society of Europe Annual Meeting Abstracts; 2008 Sep 13‐17; Copenhagen, Denmark2008:309. WheatleyK , KalraPA , MossJ , IvesN , Fitzpatrick‐EllisK , GrayR , et al. Lack of benefit of renal artery revascularization in atherosclerotic renovascular disease (ARVD): results of the ASTRAL trial. Renal Week 2008, 41st Annual Meeting &amp; Scientific Exposition; 2008 Nov 4‐9; Pennsylvania,USA2008. ">ASTRAL</a>; <a href="./references#CD002944-bbs2-0002" title="CooperCJ , MurphyTP , MatsumotoA , SteffesM , CohenDJ , JaffM , et al. Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trial. American Heart Journal2006;152(1):59‐66. CooperCJM , MurphyTP , CutlipDE , JamersonK , HenrichW , ReidDM , et al. Stenting and medical therapy for atherosclerotic renal‐artery stenosis. New England Journal of Medicine2014;370:13‐22. MatsumotoA , H , CooperC , MurphyT , CutlipD , ConawayM , et al. Severity of renal artery lesions in patients enrolled into the CORAL trial. Journal of Vascular and Interventional Radiology2010;21(2 Suppl 1):S19. MatsumotoAH , CooperCJ , MurphyTP , CutlipM , ConawayMR , DworkinL . Severity of renal artery lesions in patients enrolled into the CORAL trial. Cardiovascular and Interventional Radiological Society of Europe Annual Meeting Abstracts; 2008 Sep 13‐17; Copenhagen, Denmark2008:308. MurphyTP , CooperCJ , DworkinLD , HenrichWL , RundbackJH , MatsumotoAH , et al. The Cardiovascular Outcomes with Renal Atherosclerotic Lesions (CORAL) study: rationale and methods. Journal of Vascular and Interventional Radiology2005;16(10):1295‐300. NCT00081731 . Benefits of medical therapy plus stenting for renal atherosclerotic lesions. http://clinicaltrials.gov/ct/show/NCT00081731?order=1. [URL: http://clinicaltrials.gov/ct/show/NCT00081731?order=1] ">CORAL</a>; <a href="./references#CD002944-bbs2-0005" title="ScarpioniR , MichielettiE , CristinelliL , UgolottiU , ScolariF , VenturelliC , et al. Atherosclerotic renovascular disease: medical therapy versus medical therapy plus renal artery stenting in preventing renal failure progression: the rationale and study design of a prospective, multicenter and randomized trial (NITER). Journal of Nephrology2005;18(4):423‐8. ScarpioniR , MichielettiE , PavoneL . Atherosclerotic renovascular disease (ARVD): medical therapy plus renal artery stenting (PRTS), compared with medical therapy alone, do not offer more chances in preventing C‐V events or the progression of renal failure. Preliminary results of a prospective, multicenter and randomized trial. Abstract World Congress of Nephrology; May 22, 2009; Milan, Italy2009. ">NITER</a>; <a href="./references#CD002944-bbs2-0006" title="SchwarzwalderU , HaukM , ZellerT . RADAR ‐ A randomised, multi‐centre, prospective study comparing best medical treatment versus best medical treatment plus renal artery stenting in patients with haemodynamically relevant atherosclerotic renal artery stenosis. Trials2009;10:60. [NCT00640406] ZellerT . RADAR ‐ Data of a prematurely terminated randomized, multi‐centre prospective study comparing best medical treatment versus best medical treatment plus renal artery stenting in patients with hemodynamically relevant atherosclerotic renal artery stenosis. VASA. Zeitschrift fur Gefasskrankheiten. Journal for Vascular Diseases2013;42:40. ">RADAR</a>; <a href="./references#CD002944-bbs2-0008" title="BaxL , MaliWP , BuskensE , KoomansHA , BeutlerJJ , BraamB , et al. The benefit of STent placement and blood pressure and lipid‐lowering for the prevention of progression of renal dysfunction caused by Atherosclerotic ostial stenosis of the Renal artery. The STAR‐study: rationale and study design. Journal of Nephrology2003;16(6):807‐12. BaxL , WoittiezAJ , KouwenbergHJ , MaliWP , BuskensE , BeekFJ , et al. Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial. Annals of Internal Medicine2009;150(12):840‐8. ">STAR</a>). Seven trials were fully randomised (<a href="./references#CD002944-bbs2-0001" title="ASTRAL Investigators, WheatleyK , IvesN , GrayR , KalraPA , MossJG , et al. Revascularization versus medical therapy for renal‐artery stenosis. New England Journal of Medicine2009;361(20):1953‐62. ISRCTN59586944 . Angioplasty and stent for renal artery lesions. ISRCTN Register2007. [URL: http://www.controlled‐trials.com/ISRCTN59586944/Angioplasty+stent+for+renal+artery+lesions] KalraP , MossJ , IvesN , HandleyK , GrayR , WheatleyK . Outcome of patients with highly significant and clinically relevant RAS within the ASTRAL trial. Renal Week 2008, 41st Annual Meeting &amp; Scientific Exposition; 2008 Nov 4‐9; Pennsylvania,USA2008. KalraPA , MossJ , IvesN , Fitzpatrick EllisK , GrayR , WheatleyK , et al. The impact of renal artery revascularization in atherosclerotic renovascular disease: the angioplasty and stenting for renal artery lesions (ASTRAL) trial [abstract no: 090]. Nephrology2008;13 Suppl 3:A123. MistryS , IvesN , HardingJ , Fitzpatrick‐EllisK , LipkinG , KalraPA , et al. Angioplasty and STent for Renal Artery Lesions (ASTRAL trial): rationale, methods and results so far. Journal of Human Hypertension2007;21(7):511‐5. MossJG . ASTRAL trial initial results. Cardiovascular and Interventional Radiological Society of Europe Annual Meeting Abstracts; 2008 Sep 13‐17; Copenhagen, Denmark2008:309. WheatleyK , KalraPA , MossJ , IvesN , Fitzpatrick‐EllisK , GrayR , et al. Lack of benefit of renal artery revascularization in atherosclerotic renovascular disease (ARVD): results of the ASTRAL trial. Renal Week 2008, 41st Annual Meeting &amp; Scientific Exposition; 2008 Nov 4‐9; Pennsylvania,USA2008. ">ASTRAL</a>; <a href="./references#CD002944-bbs2-0002" title="CooperCJ , MurphyTP , MatsumotoA , SteffesM , CohenDJ , JaffM , et al. Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trial. American Heart Journal2006;152(1):59‐66. CooperCJM , MurphyTP , CutlipDE , JamersonK , HenrichW , ReidDM , et al. Stenting and medical therapy for atherosclerotic renal‐artery stenosis. New England Journal of Medicine2014;370:13‐22. MatsumotoA , H , CooperC , MurphyT , CutlipD , ConawayM , et al. Severity of renal artery lesions in patients enrolled into the CORAL trial. Journal of Vascular and Interventional Radiology2010;21(2 Suppl 1):S19. MatsumotoAH , CooperCJ , MurphyTP , CutlipM , ConawayMR , DworkinL . Severity of renal artery lesions in patients enrolled into the CORAL trial. Cardiovascular and Interventional Radiological Society of Europe Annual Meeting Abstracts; 2008 Sep 13‐17; Copenhagen, Denmark2008:308. MurphyTP , CooperCJ , DworkinLD , HenrichWL , RundbackJH , MatsumotoAH , et al. The Cardiovascular Outcomes with Renal Atherosclerotic Lesions (CORAL) study: rationale and methods. Journal of Vascular and Interventional Radiology2005;16(10):1295‐300. NCT00081731 . Benefits of medical therapy plus stenting for renal atherosclerotic lesions. http://clinicaltrials.gov/ct/show/NCT00081731?order=1. [URL: http://clinicaltrials.gov/ct/show/NCT00081731?order=1] ">CORAL</a>; <a href="./references#CD002944-bbs2-0003" title="KrijnenP , vanJaarsveldBC , HuninkMG , HabbemaJD . The effect of treatment on health‐related quality of life in patients with hypertension and renal artery stenosis. Journal of Human Hypertension2005;19(6):467‐70. vanJaarsveldB , KrijnenP , BartelinkA , DeesAd , DerkxFH , Man in't VeldA , et al. The Dutch Renal Artery Stenosis Intervention Cooperative (DRASTIC) Study: rationale and inclusion data. Journal of Hypertension1998;16 Suppl 6:S21‐7. vanJaarsveldB , KrijnenP , BartelinkA , DeesAd , DerkxFH , Man in't VeldA , et al. The Dutch Renal Artery Stenosis Intervention Cooperative (DRASTIC) Study: rationale and inclusion data. Journal of Hypertension1998;16 Suppl 6:S21‐7. vanJaarsveldBC , KrijnenP . Prospective studies of diagnosis and intervention: the Dutch experience. Seminars in Nephrology2000;20(5):463‐73. vanJaarsveldBC , KrijnenP , PietermanH , DerkxF , DeinumJ , PostmaCT , et al. The effect of balloon angioplasty on hypertension in atherosclerotic renal artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group. New England Journal of Medicine2000;342(14):1007‐14. ">DRASTIC</a>; <a href="./references#CD002944-bbs2-0004" title="PlouinPF , ChatellierG , DarnéB , RaynaudA . Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis. A randomized trial. Essai Multicentrique Medicaments vs Angioplastie (EMMA) Study Group. Hypertension1998;31(3):823‐9. Scottish and Newcastle Renovascular Collaborative Group. Prospective randomized trial of interventional (angioplasty) versus medical therapy in hypertensive patients with atheromatous renal artery stenosis. Journal of Hypertension1994; Vol. 12:1312. ">EMMA</a>; <a href="./references#CD002944-bbs2-0005" title="ScarpioniR , MichielettiE , CristinelliL , UgolottiU , ScolariF , VenturelliC , et al. Atherosclerotic renovascular disease: medical therapy versus medical therapy plus renal artery stenting in preventing renal failure progression: the rationale and study design of a prospective, multicenter and randomized trial (NITER). Journal of Nephrology2005;18(4):423‐8. ScarpioniR , MichielettiE , PavoneL . Atherosclerotic renovascular disease (ARVD): medical therapy plus renal artery stenting (PRTS), compared with medical therapy alone, do not offer more chances in preventing C‐V events or the progression of renal failure. Preliminary results of a prospective, multicenter and randomized trial. Abstract World Congress of Nephrology; May 22, 2009; Milan, Italy2009. ">NITER</a>; <a href="./references#CD002944-bbs2-0006" title="SchwarzwalderU , HaukM , ZellerT . RADAR ‐ A randomised, multi‐centre, prospective study comparing best medical treatment versus best medical treatment plus renal artery stenting in patients with haemodynamically relevant atherosclerotic renal artery stenosis. Trials2009;10:60. [NCT00640406] ZellerT . RADAR ‐ Data of a prematurely terminated randomized, multi‐centre prospective study comparing best medical treatment versus best medical treatment plus renal artery stenting in patients with hemodynamically relevant atherosclerotic renal artery stenosis. VASA. Zeitschrift fur Gefasskrankheiten. Journal for Vascular Diseases2013;42:40. ">RADAR</a>; <a href="./references#CD002944-bbs2-0008" title="BaxL , MaliWP , BuskensE , KoomansHA , BeutlerJJ , BraamB , et al. The benefit of STent placement and blood pressure and lipid‐lowering for the prevention of progression of renal dysfunction caused by Atherosclerotic ostial stenosis of the Renal artery. The STAR‐study: rationale and study design. Journal of Nephrology2003;16(6):807‐12. BaxL , WoittiezAJ , KouwenbergHJ , MaliWP , BuskensE , BeekFJ , et al. Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial. Annals of Internal Medicine2009;150(12):840‐8. ">STAR</a>) whilst one trial (<a href="./references#CD002944-bbs2-0007" title="WebsterJ , MarshallF , AbdallaM , DominiczakA , EdwardsR , IslesCG , et al. Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. Scottish and Newcastle Renal Artery Stenosis Collaborative Group. Journal of Human Hypertension1998;12(5):329‐35. ">SNRASCG</a>) reported results of randomised and non‐randomised participants separately. We only considered the results of the randomised participants for this review. </p> <p>No randomised controlled trial with a shorter follow‐up than six months was found.</p> <p>Since only eight trials were identified, no kappa test to assess inter‐rater agreement was performed. </p> <p>In all eight included trials hypertensive men and women with renal artery stenosis were randomly allocated to balloon angioplasty or medical therapy with antihypertensive drugs. The number of included participants in the studies ranged from 49 to 947. Follow‐up was six months in the <a href="./references#CD002944-bbs2-0004" title="PlouinPF , ChatellierG , DarnéB , RaynaudA . Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis. A randomized trial. Essai Multicentrique Medicaments vs Angioplastie (EMMA) Study Group. Hypertension1998;31(3):823‐9. Scottish and Newcastle Renovascular Collaborative Group. Prospective randomized trial of interventional (angioplasty) versus medical therapy in hypertensive patients with atheromatous renal artery stenosis. Journal of Hypertension1994; Vol. 12:1312. ">EMMA</a> and <a href="./references#CD002944-bbs2-0007" title="WebsterJ , MarshallF , AbdallaM , DominiczakA , EdwardsR , IslesCG , et al. Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. Scottish and Newcastle Renal Artery Stenosis Collaborative Group. Journal of Human Hypertension1998;12(5):329‐35. ">SNRASCG</a> trials, 12 months in the <a href="./references#CD002944-bbs2-0003" title="KrijnenP , vanJaarsveldBC , HuninkMG , HabbemaJD . The effect of treatment on health‐related quality of life in patients with hypertension and renal artery stenosis. Journal of Human Hypertension2005;19(6):467‐70. vanJaarsveldB , KrijnenP , BartelinkA , DeesAd , DerkxFH , Man in't VeldA , et al. The Dutch Renal Artery Stenosis Intervention Cooperative (DRASTIC) Study: rationale and inclusion data. Journal of Hypertension1998;16 Suppl 6:S21‐7. vanJaarsveldB , KrijnenP , BartelinkA , DeesAd , DerkxFH , Man in't VeldA , et al. The Dutch Renal Artery Stenosis Intervention Cooperative (DRASTIC) Study: rationale and inclusion data. Journal of Hypertension1998;16 Suppl 6:S21‐7. vanJaarsveldBC , KrijnenP . Prospective studies of diagnosis and intervention: the Dutch experience. Seminars in Nephrology2000;20(5):463‐73. vanJaarsveldBC , KrijnenP , PietermanH , DerkxF , DeinumJ , PostmaCT , et al. The effect of balloon angioplasty on hypertension in atherosclerotic renal artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group. New England Journal of Medicine2000;342(14):1007‐14. ">DRASTIC</a> trial, 24 months in the <a href="./references#CD002944-bbs2-0008" title="BaxL , MaliWP , BuskensE , KoomansHA , BeutlerJJ , BraamB , et al. The benefit of STent placement and blood pressure and lipid‐lowering for the prevention of progression of renal dysfunction caused by Atherosclerotic ostial stenosis of the Renal artery. The STAR‐study: rationale and study design. Journal of Nephrology2003;16(6):807‐12. BaxL , WoittiezAJ , KouwenbergHJ , MaliWP , BuskensE , BeekFJ , et al. Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial. Annals of Internal Medicine2009;150(12):840‐8. ">STAR</a> trial, 32 months in the <a href="./references#CD002944-bbs2-0006" title="SchwarzwalderU , HaukM , ZellerT . RADAR ‐ A randomised, multi‐centre, prospective study comparing best medical treatment versus best medical treatment plus renal artery stenting in patients with haemodynamically relevant atherosclerotic renal artery stenosis. Trials2009;10:60. [NCT00640406] ZellerT . RADAR ‐ Data of a prematurely terminated randomized, multi‐centre prospective study comparing best medical treatment versus best medical treatment plus renal artery stenting in patients with hemodynamically relevant atherosclerotic renal artery stenosis. VASA. Zeitschrift fur Gefasskrankheiten. Journal for Vascular Diseases2013;42:40. ">RADAR</a> trial, 43 months in the <a href="./references#CD002944-bbs2-0005" title="ScarpioniR , MichielettiE , CristinelliL , UgolottiU , ScolariF , VenturelliC , et al. Atherosclerotic renovascular disease: medical therapy versus medical therapy plus renal artery stenting in preventing renal failure progression: the rationale and study design of a prospective, multicenter and randomized trial (NITER). Journal of Nephrology2005;18(4):423‐8. ScarpioniR , MichielettiE , PavoneL . Atherosclerotic renovascular disease (ARVD): medical therapy plus renal artery stenting (PRTS), compared with medical therapy alone, do not offer more chances in preventing C‐V events or the progression of renal failure. Preliminary results of a prospective, multicenter and randomized trial. Abstract World Congress of Nephrology; May 22, 2009; Milan, Italy2009. ">NITER</a> and <a href="./references#CD002944-bbs2-0002" title="CooperCJ , MurphyTP , MatsumotoA , SteffesM , CohenDJ , JaffM , et al. Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trial. American Heart Journal2006;152(1):59‐66. CooperCJM , MurphyTP , CutlipDE , JamersonK , HenrichW , ReidDM , et al. Stenting and medical therapy for atherosclerotic renal‐artery stenosis. New England Journal of Medicine2014;370:13‐22. MatsumotoA , H , CooperC , MurphyT , CutlipD , ConawayM , et al. Severity of renal artery lesions in patients enrolled into the CORAL trial. Journal of Vascular and Interventional Radiology2010;21(2 Suppl 1):S19. MatsumotoAH , CooperCJ , MurphyTP , CutlipM , ConawayMR , DworkinL . Severity of renal artery lesions in patients enrolled into the CORAL trial. Cardiovascular and Interventional Radiological Society of Europe Annual Meeting Abstracts; 2008 Sep 13‐17; Copenhagen, Denmark2008:308. MurphyTP , CooperCJ , DworkinLD , HenrichWL , RundbackJH , MatsumotoAH , et al. The Cardiovascular Outcomes with Renal Atherosclerotic Lesions (CORAL) study: rationale and methods. Journal of Vascular and Interventional Radiology2005;16(10):1295‐300. NCT00081731 . Benefits of medical therapy plus stenting for renal atherosclerotic lesions. http://clinicaltrials.gov/ct/show/NCT00081731?order=1. [URL: http://clinicaltrials.gov/ct/show/NCT00081731?order=1] ">CORAL</a> trials and five years in the <a href="./references#CD002944-bbs2-0001" title="ASTRAL Investigators, WheatleyK , IvesN , GrayR , KalraPA , MossJG , et al. Revascularization versus medical therapy for renal‐artery stenosis. New England Journal of Medicine2009;361(20):1953‐62. ISRCTN59586944 . Angioplasty and stent for renal artery lesions. ISRCTN Register2007. [URL: http://www.controlled‐trials.com/ISRCTN59586944/Angioplasty+stent+for+renal+artery+lesions] KalraP , MossJ , IvesN , HandleyK , GrayR , WheatleyK . Outcome of patients with highly significant and clinically relevant RAS within the ASTRAL trial. Renal Week 2008, 41st Annual Meeting &amp; Scientific Exposition; 2008 Nov 4‐9; Pennsylvania,USA2008. KalraPA , MossJ , IvesN , Fitzpatrick EllisK , GrayR , WheatleyK , et al. The impact of renal artery revascularization in atherosclerotic renovascular disease: the angioplasty and stenting for renal artery lesions (ASTRAL) trial [abstract no: 090]. Nephrology2008;13 Suppl 3:A123. MistryS , IvesN , HardingJ , Fitzpatrick‐EllisK , LipkinG , KalraPA , et al. Angioplasty and STent for Renal Artery Lesions (ASTRAL trial): rationale, methods and results so far. Journal of Human Hypertension2007;21(7):511‐5. MossJG . ASTRAL trial initial results. Cardiovascular and Interventional Radiological Society of Europe Annual Meeting Abstracts; 2008 Sep 13‐17; Copenhagen, Denmark2008:309. WheatleyK , KalraPA , MossJ , IvesN , Fitzpatrick‐EllisK , GrayR , et al. Lack of benefit of renal artery revascularization in atherosclerotic renovascular disease (ARVD): results of the ASTRAL trial. Renal Week 2008, 41st Annual Meeting &amp; Scientific Exposition; 2008 Nov 4‐9; Pennsylvania,USA2008. ">ASTRAL</a> trial. The <a href="./references#CD002944-bbs2-0004" title="PlouinPF , ChatellierG , DarnéB , RaynaudA . Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis. A randomized trial. Essai Multicentrique Medicaments vs Angioplastie (EMMA) Study Group. Hypertension1998;31(3):823‐9. Scottish and Newcastle Renovascular Collaborative Group. Prospective randomized trial of interventional (angioplasty) versus medical therapy in hypertensive patients with atheromatous renal artery stenosis. Journal of Hypertension1994; Vol. 12:1312. ">EMMA</a> and <a href="./references#CD002944-bbs2-0007" title="WebsterJ , MarshallF , AbdallaM , DominiczakA , EdwardsR , IslesCG , et al. Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. Scottish and Newcastle Renal Artery Stenosis Collaborative Group. Journal of Human Hypertension1998;12(5):329‐35. ">SNRASCG</a> trials had two to six‐week run‐in periods on standardised antihypertensive treatment. In the <a href="./references#CD002944-bbs2-0004" title="PlouinPF , ChatellierG , DarnéB , RaynaudA . Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis. A randomized trial. Essai Multicentrique Medicaments vs Angioplastie (EMMA) Study Group. Hypertension1998;31(3):823‐9. Scottish and Newcastle Renovascular Collaborative Group. Prospective randomized trial of interventional (angioplasty) versus medical therapy in hypertensive patients with atheromatous renal artery stenosis. Journal of Hypertension1994; Vol. 12:1312. ">EMMA</a> and <a href="./references#CD002944-bbs2-0003" title="KrijnenP , vanJaarsveldBC , HuninkMG , HabbemaJD . The effect of treatment on health‐related quality of life in patients with hypertension and renal artery stenosis. Journal of Human Hypertension2005;19(6):467‐70. vanJaarsveldB , KrijnenP , BartelinkA , DeesAd , DerkxFH , Man in't VeldA , et al. The Dutch Renal Artery Stenosis Intervention Cooperative (DRASTIC) Study: rationale and inclusion data. Journal of Hypertension1998;16 Suppl 6:S21‐7. vanJaarsveldB , KrijnenP , BartelinkA , DeesAd , DerkxFH , Man in't VeldA , et al. The Dutch Renal Artery Stenosis Intervention Cooperative (DRASTIC) Study: rationale and inclusion data. Journal of Hypertension1998;16 Suppl 6:S21‐7. vanJaarsveldBC , KrijnenP . Prospective studies of diagnosis and intervention: the Dutch experience. Seminars in Nephrology2000;20(5):463‐73. vanJaarsveldBC , KrijnenP , PietermanH , DerkxF , DeinumJ , PostmaCT , et al. The effect of balloon angioplasty on hypertension in atherosclerotic renal artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group. New England Journal of Medicine2000;342(14):1007‐14. ">DRASTIC</a> trials antihypertensive drug therapy was stopped at the time of the intervention in participants assigned to balloon angioplasty, and subsequently reinstated if necessary. In the <a href="./references#CD002944-bbs2-0001" title="ASTRAL Investigators, WheatleyK , IvesN , GrayR , KalraPA , MossJG , et al. Revascularization versus medical therapy for renal‐artery stenosis. New England Journal of Medicine2009;361(20):1953‐62. ISRCTN59586944 . Angioplasty and stent for renal artery lesions. ISRCTN Register2007. [URL: http://www.controlled‐trials.com/ISRCTN59586944/Angioplasty+stent+for+renal+artery+lesions] KalraP , MossJ , IvesN , HandleyK , GrayR , WheatleyK . Outcome of patients with highly significant and clinically relevant RAS within the ASTRAL trial. Renal Week 2008, 41st Annual Meeting &amp; Scientific Exposition; 2008 Nov 4‐9; Pennsylvania,USA2008. KalraPA , MossJ , IvesN , Fitzpatrick EllisK , GrayR , WheatleyK , et al. The impact of renal artery revascularization in atherosclerotic renovascular disease: the angioplasty and stenting for renal artery lesions (ASTRAL) trial [abstract no: 090]. Nephrology2008;13 Suppl 3:A123. MistryS , IvesN , HardingJ , Fitzpatrick‐EllisK , LipkinG , KalraPA , et al. Angioplasty and STent for Renal Artery Lesions (ASTRAL trial): rationale, methods and results so far. Journal of Human Hypertension2007;21(7):511‐5. MossJG . ASTRAL trial initial results. Cardiovascular and Interventional Radiological Society of Europe Annual Meeting Abstracts; 2008 Sep 13‐17; Copenhagen, Denmark2008:309. WheatleyK , KalraPA , MossJ , IvesN , Fitzpatrick‐EllisK , GrayR , et al. Lack of benefit of renal artery revascularization in atherosclerotic renovascular disease (ARVD): results of the ASTRAL trial. Renal Week 2008, 41st Annual Meeting &amp; Scientific Exposition; 2008 Nov 4‐9; Pennsylvania,USA2008. ">ASTRAL</a>, <a href="./references#CD002944-bbs2-0002" title="CooperCJ , MurphyTP , MatsumotoA , SteffesM , CohenDJ , JaffM , et al. Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trial. American Heart Journal2006;152(1):59‐66. CooperCJM , MurphyTP , CutlipDE , JamersonK , HenrichW , ReidDM , et al. Stenting and medical therapy for atherosclerotic renal‐artery stenosis. New England Journal of Medicine2014;370:13‐22. MatsumotoA , H , CooperC , MurphyT , CutlipD , ConawayM , et al. Severity of renal artery lesions in patients enrolled into the CORAL trial. Journal of Vascular and Interventional Radiology2010;21(2 Suppl 1):S19. MatsumotoAH , CooperCJ , MurphyTP , CutlipM , ConawayMR , DworkinL . Severity of renal artery lesions in patients enrolled into the CORAL trial. Cardiovascular and Interventional Radiological Society of Europe Annual Meeting Abstracts; 2008 Sep 13‐17; Copenhagen, Denmark2008:308. MurphyTP , CooperCJ , DworkinLD , HenrichWL , RundbackJH , MatsumotoAH , et al. The Cardiovascular Outcomes with Renal Atherosclerotic Lesions (CORAL) study: rationale and methods. Journal of Vascular and Interventional Radiology2005;16(10):1295‐300. NCT00081731 . Benefits of medical therapy plus stenting for renal atherosclerotic lesions. http://clinicaltrials.gov/ct/show/NCT00081731?order=1. [URL: http://clinicaltrials.gov/ct/show/NCT00081731?order=1] ">CORAL</a>, <a href="./references#CD002944-bbs2-0007" title="WebsterJ , MarshallF , AbdallaM , DominiczakA , EdwardsR , IslesCG , et al. Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. Scottish and Newcastle Renal Artery Stenosis Collaborative Group. Journal of Human Hypertension1998;12(5):329‐35. ">SNRASCG</a> and <a href="./references#CD002944-bbs2-0008" title="BaxL , MaliWP , BuskensE , KoomansHA , BeutlerJJ , BraamB , et al. The benefit of STent placement and blood pressure and lipid‐lowering for the prevention of progression of renal dysfunction caused by Atherosclerotic ostial stenosis of the Renal artery. The STAR‐study: rationale and study design. Journal of Nephrology2003;16(6):807‐12. BaxL , WoittiezAJ , KouwenbergHJ , MaliWP , BuskensE , BeekFJ , et al. Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial. Annals of Internal Medicine2009;150(12):840‐8. ">STAR</a> trials antihypertensive drug therapy was continued after balloon angioplasty. Information on the presence or absence of any run‐in period or the discontinuation of antihypertensive drug therapy was not available for the <a href="./references#CD002944-bbs2-0005" title="ScarpioniR , MichielettiE , CristinelliL , UgolottiU , ScolariF , VenturelliC , et al. Atherosclerotic renovascular disease: medical therapy versus medical therapy plus renal artery stenting in preventing renal failure progression: the rationale and study design of a prospective, multicenter and randomized trial (NITER). Journal of Nephrology2005;18(4):423‐8. ScarpioniR , MichielettiE , PavoneL . Atherosclerotic renovascular disease (ARVD): medical therapy plus renal artery stenting (PRTS), compared with medical therapy alone, do not offer more chances in preventing C‐V events or the progression of renal failure. Preliminary results of a prospective, multicenter and randomized trial. Abstract World Congress of Nephrology; May 22, 2009; Milan, Italy2009. ">NITER</a> and <a href="./references#CD002944-bbs2-0006" title="SchwarzwalderU , HaukM , ZellerT . RADAR ‐ A randomised, multi‐centre, prospective study comparing best medical treatment versus best medical treatment plus renal artery stenting in patients with haemodynamically relevant atherosclerotic renal artery stenosis. Trials2009;10:60. [NCT00640406] ZellerT . RADAR ‐ Data of a prematurely terminated randomized, multi‐centre prospective study comparing best medical treatment versus best medical treatment plus renal artery stenting in patients with hemodynamically relevant atherosclerotic renal artery stenosis. VASA. Zeitschrift fur Gefasskrankheiten. Journal for Vascular Diseases2013;42:40. ">RADAR</a> trials. </p> <p>Not all participants allocated to balloon angioplasty underwent the procedure, predominantly due to minimal stenosis being present at the time of angiography. In the <a href="./references#CD002944-bbs2-0001" title="ASTRAL Investigators, WheatleyK , IvesN , GrayR , KalraPA , MossJG , et al. Revascularization versus medical therapy for renal‐artery stenosis. New England Journal of Medicine2009;361(20):1953‐62. ISRCTN59586944 . Angioplasty and stent for renal artery lesions. ISRCTN Register2007. [URL: http://www.controlled‐trials.com/ISRCTN59586944/Angioplasty+stent+for+renal+artery+lesions] KalraP , MossJ , IvesN , HandleyK , GrayR , WheatleyK . Outcome of patients with highly significant and clinically relevant RAS within the ASTRAL trial. Renal Week 2008, 41st Annual Meeting &amp; Scientific Exposition; 2008 Nov 4‐9; Pennsylvania,USA2008. KalraPA , MossJ , IvesN , Fitzpatrick EllisK , GrayR , WheatleyK , et al. The impact of renal artery revascularization in atherosclerotic renovascular disease: the angioplasty and stenting for renal artery lesions (ASTRAL) trial [abstract no: 090]. Nephrology2008;13 Suppl 3:A123. MistryS , IvesN , HardingJ , Fitzpatrick‐EllisK , LipkinG , KalraPA , et al. Angioplasty and STent for Renal Artery Lesions (ASTRAL trial): rationale, methods and results so far. Journal of Human Hypertension2007;21(7):511‐5. MossJG . ASTRAL trial initial results. Cardiovascular and Interventional Radiological Society of Europe Annual Meeting Abstracts; 2008 Sep 13‐17; Copenhagen, Denmark2008:309. WheatleyK , KalraPA , MossJ , IvesN , Fitzpatrick‐EllisK , GrayR , et al. Lack of benefit of renal artery revascularization in atherosclerotic renovascular disease (ARVD): results of the ASTRAL trial. Renal Week 2008, 41st Annual Meeting &amp; Scientific Exposition; 2008 Nov 4‐9; Pennsylvania,USA2008. ">ASTRAL</a> trial 335 of the 403 (83%) participants allocated to balloon angioplasty underwent attempted revascularisation compared with 46 out of 64 (72%) in the <a href="./references#CD002944-bbs2-0008" title="BaxL , MaliWP , BuskensE , KoomansHA , BeutlerJJ , BraamB , et al. The benefit of STent placement and blood pressure and lipid‐lowering for the prevention of progression of renal dysfunction caused by Atherosclerotic ostial stenosis of the Renal artery. The STAR‐study: rationale and study design. Journal of Nephrology2003;16(6):807‐12. BaxL , WoittiezAJ , KouwenbergHJ , MaliWP , BuskensE , BeekFJ , et al. Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial. Annals of Internal Medicine2009;150(12):840‐8. ">STAR</a> trial and 442 out of 467 (95%) in the <a href="./references#CD002944-bbs2-0002" title="CooperCJ , MurphyTP , MatsumotoA , SteffesM , CohenDJ , JaffM , et al. Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trial. American Heart Journal2006;152(1):59‐66. CooperCJM , MurphyTP , CutlipDE , JamersonK , HenrichW , ReidDM , et al. Stenting and medical therapy for atherosclerotic renal‐artery stenosis. New England Journal of Medicine2014;370:13‐22. MatsumotoA , H , CooperC , MurphyT , CutlipD , ConawayM , et al. Severity of renal artery lesions in patients enrolled into the CORAL trial. Journal of Vascular and Interventional Radiology2010;21(2 Suppl 1):S19. MatsumotoAH , CooperCJ , MurphyTP , CutlipM , ConawayMR , DworkinL . Severity of renal artery lesions in patients enrolled into the CORAL trial. Cardiovascular and Interventional Radiological Society of Europe Annual Meeting Abstracts; 2008 Sep 13‐17; Copenhagen, Denmark2008:308. MurphyTP , CooperCJ , DworkinLD , HenrichWL , RundbackJH , MatsumotoAH , et al. The Cardiovascular Outcomes with Renal Atherosclerotic Lesions (CORAL) study: rationale and methods. Journal of Vascular and Interventional Radiology2005;16(10):1295‐300. NCT00081731 . Benefits of medical therapy plus stenting for renal atherosclerotic lesions. http://clinicaltrials.gov/ct/show/NCT00081731?order=1. [URL: http://clinicaltrials.gov/ct/show/NCT00081731?order=1] ">CORAL</a> trial. All of these three trials (<a href="./references#CD002944-bbs2-0001" title="ASTRAL Investigators, WheatleyK , IvesN , GrayR , KalraPA , MossJG , et al. Revascularization versus medical therapy for renal‐artery stenosis. New England Journal of Medicine2009;361(20):1953‐62. ISRCTN59586944 . Angioplasty and stent for renal artery lesions. ISRCTN Register2007. [URL: http://www.controlled‐trials.com/ISRCTN59586944/Angioplasty+stent+for+renal+artery+lesions] KalraP , MossJ , IvesN , HandleyK , GrayR , WheatleyK . Outcome of patients with highly significant and clinically relevant RAS within the ASTRAL trial. Renal Week 2008, 41st Annual Meeting &amp; Scientific Exposition; 2008 Nov 4‐9; Pennsylvania,USA2008. KalraPA , MossJ , IvesN , Fitzpatrick EllisK , GrayR , WheatleyK , et al. The impact of renal artery revascularization in atherosclerotic renovascular disease: the angioplasty and stenting for renal artery lesions (ASTRAL) trial [abstract no: 090]. Nephrology2008;13 Suppl 3:A123. MistryS , IvesN , HardingJ , Fitzpatrick‐EllisK , LipkinG , KalraPA , et al. Angioplasty and STent for Renal Artery Lesions (ASTRAL trial): rationale, methods and results so far. Journal of Human Hypertension2007;21(7):511‐5. MossJG . ASTRAL trial initial results. Cardiovascular and Interventional Radiological Society of Europe Annual Meeting Abstracts; 2008 Sep 13‐17; Copenhagen, Denmark2008:309. WheatleyK , KalraPA , MossJ , IvesN , Fitzpatrick‐EllisK , GrayR , et al. Lack of benefit of renal artery revascularization in atherosclerotic renovascular disease (ARVD): results of the ASTRAL trial. Renal Week 2008, 41st Annual Meeting &amp; Scientific Exposition; 2008 Nov 4‐9; Pennsylvania,USA2008. ">ASTRAL</a>; <a href="./references#CD002944-bbs2-0002" title="CooperCJ , MurphyTP , MatsumotoA , SteffesM , CohenDJ , JaffM , et al. Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trial. American Heart Journal2006;152(1):59‐66. CooperCJM , MurphyTP , CutlipDE , JamersonK , HenrichW , ReidDM , et al. Stenting and medical therapy for atherosclerotic renal‐artery stenosis. New England Journal of Medicine2014;370:13‐22. MatsumotoA , H , CooperC , MurphyT , CutlipD , ConawayM , et al. Severity of renal artery lesions in patients enrolled into the CORAL trial. Journal of Vascular and Interventional Radiology2010;21(2 Suppl 1):S19. MatsumotoAH , CooperCJ , MurphyTP , CutlipM , ConawayMR , DworkinL . Severity of renal artery lesions in patients enrolled into the CORAL trial. Cardiovascular and Interventional Radiological Society of Europe Annual Meeting Abstracts; 2008 Sep 13‐17; Copenhagen, Denmark2008:308. MurphyTP , CooperCJ , DworkinLD , HenrichWL , RundbackJH , MatsumotoAH , et al. The Cardiovascular Outcomes with Renal Atherosclerotic Lesions (CORAL) study: rationale and methods. Journal of Vascular and Interventional Radiology2005;16(10):1295‐300. NCT00081731 . Benefits of medical therapy plus stenting for renal atherosclerotic lesions. http://clinicaltrials.gov/ct/show/NCT00081731?order=1. [URL: http://clinicaltrials.gov/ct/show/NCT00081731?order=1] ">CORAL</a>; <a href="./references#CD002944-bbs2-0008" title="BaxL , MaliWP , BuskensE , KoomansHA , BeutlerJJ , BraamB , et al. The benefit of STent placement and blood pressure and lipid‐lowering for the prevention of progression of renal dysfunction caused by Atherosclerotic ostial stenosis of the Renal artery. The STAR‐study: rationale and study design. Journal of Nephrology2003;16(6):807‐12. BaxL , WoittiezAJ , KouwenbergHJ , MaliWP , BuskensE , BeekFJ , et al. Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial. Annals of Internal Medicine2009;150(12):840‐8. ">STAR</a>) analysed their data on an intention‐to‐treat basis. All participants allocated to balloon angioplasty in the <a href="./references#CD002944-bbs2-0004" title="PlouinPF , ChatellierG , DarnéB , RaynaudA . Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis. A randomized trial. Essai Multicentrique Medicaments vs Angioplastie (EMMA) Study Group. Hypertension1998;31(3):823‐9. Scottish and Newcastle Renovascular Collaborative Group. Prospective randomized trial of interventional (angioplasty) versus medical therapy in hypertensive patients with atheromatous renal artery stenosis. Journal of Hypertension1994; Vol. 12:1312. ">EMMA</a>, <a href="./references#CD002944-bbs2-0003" title="KrijnenP , vanJaarsveldBC , HuninkMG , HabbemaJD . The effect of treatment on health‐related quality of life in patients with hypertension and renal artery stenosis. Journal of Human Hypertension2005;19(6):467‐70. vanJaarsveldB , KrijnenP , BartelinkA , DeesAd , DerkxFH , Man in't VeldA , et al. The Dutch Renal Artery Stenosis Intervention Cooperative (DRASTIC) Study: rationale and inclusion data. Journal of Hypertension1998;16 Suppl 6:S21‐7. vanJaarsveldB , KrijnenP , BartelinkA , DeesAd , DerkxFH , Man in't VeldA , et al. The Dutch Renal Artery Stenosis Intervention Cooperative (DRASTIC) Study: rationale and inclusion data. Journal of Hypertension1998;16 Suppl 6:S21‐7. vanJaarsveldBC , KrijnenP . Prospective studies of diagnosis and intervention: the Dutch experience. Seminars in Nephrology2000;20(5):463‐73. vanJaarsveldBC , KrijnenP , PietermanH , DerkxF , DeinumJ , PostmaCT , et al. The effect of balloon angioplasty on hypertension in atherosclerotic renal artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group. New England Journal of Medicine2000;342(14):1007‐14. ">DRASTIC</a>, <a href="./references#CD002944-bbs2-0007" title="WebsterJ , MarshallF , AbdallaM , DominiczakA , EdwardsR , IslesCG , et al. Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. Scottish and Newcastle Renal Artery Stenosis Collaborative Group. Journal of Human Hypertension1998;12(5):329‐35. ">SNRASCG</a> and <a href="./references#CD002944-bbs2-0005" title="ScarpioniR , MichielettiE , CristinelliL , UgolottiU , ScolariF , VenturelliC , et al. Atherosclerotic renovascular disease: medical therapy versus medical therapy plus renal artery stenting in preventing renal failure progression: the rationale and study design of a prospective, multicenter and randomized trial (NITER). Journal of Nephrology2005;18(4):423‐8. ScarpioniR , MichielettiE , PavoneL . Atherosclerotic renovascular disease (ARVD): medical therapy plus renal artery stenting (PRTS), compared with medical therapy alone, do not offer more chances in preventing C‐V events or the progression of renal failure. Preliminary results of a prospective, multicenter and randomized trial. Abstract World Congress of Nephrology; May 22, 2009; Milan, Italy2009. ">NITER</a> trials underwent attempted revascularisation, although in five participants in the intervention group in the <a href="./references#CD002944-bbs2-0007" title="WebsterJ , MarshallF , AbdallaM , DominiczakA , EdwardsR , IslesCG , et al. Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. Scottish and Newcastle Renal Artery Stenosis Collaborative Group. Journal of Human Hypertension1998;12(5):329‐35. ">SNRASCG</a> trial this was in the form of either a vein bypass or a nephrectomy. Data for the <a href="./references#CD002944-bbs2-0006" title="SchwarzwalderU , HaukM , ZellerT . RADAR ‐ A randomised, multi‐centre, prospective study comparing best medical treatment versus best medical treatment plus renal artery stenting in patients with haemodynamically relevant atherosclerotic renal artery stenosis. Trials2009;10:60. [NCT00640406] ZellerT . RADAR ‐ Data of a prematurely terminated randomized, multi‐centre prospective study comparing best medical treatment versus best medical treatment plus renal artery stenting in patients with hemodynamically relevant atherosclerotic renal artery stenosis. VASA. Zeitschrift fur Gefasskrankheiten. Journal for Vascular Diseases2013;42:40. ">RADAR</a> trial were not available. </p> <p>In the <a href="./references#CD002944-bbs2-0007" title="WebsterJ , MarshallF , AbdallaM , DominiczakA , EdwardsR , IslesCG , et al. Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. Scottish and Newcastle Renal Artery Stenosis Collaborative Group. Journal of Human Hypertension1998;12(5):329‐35. ">SNRASCG</a> trial no patient in the balloon angioplasty group underwent stent insertion. In the <a href="./references#CD002944-bbs2-0003" title="KrijnenP , vanJaarsveldBC , HuninkMG , HabbemaJD . The effect of treatment on health‐related quality of life in patients with hypertension and renal artery stenosis. Journal of Human Hypertension2005;19(6):467‐70. vanJaarsveldB , KrijnenP , BartelinkA , DeesAd , DerkxFH , Man in't VeldA , et al. The Dutch Renal Artery Stenosis Intervention Cooperative (DRASTIC) Study: rationale and inclusion data. Journal of Hypertension1998;16 Suppl 6:S21‐7. vanJaarsveldB , KrijnenP , BartelinkA , DeesAd , DerkxFH , Man in't VeldA , et al. The Dutch Renal Artery Stenosis Intervention Cooperative (DRASTIC) Study: rationale and inclusion data. Journal of Hypertension1998;16 Suppl 6:S21‐7. vanJaarsveldBC , KrijnenP . Prospective studies of diagnosis and intervention: the Dutch experience. Seminars in Nephrology2000;20(5):463‐73. vanJaarsveldBC , KrijnenP , PietermanH , DerkxF , DeinumJ , PostmaCT , et al. The effect of balloon angioplasty on hypertension in atherosclerotic renal artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group. New England Journal of Medicine2000;342(14):1007‐14. ">DRASTIC</a> trial 2 of 56 (4%) participants assigned to balloon angioplasty received a stent compared with 2 of 23 (9%) participants in the <a href="./references#CD002944-bbs2-0004" title="PlouinPF , ChatellierG , DarnéB , RaynaudA . Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis. A randomized trial. Essai Multicentrique Medicaments vs Angioplastie (EMMA) Study Group. Hypertension1998;31(3):823‐9. Scottish and Newcastle Renovascular Collaborative Group. Prospective randomized trial of interventional (angioplasty) versus medical therapy in hypertensive patients with atheromatous renal artery stenosis. Journal of Hypertension1994; Vol. 12:1312. ">EMMA</a> trial; 46 of 64 (72%) in the <a href="./references#CD002944-bbs2-0008" title="BaxL , MaliWP , BuskensE , KoomansHA , BeutlerJJ , BraamB , et al. The benefit of STent placement and blood pressure and lipid‐lowering for the prevention of progression of renal dysfunction caused by Atherosclerotic ostial stenosis of the Renal artery. The STAR‐study: rationale and study design. Journal of Nephrology2003;16(6):807‐12. BaxL , WoittiezAJ , KouwenbergHJ , MaliWP , BuskensE , BeekFJ , et al. Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial. Annals of Internal Medicine2009;150(12):840‐8. ">STAR</a> trial; 317 of 403 (79%) in the <a href="./references#CD002944-bbs2-0001" title="ASTRAL Investigators, WheatleyK , IvesN , GrayR , KalraPA , MossJG , et al. Revascularization versus medical therapy for renal‐artery stenosis. New England Journal of Medicine2009;361(20):1953‐62. ISRCTN59586944 . Angioplasty and stent for renal artery lesions. ISRCTN Register2007. [URL: http://www.controlled‐trials.com/ISRCTN59586944/Angioplasty+stent+for+renal+artery+lesions] KalraP , MossJ , IvesN , HandleyK , GrayR , WheatleyK . Outcome of patients with highly significant and clinically relevant RAS within the ASTRAL trial. Renal Week 2008, 41st Annual Meeting &amp; Scientific Exposition; 2008 Nov 4‐9; Pennsylvania,USA2008. KalraPA , MossJ , IvesN , Fitzpatrick EllisK , GrayR , WheatleyK , et al. The impact of renal artery revascularization in atherosclerotic renovascular disease: the angioplasty and stenting for renal artery lesions (ASTRAL) trial [abstract no: 090]. Nephrology2008;13 Suppl 3:A123. MistryS , IvesN , HardingJ , Fitzpatrick‐EllisK , LipkinG , KalraPA , et al. Angioplasty and STent for Renal Artery Lesions (ASTRAL trial): rationale, methods and results so far. Journal of Human Hypertension2007;21(7):511‐5. MossJG . ASTRAL trial initial results. Cardiovascular and Interventional Radiological Society of Europe Annual Meeting Abstracts; 2008 Sep 13‐17; Copenhagen, Denmark2008:309. WheatleyK , KalraPA , MossJ , IvesN , Fitzpatrick‐EllisK , GrayR , et al. Lack of benefit of renal artery revascularization in atherosclerotic renovascular disease (ARVD): results of the ASTRAL trial. Renal Week 2008, 41st Annual Meeting &amp; Scientific Exposition; 2008 Nov 4‐9; Pennsylvania,USA2008. ">ASTRAL</a> trial and 442 out of 467 (95%) in the <a href="./references#CD002944-bbs2-0002" title="CooperCJ , MurphyTP , MatsumotoA , SteffesM , CohenDJ , JaffM , et al. Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trial. American Heart Journal2006;152(1):59‐66. CooperCJM , MurphyTP , CutlipDE , JamersonK , HenrichW , ReidDM , et al. Stenting and medical therapy for atherosclerotic renal‐artery stenosis. New England Journal of Medicine2014;370:13‐22. MatsumotoA , H , CooperC , MurphyT , CutlipD , ConawayM , et al. Severity of renal artery lesions in patients enrolled into the CORAL trial. Journal of Vascular and Interventional Radiology2010;21(2 Suppl 1):S19. MatsumotoAH , CooperCJ , MurphyTP , CutlipM , ConawayMR , DworkinL . Severity of renal artery lesions in patients enrolled into the CORAL trial. Cardiovascular and Interventional Radiological Society of Europe Annual Meeting Abstracts; 2008 Sep 13‐17; Copenhagen, Denmark2008:308. MurphyTP , CooperCJ , DworkinLD , HenrichWL , RundbackJH , MatsumotoAH , et al. The Cardiovascular Outcomes with Renal Atherosclerotic Lesions (CORAL) study: rationale and methods. Journal of Vascular and Interventional Radiology2005;16(10):1295‐300. NCT00081731 . Benefits of medical therapy plus stenting for renal atherosclerotic lesions. http://clinicaltrials.gov/ct/show/NCT00081731?order=1. [URL: http://clinicaltrials.gov/ct/show/NCT00081731?order=1] ">CORAL</a> trial. All of the participants assigned to angioplasty underwent stent insertion in the <a href="./references#CD002944-bbs2-0005" title="ScarpioniR , MichielettiE , CristinelliL , UgolottiU , ScolariF , VenturelliC , et al. Atherosclerotic renovascular disease: medical therapy versus medical therapy plus renal artery stenting in preventing renal failure progression: the rationale and study design of a prospective, multicenter and randomized trial (NITER). Journal of Nephrology2005;18(4):423‐8. ScarpioniR , MichielettiE , PavoneL . Atherosclerotic renovascular disease (ARVD): medical therapy plus renal artery stenting (PRTS), compared with medical therapy alone, do not offer more chances in preventing C‐V events or the progression of renal failure. Preliminary results of a prospective, multicenter and randomized trial. Abstract World Congress of Nephrology; May 22, 2009; Milan, Italy2009. ">NITER</a> trial. Data for the <a href="./references#CD002944-bbs2-0006" title="SchwarzwalderU , HaukM , ZellerT . RADAR ‐ A randomised, multi‐centre, prospective study comparing best medical treatment versus best medical treatment plus renal artery stenting in patients with haemodynamically relevant atherosclerotic renal artery stenosis. Trials2009;10:60. [NCT00640406] ZellerT . RADAR ‐ Data of a prematurely terminated randomized, multi‐centre prospective study comparing best medical treatment versus best medical treatment plus renal artery stenting in patients with hemodynamically relevant atherosclerotic renal artery stenosis. VASA. Zeitschrift fur Gefasskrankheiten. Journal for Vascular Diseases2013;42:40. ">RADAR</a> trial were not available. </p> <p>There was a large variation between trials in the proportion of participants crossing over from medical treatment to balloon angioplasty. In the <a href="./references#CD002944-bbs2-0004" title="PlouinPF , ChatellierG , DarnéB , RaynaudA . Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis. A randomized trial. Essai Multicentrique Medicaments vs Angioplastie (EMMA) Study Group. Hypertension1998;31(3):823‐9. Scottish and Newcastle Renovascular Collaborative Group. Prospective randomized trial of interventional (angioplasty) versus medical therapy in hypertensive patients with atheromatous renal artery stenosis. Journal of Hypertension1994; Vol. 12:1312. ">EMMA</a> trial seven of 26 (27%) participants assigned to medical therapy stopped drug treatment early due to refractory hypertension (defined as diastolic BP greater than 104 mmHg despite a maximal tolerated antihypertensive regimen) and subsequently underwent angioplasty. The clinical characteristics of these seven participants immediately before angioplasty were used for data analysis. In the <a href="./references#CD002944-bbs2-0003" title="KrijnenP , vanJaarsveldBC , HuninkMG , HabbemaJD . The effect of treatment on health‐related quality of life in patients with hypertension and renal artery stenosis. Journal of Human Hypertension2005;19(6):467‐70. vanJaarsveldB , KrijnenP , BartelinkA , DeesAd , DerkxFH , Man in't VeldA , et al. The Dutch Renal Artery Stenosis Intervention Cooperative (DRASTIC) Study: rationale and inclusion data. Journal of Hypertension1998;16 Suppl 6:S21‐7. vanJaarsveldB , KrijnenP , BartelinkA , DeesAd , DerkxFH , Man in't VeldA , et al. The Dutch Renal Artery Stenosis Intervention Cooperative (DRASTIC) Study: rationale and inclusion data. Journal of Hypertension1998;16 Suppl 6:S21‐7. vanJaarsveldBC , KrijnenP . Prospective studies of diagnosis and intervention: the Dutch experience. Seminars in Nephrology2000;20(5):463‐73. vanJaarsveldBC , KrijnenP , PietermanH , DerkxF , DeinumJ , PostmaCT , et al. The effect of balloon angioplasty on hypertension in atherosclerotic renal artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group. New England Journal of Medicine2000;342(14):1007‐14. ">DRASTIC</a> trial 22 of 50 (44%) participants underwent angioplasty due to diastolic BP measures greater than 95 mmHg despite treatment with three or more antihypertensive drugs; or progressive renovascular occlusive disease, defined as an increase of at least 18 µmol/L in serum creatinine or worsening of the time‐activity renogram on scintigraphy, after three months of medical therapy. The data from these participants were analysed in the medical therapy group at 12 months follow‐up although they had undergone balloon angioplasty after three months follow‐up. In the <a href="./references#CD002944-bbs2-0008" title="BaxL , MaliWP , BuskensE , KoomansHA , BeutlerJJ , BraamB , et al. The benefit of STent placement and blood pressure and lipid‐lowering for the prevention of progression of renal dysfunction caused by Atherosclerotic ostial stenosis of the Renal artery. The STAR‐study: rationale and study design. Journal of Nephrology2003;16(6):807‐12. BaxL , WoittiezAJ , KouwenbergHJ , MaliWP , BuskensE , BeekFJ , et al. Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial. Annals of Internal Medicine2009;150(12):840‐8. ">STAR</a> trial one out of 76 participants (1%) underwent angioplasty with stenting due to refractory hypertension (defined as BP greater than &gt; 180/100 mmHg despite a maximal tolerated antihypertensive regime). The data for this one participant were included in the medical therapy group follow‐up data. In the <a href="./references#CD002944-bbs2-0001" title="ASTRAL Investigators, WheatleyK , IvesN , GrayR , KalraPA , MossJG , et al. Revascularization versus medical therapy for renal‐artery stenosis. New England Journal of Medicine2009;361(20):1953‐62. ISRCTN59586944 . Angioplasty and stent for renal artery lesions. ISRCTN Register2007. [URL: http://www.controlled‐trials.com/ISRCTN59586944/Angioplasty+stent+for+renal+artery+lesions] KalraP , MossJ , IvesN , HandleyK , GrayR , WheatleyK . Outcome of patients with highly significant and clinically relevant RAS within the ASTRAL trial. Renal Week 2008, 41st Annual Meeting &amp; Scientific Exposition; 2008 Nov 4‐9; Pennsylvania,USA2008. KalraPA , MossJ , IvesN , Fitzpatrick EllisK , GrayR , WheatleyK , et al. The impact of renal artery revascularization in atherosclerotic renovascular disease: the angioplasty and stenting for renal artery lesions (ASTRAL) trial [abstract no: 090]. Nephrology2008;13 Suppl 3:A123. MistryS , IvesN , HardingJ , Fitzpatrick‐EllisK , LipkinG , KalraPA , et al. Angioplasty and STent for Renal Artery Lesions (ASTRAL trial): rationale, methods and results so far. Journal of Human Hypertension2007;21(7):511‐5. MossJG . ASTRAL trial initial results. Cardiovascular and Interventional Radiological Society of Europe Annual Meeting Abstracts; 2008 Sep 13‐17; Copenhagen, Denmark2008:309. WheatleyK , KalraPA , MossJ , IvesN , Fitzpatrick‐EllisK , GrayR , et al. Lack of benefit of renal artery revascularization in atherosclerotic renovascular disease (ARVD): results of the ASTRAL trial. Renal Week 2008, 41st Annual Meeting &amp; Scientific Exposition; 2008 Nov 4‐9; Pennsylvania,USA2008. ">ASTRAL</a> trial 24 out of 403 (6%) underwent balloon angioplasty. The specific reasons for participants crossing over were not given and these participants were included in the medical treatment group follow‐up data. In the <a href="./references#CD002944-bbs2-0002" title="CooperCJ , MurphyTP , MatsumotoA , SteffesM , CohenDJ , JaffM , et al. Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trial. American Heart Journal2006;152(1):59‐66. CooperCJM , MurphyTP , CutlipDE , JamersonK , HenrichW , ReidDM , et al. Stenting and medical therapy for atherosclerotic renal‐artery stenosis. New England Journal of Medicine2014;370:13‐22. MatsumotoA , H , CooperC , MurphyT , CutlipD , ConawayM , et al. Severity of renal artery lesions in patients enrolled into the CORAL trial. Journal of Vascular and Interventional Radiology2010;21(2 Suppl 1):S19. MatsumotoAH , CooperCJ , MurphyTP , CutlipM , ConawayMR , DworkinL . Severity of renal artery lesions in patients enrolled into the CORAL trial. Cardiovascular and Interventional Radiological Society of Europe Annual Meeting Abstracts; 2008 Sep 13‐17; Copenhagen, Denmark2008:308. MurphyTP , CooperCJ , DworkinLD , HenrichWL , RundbackJH , MatsumotoAH , et al. The Cardiovascular Outcomes with Renal Atherosclerotic Lesions (CORAL) study: rationale and methods. Journal of Vascular and Interventional Radiology2005;16(10):1295‐300. NCT00081731 . Benefits of medical therapy plus stenting for renal atherosclerotic lesions. http://clinicaltrials.gov/ct/show/NCT00081731?order=1. [URL: http://clinicaltrials.gov/ct/show/NCT00081731?order=1] ">CORAL</a> trial 19 out of 480 (4%) crossed over. They were included in the intention‐to‐treat analysis in the medical treatment group. No participants in the <a href="./references#CD002944-bbs2-0007" title="WebsterJ , MarshallF , AbdallaM , DominiczakA , EdwardsR , IslesCG , et al. Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. Scottish and Newcastle Renal Artery Stenosis Collaborative Group. Journal of Human Hypertension1998;12(5):329‐35. ">SNRASCG</a> trial that were assigned to medical treatment subsequently underwent balloon angioplasty. Data for the <a href="./references#CD002944-bbs2-0006" title="SchwarzwalderU , HaukM , ZellerT . RADAR ‐ A randomised, multi‐centre, prospective study comparing best medical treatment versus best medical treatment plus renal artery stenting in patients with haemodynamically relevant atherosclerotic renal artery stenosis. Trials2009;10:60. [NCT00640406] ZellerT . RADAR ‐ Data of a prematurely terminated randomized, multi‐centre prospective study comparing best medical treatment versus best medical treatment plus renal artery stenting in patients with hemodynamically relevant atherosclerotic renal artery stenosis. VASA. Zeitschrift fur Gefasskrankheiten. Journal for Vascular Diseases2013;42:40. ">RADAR</a> and <a href="./references#CD002944-bbs2-0005" title="ScarpioniR , MichielettiE , CristinelliL , UgolottiU , ScolariF , VenturelliC , et al. Atherosclerotic renovascular disease: medical therapy versus medical therapy plus renal artery stenting in preventing renal failure progression: the rationale and study design of a prospective, multicenter and randomized trial (NITER). Journal of Nephrology2005;18(4):423‐8. ScarpioniR , MichielettiE , PavoneL . Atherosclerotic renovascular disease (ARVD): medical therapy plus renal artery stenting (PRTS), compared with medical therapy alone, do not offer more chances in preventing C‐V events or the progression of renal failure. Preliminary results of a prospective, multicenter and randomized trial. Abstract World Congress of Nephrology; May 22, 2009; Milan, Italy2009. ">NITER</a> trials were not available. </p> <p>In the <a href="./references#CD002944-bbs2-0004" title="PlouinPF , ChatellierG , DarnéB , RaynaudA . Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis. A randomized trial. Essai Multicentrique Medicaments vs Angioplastie (EMMA) Study Group. Hypertension1998;31(3):823‐9. Scottish and Newcastle Renovascular Collaborative Group. Prospective randomized trial of interventional (angioplasty) versus medical therapy in hypertensive patients with atheromatous renal artery stenosis. Journal of Hypertension1994; Vol. 12:1312. ">EMMA</a> trial ambulatory BP was the primary outcome of the study, whereas the <a href="./references#CD002944-bbs2-0007" title="WebsterJ , MarshallF , AbdallaM , DominiczakA , EdwardsR , IslesCG , et al. Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. Scottish and Newcastle Renal Artery Stenosis Collaborative Group. Journal of Human Hypertension1998;12(5):329‐35. ">SNRASCG</a> and <a href="./references#CD002944-bbs2-0003" title="KrijnenP , vanJaarsveldBC , HuninkMG , HabbemaJD . The effect of treatment on health‐related quality of life in patients with hypertension and renal artery stenosis. Journal of Human Hypertension2005;19(6):467‐70. vanJaarsveldB , KrijnenP , BartelinkA , DeesAd , DerkxFH , Man in't VeldA , et al. The Dutch Renal Artery Stenosis Intervention Cooperative (DRASTIC) Study: rationale and inclusion data. Journal of Hypertension1998;16 Suppl 6:S21‐7. vanJaarsveldB , KrijnenP , BartelinkA , DeesAd , DerkxFH , Man in't VeldA , et al. The Dutch Renal Artery Stenosis Intervention Cooperative (DRASTIC) Study: rationale and inclusion data. Journal of Hypertension1998;16 Suppl 6:S21‐7. vanJaarsveldBC , KrijnenP . Prospective studies of diagnosis and intervention: the Dutch experience. Seminars in Nephrology2000;20(5):463‐73. vanJaarsveldBC , KrijnenP , PietermanH , DerkxF , DeinumJ , PostmaCT , et al. The effect of balloon angioplasty on hypertension in atherosclerotic renal artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group. New England Journal of Medicine2000;342(14):1007‐14. ">DRASTIC</a> trials used office BP as the primary outcome measure (office BP is the average of three sitting BP measurements taken in the presence of a physician after five minutes rest). The more recent <a href="./references#CD002944-bbs2-0001" title="ASTRAL Investigators, WheatleyK , IvesN , GrayR , KalraPA , MossJG , et al. Revascularization versus medical therapy for renal‐artery stenosis. New England Journal of Medicine2009;361(20):1953‐62. ISRCTN59586944 . Angioplasty and stent for renal artery lesions. ISRCTN Register2007. [URL: http://www.controlled‐trials.com/ISRCTN59586944/Angioplasty+stent+for+renal+artery+lesions] KalraP , MossJ , IvesN , HandleyK , GrayR , WheatleyK . Outcome of patients with highly significant and clinically relevant RAS within the ASTRAL trial. Renal Week 2008, 41st Annual Meeting &amp; Scientific Exposition; 2008 Nov 4‐9; Pennsylvania,USA2008. KalraPA , MossJ , IvesN , Fitzpatrick EllisK , GrayR , WheatleyK , et al. The impact of renal artery revascularization in atherosclerotic renovascular disease: the angioplasty and stenting for renal artery lesions (ASTRAL) trial [abstract no: 090]. Nephrology2008;13 Suppl 3:A123. MistryS , IvesN , HardingJ , Fitzpatrick‐EllisK , LipkinG , KalraPA , et al. Angioplasty and STent for Renal Artery Lesions (ASTRAL trial): rationale, methods and results so far. Journal of Human Hypertension2007;21(7):511‐5. MossJG . ASTRAL trial initial results. Cardiovascular and Interventional Radiological Society of Europe Annual Meeting Abstracts; 2008 Sep 13‐17; Copenhagen, Denmark2008:309. WheatleyK , KalraPA , MossJ , IvesN , Fitzpatrick‐EllisK , GrayR , et al. Lack of benefit of renal artery revascularization in atherosclerotic renovascular disease (ARVD): results of the ASTRAL trial. Renal Week 2008, 41st Annual Meeting &amp; Scientific Exposition; 2008 Nov 4‐9; Pennsylvania,USA2008. ">ASTRAL</a> and <a href="./references#CD002944-bbs2-0008" title="BaxL , MaliWP , BuskensE , KoomansHA , BeutlerJJ , BraamB , et al. The benefit of STent placement and blood pressure and lipid‐lowering for the prevention of progression of renal dysfunction caused by Atherosclerotic ostial stenosis of the Renal artery. The STAR‐study: rationale and study design. Journal of Nephrology2003;16(6):807‐12. BaxL , WoittiezAJ , KouwenbergHJ , MaliWP , BuskensE , BeekFJ , et al. Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial. Annals of Internal Medicine2009;150(12):840‐8. ">STAR</a> trials both defined renal endpoints as their primary outcomes with the <a href="./references#CD002944-bbs2-0001" title="ASTRAL Investigators, WheatleyK , IvesN , GrayR , KalraPA , MossJG , et al. Revascularization versus medical therapy for renal‐artery stenosis. New England Journal of Medicine2009;361(20):1953‐62. ISRCTN59586944 . Angioplasty and stent for renal artery lesions. ISRCTN Register2007. [URL: http://www.controlled‐trials.com/ISRCTN59586944/Angioplasty+stent+for+renal+artery+lesions] KalraP , MossJ , IvesN , HandleyK , GrayR , WheatleyK . Outcome of patients with highly significant and clinically relevant RAS within the ASTRAL trial. Renal Week 2008, 41st Annual Meeting &amp; Scientific Exposition; 2008 Nov 4‐9; Pennsylvania,USA2008. KalraPA , MossJ , IvesN , Fitzpatrick EllisK , GrayR , WheatleyK , et al. The impact of renal artery revascularization in atherosclerotic renovascular disease: the angioplasty and stenting for renal artery lesions (ASTRAL) trial [abstract no: 090]. Nephrology2008;13 Suppl 3:A123. MistryS , IvesN , HardingJ , Fitzpatrick‐EllisK , LipkinG , KalraPA , et al. Angioplasty and STent for Renal Artery Lesions (ASTRAL trial): rationale, methods and results so far. Journal of Human Hypertension2007;21(7):511‐5. MossJG . ASTRAL trial initial results. Cardiovascular and Interventional Radiological Society of Europe Annual Meeting Abstracts; 2008 Sep 13‐17; Copenhagen, Denmark2008:309. WheatleyK , KalraPA , MossJ , IvesN , Fitzpatrick‐EllisK , GrayR , et al. Lack of benefit of renal artery revascularization in atherosclerotic renovascular disease (ARVD): results of the ASTRAL trial. Renal Week 2008, 41st Annual Meeting &amp; Scientific Exposition; 2008 Nov 4‐9; Pennsylvania,USA2008. ">ASTRAL</a> trial assessing the change in renal function (measured by the mean slope of the reciprocal of the serum creatinine level over time) and the <a href="./references#CD002944-bbs2-0008" title="BaxL , MaliWP , BuskensE , KoomansHA , BeutlerJJ , BraamB , et al. The benefit of STent placement and blood pressure and lipid‐lowering for the prevention of progression of renal dysfunction caused by Atherosclerotic ostial stenosis of the Renal artery. The STAR‐study: rationale and study design. Journal of Nephrology2003;16(6):807‐12. BaxL , WoittiezAJ , KouwenbergHJ , MaliWP , BuskensE , BeekFJ , et al. Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial. Annals of Internal Medicine2009;150(12):840‐8. ">STAR</a> trial assessing worsening renal function (defined as a 20% or greater decrease in estimated creatinine clearance compared with baseline). Changes in BP were measured in both studies as a secondary outcome. The primary outcome of the <a href="./references#CD002944-bbs2-0005" title="ScarpioniR , MichielettiE , CristinelliL , UgolottiU , ScolariF , VenturelliC , et al. Atherosclerotic renovascular disease: medical therapy versus medical therapy plus renal artery stenting in preventing renal failure progression: the rationale and study design of a prospective, multicenter and randomized trial (NITER). Journal of Nephrology2005;18(4):423‐8. ScarpioniR , MichielettiE , PavoneL . Atherosclerotic renovascular disease (ARVD): medical therapy plus renal artery stenting (PRTS), compared with medical therapy alone, do not offer more chances in preventing C‐V events or the progression of renal failure. Preliminary results of a prospective, multicenter and randomized trial. Abstract World Congress of Nephrology; May 22, 2009; Milan, Italy2009. ">NITER</a> trial was unclear as full details of this study have not yet been published. The <a href="./references#CD002944-bbs2-0002" title="CooperCJ , MurphyTP , MatsumotoA , SteffesM , CohenDJ , JaffM , et al. Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trial. American Heart Journal2006;152(1):59‐66. CooperCJM , MurphyTP , CutlipDE , JamersonK , HenrichW , ReidDM , et al. Stenting and medical therapy for atherosclerotic renal‐artery stenosis. New England Journal of Medicine2014;370:13‐22. MatsumotoA , H , CooperC , MurphyT , CutlipD , ConawayM , et al. Severity of renal artery lesions in patients enrolled into the CORAL trial. Journal of Vascular and Interventional Radiology2010;21(2 Suppl 1):S19. MatsumotoAH , CooperCJ , MurphyTP , CutlipM , ConawayMR , DworkinL . Severity of renal artery lesions in patients enrolled into the CORAL trial. Cardiovascular and Interventional Radiological Society of Europe Annual Meeting Abstracts; 2008 Sep 13‐17; Copenhagen, Denmark2008:308. MurphyTP , CooperCJ , DworkinLD , HenrichWL , RundbackJH , MatsumotoAH , et al. The Cardiovascular Outcomes with Renal Atherosclerotic Lesions (CORAL) study: rationale and methods. Journal of Vascular and Interventional Radiology2005;16(10):1295‐300. NCT00081731 . Benefits of medical therapy plus stenting for renal atherosclerotic lesions. http://clinicaltrials.gov/ct/show/NCT00081731?order=1. [URL: http://clinicaltrials.gov/ct/show/NCT00081731?order=1] ">CORAL</a> trial had a primary outcome that was a composite of adverse cardiovascular and renal events. The <a href="./references#CD002944-bbs2-0006" title="SchwarzwalderU , HaukM , ZellerT . RADAR ‐ A randomised, multi‐centre, prospective study comparing best medical treatment versus best medical treatment plus renal artery stenting in patients with haemodynamically relevant atherosclerotic renal artery stenosis. Trials2009;10:60. [NCT00640406] ZellerT . RADAR ‐ Data of a prematurely terminated randomized, multi‐centre prospective study comparing best medical treatment versus best medical treatment plus renal artery stenting in patients with hemodynamically relevant atherosclerotic renal artery stenosis. VASA. Zeitschrift fur Gefasskrankheiten. Journal for Vascular Diseases2013;42:40. ">RADAR</a> trial primary endpoint was the change in estimated glomerular filtration (eGFR) rate over 12 months. </p> <p>The <a href="./references#CD002944-bbs2-0007" title="WebsterJ , MarshallF , AbdallaM , DominiczakA , EdwardsR , IslesCG , et al. Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. Scottish and Newcastle Renal Artery Stenosis Collaborative Group. Journal of Human Hypertension1998;12(5):329‐35. ">SNRASCG</a> trial presented the results for participants with bilateral renal artery stenosis separately from those with unilateral stenosis. These results were pooled to enable comparison with the five other studies which did not present separate analyses for participants with uni‐ and bilateral stenoses. </p> <p>For further details see <a href="./references#CD002944-sec-0085" title="">Characteristics of included studies</a>. </p> </section> <section id="CD002944-sec-0048"> <h4 class="title">Excluded studies</h4> <p>Two studies were excluded in this update because they did not meet the inclusion criteria. One was excluded as it was not a randomised controlled trial (<a href="./references#CD002944-bbs2-0010" title="ZiakkaS , UrsuM , PoulikakosD , PapadopoulosC , KarakasisF , KaperonisN , et al. Predictive factors and therapeutic approach of renovascular disease: four years' follow‐up. Renal Failure2008;30(10):965‐70. ">Ziakka 2008</a>) and the other as it compared surgery to balloon angioplasty without a medical treatment control group (<a href="./references#CD002944-bbs2-0009" title="BalzerKM , PfeifferT , RossbachS , VoiculescuA , ModderU , GodehardtE , et al. Prospective randomized trial of operative vs interventional treatment for renal artery ostial occlusive disease (RAOOD). Journal of Vascular Surgery2009;49(3):667‐75. ">Balzer 2009</a>). See <a href="./references#CD002944-sec-0086" title="">Characteristics of excluded studies</a> for further details. </p> </section> </section> <section id="CD002944-sec-0049"> <h3 class="title">Risk of bias in included studies</h3> <p>The methodologic quality of the included trials varied substantially. See <a href="#CD002944-fig-0002">Figure 2</a> and <a href="#CD002944-fig-0003">Figure 3</a> for a graphical presentation of the risk of bias. Insufﬁcient information was the main reason for an 'unclear' rating being given. The methods used for two of the trials (<a href="./references#CD002944-bbs2-0005" title="ScarpioniR , MichielettiE , CristinelliL , UgolottiU , ScolariF , VenturelliC , et al. Atherosclerotic renovascular disease: medical therapy versus medical therapy plus renal artery stenting in preventing renal failure progression: the rationale and study design of a prospective, multicenter and randomized trial (NITER). Journal of Nephrology2005;18(4):423‐8. ScarpioniR , MichielettiE , PavoneL . Atherosclerotic renovascular disease (ARVD): medical therapy plus renal artery stenting (PRTS), compared with medical therapy alone, do not offer more chances in preventing C‐V events or the progression of renal failure. Preliminary results of a prospective, multicenter and randomized trial. Abstract World Congress of Nephrology; May 22, 2009; Milan, Italy2009. ">NITER</a>; <a href="./references#CD002944-bbs2-0006" title="SchwarzwalderU , HaukM , ZellerT . RADAR ‐ A randomised, multi‐centre, prospective study comparing best medical treatment versus best medical treatment plus renal artery stenting in patients with haemodynamically relevant atherosclerotic renal artery stenosis. Trials2009;10:60. [NCT00640406] ZellerT . RADAR ‐ Data of a prematurely terminated randomized, multi‐centre prospective study comparing best medical treatment versus best medical treatment plus renal artery stenting in patients with hemodynamically relevant atherosclerotic renal artery stenosis. VASA. Zeitschrift fur Gefasskrankheiten. Journal for Vascular Diseases2013;42:40. ">RADAR</a>) have not yet been fully published and there was therefore insufficient information to assess the risk of bias of these studies. The description of bias given below therefore relates to the six studies for which methodological information was available. </p> <div class="figure" id="CD002944-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD002944-fig-0002" src="/cdsr/doi/10.1002/14651858.CD002944.pub2/media/CDSR/CD002944/image_n/nCD002944-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD002944-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD002944-fig-0003" src="/cdsr/doi/10.1002/14651858.CD002944.pub2/media/CDSR/CD002944/image_n/nCD002944-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD002944-sec-0050"> <h4 class="title">Allocation</h4> <p>Four of the studies adequately described the random sequence generation used (<a href="./references#CD002944-bbs2-0001" title="ASTRAL Investigators, WheatleyK , IvesN , GrayR , KalraPA , MossJG , et al. Revascularization versus medical therapy for renal‐artery stenosis. New England Journal of Medicine2009;361(20):1953‐62. ISRCTN59586944 . Angioplasty and stent for renal artery lesions. ISRCTN Register2007. [URL: http://www.controlled‐trials.com/ISRCTN59586944/Angioplasty+stent+for+renal+artery+lesions] KalraP , MossJ , IvesN , HandleyK , GrayR , WheatleyK . Outcome of patients with highly significant and clinically relevant RAS within the ASTRAL trial. Renal Week 2008, 41st Annual Meeting &amp; Scientific Exposition; 2008 Nov 4‐9; Pennsylvania,USA2008. KalraPA , MossJ , IvesN , Fitzpatrick EllisK , GrayR , WheatleyK , et al. The impact of renal artery revascularization in atherosclerotic renovascular disease: the angioplasty and stenting for renal artery lesions (ASTRAL) trial [abstract no: 090]. Nephrology2008;13 Suppl 3:A123. MistryS , IvesN , HardingJ , Fitzpatrick‐EllisK , LipkinG , KalraPA , et al. Angioplasty and STent for Renal Artery Lesions (ASTRAL trial): rationale, methods and results so far. Journal of Human Hypertension2007;21(7):511‐5. MossJG . ASTRAL trial initial results. Cardiovascular and Interventional Radiological Society of Europe Annual Meeting Abstracts; 2008 Sep 13‐17; Copenhagen, Denmark2008:309. WheatleyK , KalraPA , MossJ , IvesN , Fitzpatrick‐EllisK , GrayR , et al. Lack of benefit of renal artery revascularization in atherosclerotic renovascular disease (ARVD): results of the ASTRAL trial. Renal Week 2008, 41st Annual Meeting &amp; Scientific Exposition; 2008 Nov 4‐9; Pennsylvania,USA2008. ">ASTRAL</a>; <a href="./references#CD002944-bbs2-0002" title="CooperCJ , MurphyTP , MatsumotoA , SteffesM , CohenDJ , JaffM , et al. Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trial. American Heart Journal2006;152(1):59‐66. CooperCJM , MurphyTP , CutlipDE , JamersonK , HenrichW , ReidDM , et al. Stenting and medical therapy for atherosclerotic renal‐artery stenosis. New England Journal of Medicine2014;370:13‐22. MatsumotoA , H , CooperC , MurphyT , CutlipD , ConawayM , et al. Severity of renal artery lesions in patients enrolled into the CORAL trial. Journal of Vascular and Interventional Radiology2010;21(2 Suppl 1):S19. MatsumotoAH , CooperCJ , MurphyTP , CutlipM , ConawayMR , DworkinL . Severity of renal artery lesions in patients enrolled into the CORAL trial. Cardiovascular and Interventional Radiological Society of Europe Annual Meeting Abstracts; 2008 Sep 13‐17; Copenhagen, Denmark2008:308. MurphyTP , CooperCJ , DworkinLD , HenrichWL , RundbackJH , MatsumotoAH , et al. The Cardiovascular Outcomes with Renal Atherosclerotic Lesions (CORAL) study: rationale and methods. Journal of Vascular and Interventional Radiology2005;16(10):1295‐300. NCT00081731 . Benefits of medical therapy plus stenting for renal atherosclerotic lesions. http://clinicaltrials.gov/ct/show/NCT00081731?order=1. [URL: http://clinicaltrials.gov/ct/show/NCT00081731?order=1] ">CORAL</a>; <a href="./references#CD002944-bbs2-0003" title="KrijnenP , vanJaarsveldBC , HuninkMG , HabbemaJD . The effect of treatment on health‐related quality of life in patients with hypertension and renal artery stenosis. Journal of Human Hypertension2005;19(6):467‐70. vanJaarsveldB , KrijnenP , BartelinkA , DeesAd , DerkxFH , Man in't VeldA , et al. The Dutch Renal Artery Stenosis Intervention Cooperative (DRASTIC) Study: rationale and inclusion data. Journal of Hypertension1998;16 Suppl 6:S21‐7. vanJaarsveldB , KrijnenP , BartelinkA , DeesAd , DerkxFH , Man in't VeldA , et al. The Dutch Renal Artery Stenosis Intervention Cooperative (DRASTIC) Study: rationale and inclusion data. Journal of Hypertension1998;16 Suppl 6:S21‐7. vanJaarsveldBC , KrijnenP . Prospective studies of diagnosis and intervention: the Dutch experience. Seminars in Nephrology2000;20(5):463‐73. vanJaarsveldBC , KrijnenP , PietermanH , DerkxF , DeinumJ , PostmaCT , et al. The effect of balloon angioplasty on hypertension in atherosclerotic renal artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group. New England Journal of Medicine2000;342(14):1007‐14. ">DRASTIC</a>; <a href="./references#CD002944-bbs2-0008" title="BaxL , MaliWP , BuskensE , KoomansHA , BeutlerJJ , BraamB , et al. The benefit of STent placement and blood pressure and lipid‐lowering for the prevention of progression of renal dysfunction caused by Atherosclerotic ostial stenosis of the Renal artery. The STAR‐study: rationale and study design. Journal of Nephrology2003;16(6):807‐12. BaxL , WoittiezAJ , KouwenbergHJ , MaliWP , BuskensE , BeekFJ , et al. Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial. Annals of Internal Medicine2009;150(12):840‐8. ">STAR</a>) with all three using computer generated randomisation. The remaining studies (<a href="./references#CD002944-bbs2-0004" title="PlouinPF , ChatellierG , DarnéB , RaynaudA . Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis. A randomized trial. Essai Multicentrique Medicaments vs Angioplastie (EMMA) Study Group. Hypertension1998;31(3):823‐9. Scottish and Newcastle Renovascular Collaborative Group. Prospective randomized trial of interventional (angioplasty) versus medical therapy in hypertensive patients with atheromatous renal artery stenosis. Journal of Hypertension1994; Vol. 12:1312. ">EMMA</a>; <a href="./references#CD002944-bbs2-0007" title="WebsterJ , MarshallF , AbdallaM , DominiczakA , EdwardsR , IslesCG , et al. Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. Scottish and Newcastle Renal Artery Stenosis Collaborative Group. Journal of Human Hypertension1998;12(5):329‐35. ">SNRASCG</a>) did not state the method used to generate the allocation sequence and therefore the risk of selection bias was unclear for these studies. </p> </section> <section id="CD002944-sec-0051"> <h4 class="title">Blinding</h4> <p>Participants could not be blinded due to the nature of the trials. In one trial (<a href="./references#CD002944-bbs2-0007" title="WebsterJ , MarshallF , AbdallaM , DominiczakA , EdwardsR , IslesCG , et al. Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. Scottish and Newcastle Renal Artery Stenosis Collaborative Group. Journal of Human Hypertension1998;12(5):329‐35. ">SNRASCG</a>) the evaluators performing BP measurement were blinded to the participants' allocation. In another trial (<a href="./references#CD002944-bbs2-0004" title="PlouinPF , ChatellierG , DarnéB , RaynaudA . Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis. A randomized trial. Essai Multicentrique Medicaments vs Angioplastie (EMMA) Study Group. Hypertension1998;31(3):823‐9. Scottish and Newcastle Renovascular Collaborative Group. Prospective randomized trial of interventional (angioplasty) versus medical therapy in hypertensive patients with atheromatous renal artery stenosis. Journal of Hypertension1994; Vol. 12:1312. ">EMMA</a>) the evaluators were not blinded but an objective outcome measurement (ambulatory BP monitoring) was used. In other trials (<a href="./references#CD002944-bbs2-0001" title="ASTRAL Investigators, WheatleyK , IvesN , GrayR , KalraPA , MossJG , et al. Revascularization versus medical therapy for renal‐artery stenosis. New England Journal of Medicine2009;361(20):1953‐62. ISRCTN59586944 . Angioplasty and stent for renal artery lesions. ISRCTN Register2007. [URL: http://www.controlled‐trials.com/ISRCTN59586944/Angioplasty+stent+for+renal+artery+lesions] KalraP , MossJ , IvesN , HandleyK , GrayR , WheatleyK . Outcome of patients with highly significant and clinically relevant RAS within the ASTRAL trial. Renal Week 2008, 41st Annual Meeting &amp; Scientific Exposition; 2008 Nov 4‐9; Pennsylvania,USA2008. KalraPA , MossJ , IvesN , Fitzpatrick EllisK , GrayR , WheatleyK , et al. The impact of renal artery revascularization in atherosclerotic renovascular disease: the angioplasty and stenting for renal artery lesions (ASTRAL) trial [abstract no: 090]. Nephrology2008;13 Suppl 3:A123. MistryS , IvesN , HardingJ , Fitzpatrick‐EllisK , LipkinG , KalraPA , et al. Angioplasty and STent for Renal Artery Lesions (ASTRAL trial): rationale, methods and results so far. Journal of Human Hypertension2007;21(7):511‐5. MossJG . ASTRAL trial initial results. Cardiovascular and Interventional Radiological Society of Europe Annual Meeting Abstracts; 2008 Sep 13‐17; Copenhagen, Denmark2008:309. WheatleyK , KalraPA , MossJ , IvesN , Fitzpatrick‐EllisK , GrayR , et al. Lack of benefit of renal artery revascularization in atherosclerotic renovascular disease (ARVD): results of the ASTRAL trial. Renal Week 2008, 41st Annual Meeting &amp; Scientific Exposition; 2008 Nov 4‐9; Pennsylvania,USA2008. ">ASTRAL</a>; <a href="./references#CD002944-bbs2-0002" title="CooperCJ , MurphyTP , MatsumotoA , SteffesM , CohenDJ , JaffM , et al. Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trial. American Heart Journal2006;152(1):59‐66. CooperCJM , MurphyTP , CutlipDE , JamersonK , HenrichW , ReidDM , et al. Stenting and medical therapy for atherosclerotic renal‐artery stenosis. New England Journal of Medicine2014;370:13‐22. MatsumotoA , H , CooperC , MurphyT , CutlipD , ConawayM , et al. Severity of renal artery lesions in patients enrolled into the CORAL trial. Journal of Vascular and Interventional Radiology2010;21(2 Suppl 1):S19. MatsumotoAH , CooperCJ , MurphyTP , CutlipM , ConawayMR , DworkinL . Severity of renal artery lesions in patients enrolled into the CORAL trial. Cardiovascular and Interventional Radiological Society of Europe Annual Meeting Abstracts; 2008 Sep 13‐17; Copenhagen, Denmark2008:308. MurphyTP , CooperCJ , DworkinLD , HenrichWL , RundbackJH , MatsumotoAH , et al. The Cardiovascular Outcomes with Renal Atherosclerotic Lesions (CORAL) study: rationale and methods. Journal of Vascular and Interventional Radiology2005;16(10):1295‐300. NCT00081731 . Benefits of medical therapy plus stenting for renal atherosclerotic lesions. http://clinicaltrials.gov/ct/show/NCT00081731?order=1. [URL: http://clinicaltrials.gov/ct/show/NCT00081731?order=1] ">CORAL</a>; <a href="./references#CD002944-bbs2-0003" title="KrijnenP , vanJaarsveldBC , HuninkMG , HabbemaJD . The effect of treatment on health‐related quality of life in patients with hypertension and renal artery stenosis. Journal of Human Hypertension2005;19(6):467‐70. vanJaarsveldB , KrijnenP , BartelinkA , DeesAd , DerkxFH , Man in't VeldA , et al. The Dutch Renal Artery Stenosis Intervention Cooperative (DRASTIC) Study: rationale and inclusion data. Journal of Hypertension1998;16 Suppl 6:S21‐7. vanJaarsveldB , KrijnenP , BartelinkA , DeesAd , DerkxFH , Man in't VeldA , et al. The Dutch Renal Artery Stenosis Intervention Cooperative (DRASTIC) Study: rationale and inclusion data. Journal of Hypertension1998;16 Suppl 6:S21‐7. vanJaarsveldBC , KrijnenP . Prospective studies of diagnosis and intervention: the Dutch experience. Seminars in Nephrology2000;20(5):463‐73. vanJaarsveldBC , KrijnenP , PietermanH , DerkxF , DeinumJ , PostmaCT , et al. The effect of balloon angioplasty on hypertension in atherosclerotic renal artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group. New England Journal of Medicine2000;342(14):1007‐14. ">DRASTIC</a>; <a href="./references#CD002944-bbs2-0008" title="BaxL , MaliWP , BuskensE , KoomansHA , BeutlerJJ , BraamB , et al. The benefit of STent placement and blood pressure and lipid‐lowering for the prevention of progression of renal dysfunction caused by Atherosclerotic ostial stenosis of the Renal artery. The STAR‐study: rationale and study design. Journal of Nephrology2003;16(6):807‐12. BaxL , WoittiezAJ , KouwenbergHJ , MaliWP , BuskensE , BeekFJ , et al. Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial. Annals of Internal Medicine2009;150(12):840‐8. ">STAR</a>) the exact method of BP measurement and whether evaluators were blinded to participants' allocation was unclear. </p> </section> <section id="CD002944-sec-0052"> <h4 class="title">Incomplete outcome data</h4> <p>All six studies with available methodological information (<a href="./references#CD002944-bbs2-0001" title="ASTRAL Investigators, WheatleyK , IvesN , GrayR , KalraPA , MossJG , et al. Revascularization versus medical therapy for renal‐artery stenosis. New England Journal of Medicine2009;361(20):1953‐62. ISRCTN59586944 . Angioplasty and stent for renal artery lesions. ISRCTN Register2007. [URL: http://www.controlled‐trials.com/ISRCTN59586944/Angioplasty+stent+for+renal+artery+lesions] KalraP , MossJ , IvesN , HandleyK , GrayR , WheatleyK . Outcome of patients with highly significant and clinically relevant RAS within the ASTRAL trial. Renal Week 2008, 41st Annual Meeting &amp; Scientific Exposition; 2008 Nov 4‐9; Pennsylvania,USA2008. KalraPA , MossJ , IvesN , Fitzpatrick EllisK , GrayR , WheatleyK , et al. The impact of renal artery revascularization in atherosclerotic renovascular disease: the angioplasty and stenting for renal artery lesions (ASTRAL) trial [abstract no: 090]. Nephrology2008;13 Suppl 3:A123. MistryS , IvesN , HardingJ , Fitzpatrick‐EllisK , LipkinG , KalraPA , et al. Angioplasty and STent for Renal Artery Lesions (ASTRAL trial): rationale, methods and results so far. Journal of Human Hypertension2007;21(7):511‐5. MossJG . ASTRAL trial initial results. Cardiovascular and Interventional Radiological Society of Europe Annual Meeting Abstracts; 2008 Sep 13‐17; Copenhagen, Denmark2008:309. WheatleyK , KalraPA , MossJ , IvesN , Fitzpatrick‐EllisK , GrayR , et al. Lack of benefit of renal artery revascularization in atherosclerotic renovascular disease (ARVD): results of the ASTRAL trial. Renal Week 2008, 41st Annual Meeting &amp; Scientific Exposition; 2008 Nov 4‐9; Pennsylvania,USA2008. ">ASTRAL</a>; <a href="./references#CD002944-bbs2-0002" title="CooperCJ , MurphyTP , MatsumotoA , SteffesM , CohenDJ , JaffM , et al. Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trial. American Heart Journal2006;152(1):59‐66. CooperCJM , MurphyTP , CutlipDE , JamersonK , HenrichW , ReidDM , et al. Stenting and medical therapy for atherosclerotic renal‐artery stenosis. New England Journal of Medicine2014;370:13‐22. MatsumotoA , H , CooperC , MurphyT , CutlipD , ConawayM , et al. Severity of renal artery lesions in patients enrolled into the CORAL trial. Journal of Vascular and Interventional Radiology2010;21(2 Suppl 1):S19. MatsumotoAH , CooperCJ , MurphyTP , CutlipM , ConawayMR , DworkinL . Severity of renal artery lesions in patients enrolled into the CORAL trial. Cardiovascular and Interventional Radiological Society of Europe Annual Meeting Abstracts; 2008 Sep 13‐17; Copenhagen, Denmark2008:308. MurphyTP , CooperCJ , DworkinLD , HenrichWL , RundbackJH , MatsumotoAH , et al. The Cardiovascular Outcomes with Renal Atherosclerotic Lesions (CORAL) study: rationale and methods. Journal of Vascular and Interventional Radiology2005;16(10):1295‐300. NCT00081731 . Benefits of medical therapy plus stenting for renal atherosclerotic lesions. http://clinicaltrials.gov/ct/show/NCT00081731?order=1. [URL: http://clinicaltrials.gov/ct/show/NCT00081731?order=1] ">CORAL</a>; <a href="./references#CD002944-bbs2-0003" title="KrijnenP , vanJaarsveldBC , HuninkMG , HabbemaJD . The effect of treatment on health‐related quality of life in patients with hypertension and renal artery stenosis. Journal of Human Hypertension2005;19(6):467‐70. vanJaarsveldB , KrijnenP , BartelinkA , DeesAd , DerkxFH , Man in't VeldA , et al. The Dutch Renal Artery Stenosis Intervention Cooperative (DRASTIC) Study: rationale and inclusion data. Journal of Hypertension1998;16 Suppl 6:S21‐7. vanJaarsveldB , KrijnenP , BartelinkA , DeesAd , DerkxFH , Man in't VeldA , et al. The Dutch Renal Artery Stenosis Intervention Cooperative (DRASTIC) Study: rationale and inclusion data. Journal of Hypertension1998;16 Suppl 6:S21‐7. vanJaarsveldBC , KrijnenP . Prospective studies of diagnosis and intervention: the Dutch experience. Seminars in Nephrology2000;20(5):463‐73. vanJaarsveldBC , KrijnenP , PietermanH , DerkxF , DeinumJ , PostmaCT , et al. The effect of balloon angioplasty on hypertension in atherosclerotic renal artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group. New England Journal of Medicine2000;342(14):1007‐14. ">DRASTIC</a>; <a href="./references#CD002944-bbs2-0004" title="PlouinPF , ChatellierG , DarnéB , RaynaudA . Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis. A randomized trial. Essai Multicentrique Medicaments vs Angioplastie (EMMA) Study Group. Hypertension1998;31(3):823‐9. Scottish and Newcastle Renovascular Collaborative Group. Prospective randomized trial of interventional (angioplasty) versus medical therapy in hypertensive patients with atheromatous renal artery stenosis. Journal of Hypertension1994; Vol. 12:1312. ">EMMA</a>; <a href="./references#CD002944-bbs2-0007" title="WebsterJ , MarshallF , AbdallaM , DominiczakA , EdwardsR , IslesCG , et al. Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. Scottish and Newcastle Renal Artery Stenosis Collaborative Group. Journal of Human Hypertension1998;12(5):329‐35. ">SNRASCG</a>; <a href="./references#CD002944-bbs2-0008" title="BaxL , MaliWP , BuskensE , KoomansHA , BeutlerJJ , BraamB , et al. The benefit of STent placement and blood pressure and lipid‐lowering for the prevention of progression of renal dysfunction caused by Atherosclerotic ostial stenosis of the Renal artery. The STAR‐study: rationale and study design. Journal of Nephrology2003;16(6):807‐12. BaxL , WoittiezAJ , KouwenbergHJ , MaliWP , BuskensE , BeekFJ , et al. Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial. Annals of Internal Medicine2009;150(12):840‐8. ">STAR</a>) had only small numbers of participants lost to follow‐up and were deemed to be at low risk of attrition bias. </p> </section> <section id="CD002944-sec-0053"> <h4 class="title">Selective reporting</h4> <p>All six studies with available methodological information (<a href="./references#CD002944-bbs2-0001" title="ASTRAL Investigators, WheatleyK , IvesN , GrayR , KalraPA , MossJG , et al. Revascularization versus medical therapy for renal‐artery stenosis. New England Journal of Medicine2009;361(20):1953‐62. ISRCTN59586944 . Angioplasty and stent for renal artery lesions. ISRCTN Register2007. [URL: http://www.controlled‐trials.com/ISRCTN59586944/Angioplasty+stent+for+renal+artery+lesions] KalraP , MossJ , IvesN , HandleyK , GrayR , WheatleyK . Outcome of patients with highly significant and clinically relevant RAS within the ASTRAL trial. Renal Week 2008, 41st Annual Meeting &amp; Scientific Exposition; 2008 Nov 4‐9; Pennsylvania,USA2008. KalraPA , MossJ , IvesN , Fitzpatrick EllisK , GrayR , WheatleyK , et al. The impact of renal artery revascularization in atherosclerotic renovascular disease: the angioplasty and stenting for renal artery lesions (ASTRAL) trial [abstract no: 090]. Nephrology2008;13 Suppl 3:A123. MistryS , IvesN , HardingJ , Fitzpatrick‐EllisK , LipkinG , KalraPA , et al. Angioplasty and STent for Renal Artery Lesions (ASTRAL trial): rationale, methods and results so far. Journal of Human Hypertension2007;21(7):511‐5. MossJG . ASTRAL trial initial results. Cardiovascular and Interventional Radiological Society of Europe Annual Meeting Abstracts; 2008 Sep 13‐17; Copenhagen, Denmark2008:309. WheatleyK , KalraPA , MossJ , IvesN , Fitzpatrick‐EllisK , GrayR , et al. Lack of benefit of renal artery revascularization in atherosclerotic renovascular disease (ARVD): results of the ASTRAL trial. Renal Week 2008, 41st Annual Meeting &amp; Scientific Exposition; 2008 Nov 4‐9; Pennsylvania,USA2008. ">ASTRAL</a>; <a href="./references#CD002944-bbs2-0002" title="CooperCJ , MurphyTP , MatsumotoA , SteffesM , CohenDJ , JaffM , et al. Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trial. American Heart Journal2006;152(1):59‐66. CooperCJM , MurphyTP , CutlipDE , JamersonK , HenrichW , ReidDM , et al. Stenting and medical therapy for atherosclerotic renal‐artery stenosis. New England Journal of Medicine2014;370:13‐22. MatsumotoA , H , CooperC , MurphyT , CutlipD , ConawayM , et al. Severity of renal artery lesions in patients enrolled into the CORAL trial. Journal of Vascular and Interventional Radiology2010;21(2 Suppl 1):S19. MatsumotoAH , CooperCJ , MurphyTP , CutlipM , ConawayMR , DworkinL . Severity of renal artery lesions in patients enrolled into the CORAL trial. Cardiovascular and Interventional Radiological Society of Europe Annual Meeting Abstracts; 2008 Sep 13‐17; Copenhagen, Denmark2008:308. MurphyTP , CooperCJ , DworkinLD , HenrichWL , RundbackJH , MatsumotoAH , et al. The Cardiovascular Outcomes with Renal Atherosclerotic Lesions (CORAL) study: rationale and methods. Journal of Vascular and Interventional Radiology2005;16(10):1295‐300. NCT00081731 . Benefits of medical therapy plus stenting for renal atherosclerotic lesions. http://clinicaltrials.gov/ct/show/NCT00081731?order=1. [URL: http://clinicaltrials.gov/ct/show/NCT00081731?order=1] ">CORAL</a>; <a href="./references#CD002944-bbs2-0003" title="KrijnenP , vanJaarsveldBC , HuninkMG , HabbemaJD . The effect of treatment on health‐related quality of life in patients with hypertension and renal artery stenosis. Journal of Human Hypertension2005;19(6):467‐70. vanJaarsveldB , KrijnenP , BartelinkA , DeesAd , DerkxFH , Man in't VeldA , et al. The Dutch Renal Artery Stenosis Intervention Cooperative (DRASTIC) Study: rationale and inclusion data. Journal of Hypertension1998;16 Suppl 6:S21‐7. vanJaarsveldB , KrijnenP , BartelinkA , DeesAd , DerkxFH , Man in't VeldA , et al. The Dutch Renal Artery Stenosis Intervention Cooperative (DRASTIC) Study: rationale and inclusion data. Journal of Hypertension1998;16 Suppl 6:S21‐7. vanJaarsveldBC , KrijnenP . Prospective studies of diagnosis and intervention: the Dutch experience. Seminars in Nephrology2000;20(5):463‐73. vanJaarsveldBC , KrijnenP , PietermanH , DerkxF , DeinumJ , PostmaCT , et al. The effect of balloon angioplasty on hypertension in atherosclerotic renal artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group. New England Journal of Medicine2000;342(14):1007‐14. ">DRASTIC</a>; <a href="./references#CD002944-bbs2-0004" title="PlouinPF , ChatellierG , DarnéB , RaynaudA . Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis. A randomized trial. Essai Multicentrique Medicaments vs Angioplastie (EMMA) Study Group. Hypertension1998;31(3):823‐9. Scottish and Newcastle Renovascular Collaborative Group. Prospective randomized trial of interventional (angioplasty) versus medical therapy in hypertensive patients with atheromatous renal artery stenosis. Journal of Hypertension1994; Vol. 12:1312. ">EMMA</a>; <a href="./references#CD002944-bbs2-0007" title="WebsterJ , MarshallF , AbdallaM , DominiczakA , EdwardsR , IslesCG , et al. Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. Scottish and Newcastle Renal Artery Stenosis Collaborative Group. Journal of Human Hypertension1998;12(5):329‐35. ">SNRASCG</a>; <a href="./references#CD002944-bbs2-0008" title="BaxL , MaliWP , BuskensE , KoomansHA , BeutlerJJ , BraamB , et al. The benefit of STent placement and blood pressure and lipid‐lowering for the prevention of progression of renal dysfunction caused by Atherosclerotic ostial stenosis of the Renal artery. The STAR‐study: rationale and study design. Journal of Nephrology2003;16(6):807‐12. BaxL , WoittiezAJ , KouwenbergHJ , MaliWP , BuskensE , BeekFJ , et al. Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial. Annals of Internal Medicine2009;150(12):840‐8. ">STAR</a>) reported on all the pre‐specified outcomes and were therefore judged to be at low risk of reporting bias. </p> </section> <section id="CD002944-sec-0054"> <h4 class="title">Other potential sources of bias</h4> <p>Four studies were felt to be at high risk of other sources of bias. This was due to large numbers of participants crossing over from medical treatment to balloon angioplasty (<a href="./references#CD002944-bbs2-0003" title="KrijnenP , vanJaarsveldBC , HuninkMG , HabbemaJD . The effect of treatment on health‐related quality of life in patients with hypertension and renal artery stenosis. Journal of Human Hypertension2005;19(6):467‐70. vanJaarsveldB , KrijnenP , BartelinkA , DeesAd , DerkxFH , Man in't VeldA , et al. The Dutch Renal Artery Stenosis Intervention Cooperative (DRASTIC) Study: rationale and inclusion data. Journal of Hypertension1998;16 Suppl 6:S21‐7. vanJaarsveldB , KrijnenP , BartelinkA , DeesAd , DerkxFH , Man in't VeldA , et al. The Dutch Renal Artery Stenosis Intervention Cooperative (DRASTIC) Study: rationale and inclusion data. Journal of Hypertension1998;16 Suppl 6:S21‐7. vanJaarsveldBC , KrijnenP . Prospective studies of diagnosis and intervention: the Dutch experience. Seminars in Nephrology2000;20(5):463‐73. vanJaarsveldBC , KrijnenP , PietermanH , DerkxF , DeinumJ , PostmaCT , et al. The effect of balloon angioplasty on hypertension in atherosclerotic renal artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group. New England Journal of Medicine2000;342(14):1007‐14. ">DRASTIC</a>), significant numbers of participants allocated to angioplasty not undergoing revascularisation (<a href="./references#CD002944-bbs2-0001" title="ASTRAL Investigators, WheatleyK , IvesN , GrayR , KalraPA , MossJG , et al. Revascularization versus medical therapy for renal‐artery stenosis. New England Journal of Medicine2009;361(20):1953‐62. ISRCTN59586944 . Angioplasty and stent for renal artery lesions. ISRCTN Register2007. [URL: http://www.controlled‐trials.com/ISRCTN59586944/Angioplasty+stent+for+renal+artery+lesions] KalraP , MossJ , IvesN , HandleyK , GrayR , WheatleyK . Outcome of patients with highly significant and clinically relevant RAS within the ASTRAL trial. Renal Week 2008, 41st Annual Meeting &amp; Scientific Exposition; 2008 Nov 4‐9; Pennsylvania,USA2008. KalraPA , MossJ , IvesN , Fitzpatrick EllisK , GrayR , WheatleyK , et al. The impact of renal artery revascularization in atherosclerotic renovascular disease: the angioplasty and stenting for renal artery lesions (ASTRAL) trial [abstract no: 090]. Nephrology2008;13 Suppl 3:A123. MistryS , IvesN , HardingJ , Fitzpatrick‐EllisK , LipkinG , KalraPA , et al. Angioplasty and STent for Renal Artery Lesions (ASTRAL trial): rationale, methods and results so far. Journal of Human Hypertension2007;21(7):511‐5. MossJG . ASTRAL trial initial results. Cardiovascular and Interventional Radiological Society of Europe Annual Meeting Abstracts; 2008 Sep 13‐17; Copenhagen, Denmark2008:309. WheatleyK , KalraPA , MossJ , IvesN , Fitzpatrick‐EllisK , GrayR , et al. Lack of benefit of renal artery revascularization in atherosclerotic renovascular disease (ARVD): results of the ASTRAL trial. Renal Week 2008, 41st Annual Meeting &amp; Scientific Exposition; 2008 Nov 4‐9; Pennsylvania,USA2008. ">ASTRAL</a>; <a href="./references#CD002944-bbs2-0008" title="BaxL , MaliWP , BuskensE , KoomansHA , BeutlerJJ , BraamB , et al. The benefit of STent placement and blood pressure and lipid‐lowering for the prevention of progression of renal dysfunction caused by Atherosclerotic ostial stenosis of the Renal artery. The STAR‐study: rationale and study design. Journal of Nephrology2003;16(6):807‐12. BaxL , WoittiezAJ , KouwenbergHJ , MaliWP , BuskensE , BeekFJ , et al. Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial. Annals of Internal Medicine2009;150(12):840‐8. ">STAR</a>), or participants undergoing surgical interventions in place of angioplasty (<a href="./references#CD002944-bbs2-0007" title="WebsterJ , MarshallF , AbdallaM , DominiczakA , EdwardsR , IslesCG , et al. Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. Scottish and Newcastle Renal Artery Stenosis Collaborative Group. Journal of Human Hypertension1998;12(5):329‐35. ">SNRASCG</a>). One trial (<a href="./references#CD002944-bbs2-0001" title="ASTRAL Investigators, WheatleyK , IvesN , GrayR , KalraPA , MossJG , et al. Revascularization versus medical therapy for renal‐artery stenosis. New England Journal of Medicine2009;361(20):1953‐62. ISRCTN59586944 . Angioplasty and stent for renal artery lesions. ISRCTN Register2007. [URL: http://www.controlled‐trials.com/ISRCTN59586944/Angioplasty+stent+for+renal+artery+lesions] KalraP , MossJ , IvesN , HandleyK , GrayR , WheatleyK . Outcome of patients with highly significant and clinically relevant RAS within the ASTRAL trial. Renal Week 2008, 41st Annual Meeting &amp; Scientific Exposition; 2008 Nov 4‐9; Pennsylvania,USA2008. KalraPA , MossJ , IvesN , Fitzpatrick EllisK , GrayR , WheatleyK , et al. The impact of renal artery revascularization in atherosclerotic renovascular disease: the angioplasty and stenting for renal artery lesions (ASTRAL) trial [abstract no: 090]. Nephrology2008;13 Suppl 3:A123. MistryS , IvesN , HardingJ , Fitzpatrick‐EllisK , LipkinG , KalraPA , et al. Angioplasty and STent for Renal Artery Lesions (ASTRAL trial): rationale, methods and results so far. Journal of Human Hypertension2007;21(7):511‐5. MossJG . ASTRAL trial initial results. Cardiovascular and Interventional Radiological Society of Europe Annual Meeting Abstracts; 2008 Sep 13‐17; Copenhagen, Denmark2008:309. WheatleyK , KalraPA , MossJ , IvesN , Fitzpatrick‐EllisK , GrayR , et al. Lack of benefit of renal artery revascularization in atherosclerotic renovascular disease (ARVD): results of the ASTRAL trial. Renal Week 2008, 41st Annual Meeting &amp; Scientific Exposition; 2008 Nov 4‐9; Pennsylvania,USA2008. ">ASTRAL</a>) introduced a source of heterogeneity and bias as it enrolled participants into the trial only if their clinician was uncertain as to whether revascularisation would be of clinical benefit. Therefore, patients who otherwise met the study criteria but were felt to be likely to benefit from angioplasty were excluded from the study. </p> </section> </section> <section id="CD002944-sec-0055"> <h3 class="title" id="CD002944-sec-0055">Effects of interventions</h3> <section id="CD002944-sec-0056"> <h4 class="title">Systolic and diastolic blood pressure</h4> <p>Five of the eight trials reported systolic BP as an outcome and data were pooled from the 1743 participants in these five trials (<a href="./references#CD002944-bbs2-0001" title="ASTRAL Investigators, WheatleyK , IvesN , GrayR , KalraPA , MossJG , et al. Revascularization versus medical therapy for renal‐artery stenosis. New England Journal of Medicine2009;361(20):1953‐62. ISRCTN59586944 . Angioplasty and stent for renal artery lesions. ISRCTN Register2007. [URL: http://www.controlled‐trials.com/ISRCTN59586944/Angioplasty+stent+for+renal+artery+lesions] KalraP , MossJ , IvesN , HandleyK , GrayR , WheatleyK . Outcome of patients with highly significant and clinically relevant RAS within the ASTRAL trial. Renal Week 2008, 41st Annual Meeting &amp; Scientific Exposition; 2008 Nov 4‐9; Pennsylvania,USA2008. KalraPA , MossJ , IvesN , Fitzpatrick EllisK , GrayR , WheatleyK , et al. The impact of renal artery revascularization in atherosclerotic renovascular disease: the angioplasty and stenting for renal artery lesions (ASTRAL) trial [abstract no: 090]. Nephrology2008;13 Suppl 3:A123. MistryS , IvesN , HardingJ , Fitzpatrick‐EllisK , LipkinG , KalraPA , et al. Angioplasty and STent for Renal Artery Lesions (ASTRAL trial): rationale, methods and results so far. Journal of Human Hypertension2007;21(7):511‐5. MossJG . ASTRAL trial initial results. Cardiovascular and Interventional Radiological Society of Europe Annual Meeting Abstracts; 2008 Sep 13‐17; Copenhagen, Denmark2008:309. WheatleyK , KalraPA , MossJ , IvesN , Fitzpatrick‐EllisK , GrayR , et al. Lack of benefit of renal artery revascularization in atherosclerotic renovascular disease (ARVD): results of the ASTRAL trial. Renal Week 2008, 41st Annual Meeting &amp; Scientific Exposition; 2008 Nov 4‐9; Pennsylvania,USA2008. ">ASTRAL</a>; <a href="./references#CD002944-bbs2-0002" title="CooperCJ , MurphyTP , MatsumotoA , SteffesM , CohenDJ , JaffM , et al. Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trial. American Heart Journal2006;152(1):59‐66. CooperCJM , MurphyTP , CutlipDE , JamersonK , HenrichW , ReidDM , et al. Stenting and medical therapy for atherosclerotic renal‐artery stenosis. New England Journal of Medicine2014;370:13‐22. MatsumotoA , H , CooperC , MurphyT , CutlipD , ConawayM , et al. Severity of renal artery lesions in patients enrolled into the CORAL trial. Journal of Vascular and Interventional Radiology2010;21(2 Suppl 1):S19. MatsumotoAH , CooperCJ , MurphyTP , CutlipM , ConawayMR , DworkinL . Severity of renal artery lesions in patients enrolled into the CORAL trial. Cardiovascular and Interventional Radiological Society of Europe Annual Meeting Abstracts; 2008 Sep 13‐17; Copenhagen, Denmark2008:308. MurphyTP , CooperCJ , DworkinLD , HenrichWL , RundbackJH , MatsumotoAH , et al. The Cardiovascular Outcomes with Renal Atherosclerotic Lesions (CORAL) study: rationale and methods. Journal of Vascular and Interventional Radiology2005;16(10):1295‐300. NCT00081731 . Benefits of medical therapy plus stenting for renal atherosclerotic lesions. http://clinicaltrials.gov/ct/show/NCT00081731?order=1. [URL: http://clinicaltrials.gov/ct/show/NCT00081731?order=1] ">CORAL</a>; <a href="./references#CD002944-bbs2-0003" title="KrijnenP , vanJaarsveldBC , HuninkMG , HabbemaJD . The effect of treatment on health‐related quality of life in patients with hypertension and renal artery stenosis. Journal of Human Hypertension2005;19(6):467‐70. vanJaarsveldB , KrijnenP , BartelinkA , DeesAd , DerkxFH , Man in't VeldA , et al. The Dutch Renal Artery Stenosis Intervention Cooperative (DRASTIC) Study: rationale and inclusion data. Journal of Hypertension1998;16 Suppl 6:S21‐7. vanJaarsveldB , KrijnenP , BartelinkA , DeesAd , DerkxFH , Man in't VeldA , et al. The Dutch Renal Artery Stenosis Intervention Cooperative (DRASTIC) Study: rationale and inclusion data. Journal of Hypertension1998;16 Suppl 6:S21‐7. vanJaarsveldBC , KrijnenP . Prospective studies of diagnosis and intervention: the Dutch experience. Seminars in Nephrology2000;20(5):463‐73. vanJaarsveldBC , KrijnenP , PietermanH , DerkxF , DeinumJ , PostmaCT , et al. The effect of balloon angioplasty on hypertension in atherosclerotic renal artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group. New England Journal of Medicine2000;342(14):1007‐14. ">DRASTIC</a>; <a href="./references#CD002944-bbs2-0004" title="PlouinPF , ChatellierG , DarnéB , RaynaudA . Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis. A randomized trial. Essai Multicentrique Medicaments vs Angioplastie (EMMA) Study Group. Hypertension1998;31(3):823‐9. Scottish and Newcastle Renovascular Collaborative Group. Prospective randomized trial of interventional (angioplasty) versus medical therapy in hypertensive patients with atheromatous renal artery stenosis. Journal of Hypertension1994; Vol. 12:1312. ">EMMA</a>; <a href="./references#CD002944-bbs2-0008" title="BaxL , MaliWP , BuskensE , KoomansHA , BeutlerJJ , BraamB , et al. The benefit of STent placement and blood pressure and lipid‐lowering for the prevention of progression of renal dysfunction caused by Atherosclerotic ostial stenosis of the Renal artery. The STAR‐study: rationale and study design. Journal of Nephrology2003;16(6):807‐12. BaxL , WoittiezAJ , KouwenbergHJ , MaliWP , BuskensE , BeekFJ , et al. Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial. Annals of Internal Medicine2009;150(12):840‐8. ">STAR</a>). Only four of the seven trials reported diastolic BP and data were pooled from the 809 participants in these four trials (<a href="./references#CD002944-bbs2-0001" title="ASTRAL Investigators, WheatleyK , IvesN , GrayR , KalraPA , MossJG , et al. Revascularization versus medical therapy for renal‐artery stenosis. New England Journal of Medicine2009;361(20):1953‐62. ISRCTN59586944 . Angioplasty and stent for renal artery lesions. ISRCTN Register2007. [URL: http://www.controlled‐trials.com/ISRCTN59586944/Angioplasty+stent+for+renal+artery+lesions] KalraP , MossJ , IvesN , HandleyK , GrayR , WheatleyK . Outcome of patients with highly significant and clinically relevant RAS within the ASTRAL trial. Renal Week 2008, 41st Annual Meeting &amp; Scientific Exposition; 2008 Nov 4‐9; Pennsylvania,USA2008. KalraPA , MossJ , IvesN , Fitzpatrick EllisK , GrayR , WheatleyK , et al. The impact of renal artery revascularization in atherosclerotic renovascular disease: the angioplasty and stenting for renal artery lesions (ASTRAL) trial [abstract no: 090]. Nephrology2008;13 Suppl 3:A123. MistryS , IvesN , HardingJ , Fitzpatrick‐EllisK , LipkinG , KalraPA , et al. Angioplasty and STent for Renal Artery Lesions (ASTRAL trial): rationale, methods and results so far. Journal of Human Hypertension2007;21(7):511‐5. MossJG . ASTRAL trial initial results. Cardiovascular and Interventional Radiological Society of Europe Annual Meeting Abstracts; 2008 Sep 13‐17; Copenhagen, Denmark2008:309. WheatleyK , KalraPA , MossJ , IvesN , Fitzpatrick‐EllisK , GrayR , et al. Lack of benefit of renal artery revascularization in atherosclerotic renovascular disease (ARVD): results of the ASTRAL trial. Renal Week 2008, 41st Annual Meeting &amp; Scientific Exposition; 2008 Nov 4‐9; Pennsylvania,USA2008. ">ASTRAL</a>; <a href="./references#CD002944-bbs2-0003" title="KrijnenP , vanJaarsveldBC , HuninkMG , HabbemaJD . The effect of treatment on health‐related quality of life in patients with hypertension and renal artery stenosis. Journal of Human Hypertension2005;19(6):467‐70. vanJaarsveldB , KrijnenP , BartelinkA , DeesAd , DerkxFH , Man in't VeldA , et al. The Dutch Renal Artery Stenosis Intervention Cooperative (DRASTIC) Study: rationale and inclusion data. Journal of Hypertension1998;16 Suppl 6:S21‐7. vanJaarsveldB , KrijnenP , BartelinkA , DeesAd , DerkxFH , Man in't VeldA , et al. The Dutch Renal Artery Stenosis Intervention Cooperative (DRASTIC) Study: rationale and inclusion data. Journal of Hypertension1998;16 Suppl 6:S21‐7. vanJaarsveldBC , KrijnenP . Prospective studies of diagnosis and intervention: the Dutch experience. Seminars in Nephrology2000;20(5):463‐73. vanJaarsveldBC , KrijnenP , PietermanH , DerkxF , DeinumJ , PostmaCT , et al. The effect of balloon angioplasty on hypertension in atherosclerotic renal artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group. New England Journal of Medicine2000;342(14):1007‐14. ">DRASTIC</a>; <a href="./references#CD002944-bbs2-0004" title="PlouinPF , ChatellierG , DarnéB , RaynaudA . Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis. A randomized trial. Essai Multicentrique Medicaments vs Angioplastie (EMMA) Study Group. Hypertension1998;31(3):823‐9. Scottish and Newcastle Renovascular Collaborative Group. Prospective randomized trial of interventional (angioplasty) versus medical therapy in hypertensive patients with atheromatous renal artery stenosis. Journal of Hypertension1994; Vol. 12:1312. ">EMMA</a>; <a href="./references#CD002944-bbs2-0008" title="BaxL , MaliWP , BuskensE , KoomansHA , BeutlerJJ , BraamB , et al. The benefit of STent placement and blood pressure and lipid‐lowering for the prevention of progression of renal dysfunction caused by Atherosclerotic ostial stenosis of the Renal artery. The STAR‐study: rationale and study design. Journal of Nephrology2003;16(6):807‐12. BaxL , WoittiezAJ , KouwenbergHJ , MaliWP , BuskensE , BeekFJ , et al. Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial. Annals of Internal Medicine2009;150(12):840‐8. ">STAR</a>). One of these trials (<a href="./references#CD002944-bbs2-0008" title="BaxL , MaliWP , BuskensE , KoomansHA , BeutlerJJ , BraamB , et al. The benefit of STent placement and blood pressure and lipid‐lowering for the prevention of progression of renal dysfunction caused by Atherosclerotic ostial stenosis of the Renal artery. The STAR‐study: rationale and study design. Journal of Nephrology2003;16(6):807‐12. BaxL , WoittiezAJ , KouwenbergHJ , MaliWP , BuskensE , BeekFJ , et al. Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial. Annals of Internal Medicine2009;150(12):840‐8. ">STAR</a>) reported BP at either the end of two‐year follow‐up or when participants reached the primary endpoint (defined as a greater than 20% decline in creatinine clearance). Another trial (<a href="./references#CD002944-bbs2-0001" title="ASTRAL Investigators, WheatleyK , IvesN , GrayR , KalraPA , MossJG , et al. Revascularization versus medical therapy for renal‐artery stenosis. New England Journal of Medicine2009;361(20):1953‐62. ISRCTN59586944 . Angioplasty and stent for renal artery lesions. ISRCTN Register2007. [URL: http://www.controlled‐trials.com/ISRCTN59586944/Angioplasty+stent+for+renal+artery+lesions] KalraP , MossJ , IvesN , HandleyK , GrayR , WheatleyK . Outcome of patients with highly significant and clinically relevant RAS within the ASTRAL trial. Renal Week 2008, 41st Annual Meeting &amp; Scientific Exposition; 2008 Nov 4‐9; Pennsylvania,USA2008. KalraPA , MossJ , IvesN , Fitzpatrick EllisK , GrayR , WheatleyK , et al. The impact of renal artery revascularization in atherosclerotic renovascular disease: the angioplasty and stenting for renal artery lesions (ASTRAL) trial [abstract no: 090]. Nephrology2008;13 Suppl 3:A123. MistryS , IvesN , HardingJ , Fitzpatrick‐EllisK , LipkinG , KalraPA , et al. Angioplasty and STent for Renal Artery Lesions (ASTRAL trial): rationale, methods and results so far. Journal of Human Hypertension2007;21(7):511‐5. MossJG . ASTRAL trial initial results. Cardiovascular and Interventional Radiological Society of Europe Annual Meeting Abstracts; 2008 Sep 13‐17; Copenhagen, Denmark2008:309. WheatleyK , KalraPA , MossJ , IvesN , Fitzpatrick‐EllisK , GrayR , et al. Lack of benefit of renal artery revascularization in atherosclerotic renovascular disease (ARVD): results of the ASTRAL trial. Renal Week 2008, 41st Annual Meeting &amp; Scientific Exposition; 2008 Nov 4‐9; Pennsylvania,USA2008. ">ASTRAL</a>) reported BP results for each year during the five‐year follow‐up period and the BP results from the end of the second year of follow‐up were selected for inclusion in the meta‐analysis. The <a href="./references#CD002944-bbs2-0004" title="PlouinPF , ChatellierG , DarnéB , RaynaudA . Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis. A randomized trial. Essai Multicentrique Medicaments vs Angioplastie (EMMA) Study Group. Hypertension1998;31(3):823‐9. Scottish and Newcastle Renovascular Collaborative Group. Prospective randomized trial of interventional (angioplasty) versus medical therapy in hypertensive patients with atheromatous renal artery stenosis. Journal of Hypertension1994; Vol. 12:1312. ">EMMA</a> and <a href="./references#CD002944-bbs2-0003" title="KrijnenP , vanJaarsveldBC , HuninkMG , HabbemaJD . The effect of treatment on health‐related quality of life in patients with hypertension and renal artery stenosis. Journal of Human Hypertension2005;19(6):467‐70. vanJaarsveldB , KrijnenP , BartelinkA , DeesAd , DerkxFH , Man in't VeldA , et al. The Dutch Renal Artery Stenosis Intervention Cooperative (DRASTIC) Study: rationale and inclusion data. Journal of Hypertension1998;16 Suppl 6:S21‐7. vanJaarsveldB , KrijnenP , BartelinkA , DeesAd , DerkxFH , Man in't VeldA , et al. The Dutch Renal Artery Stenosis Intervention Cooperative (DRASTIC) Study: rationale and inclusion data. Journal of Hypertension1998;16 Suppl 6:S21‐7. vanJaarsveldBC , KrijnenP . Prospective studies of diagnosis and intervention: the Dutch experience. Seminars in Nephrology2000;20(5):463‐73. vanJaarsveldBC , KrijnenP , PietermanH , DerkxF , DeinumJ , PostmaCT , et al. The effect of balloon angioplasty on hypertension in atherosclerotic renal artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group. New England Journal of Medicine2000;342(14):1007‐14. ">DRASTIC</a> trials reported BP results at the end of the six‐month and 12‐month follow‐up periods, respectively. The <a href="./references#CD002944-bbs2-0002" title="CooperCJ , MurphyTP , MatsumotoA , SteffesM , CohenDJ , JaffM , et al. Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trial. American Heart Journal2006;152(1):59‐66. CooperCJM , MurphyTP , CutlipDE , JamersonK , HenrichW , ReidDM , et al. Stenting and medical therapy for atherosclerotic renal‐artery stenosis. New England Journal of Medicine2014;370:13‐22. MatsumotoA , H , CooperC , MurphyT , CutlipD , ConawayM , et al. Severity of renal artery lesions in patients enrolled into the CORAL trial. Journal of Vascular and Interventional Radiology2010;21(2 Suppl 1):S19. MatsumotoAH , CooperCJ , MurphyTP , CutlipM , ConawayMR , DworkinL . Severity of renal artery lesions in patients enrolled into the CORAL trial. Cardiovascular and Interventional Radiological Society of Europe Annual Meeting Abstracts; 2008 Sep 13‐17; Copenhagen, Denmark2008:308. MurphyTP , CooperCJ , DworkinLD , HenrichWL , RundbackJH , MatsumotoAH , et al. The Cardiovascular Outcomes with Renal Atherosclerotic Lesions (CORAL) study: rationale and methods. Journal of Vascular and Interventional Radiology2005;16(10):1295‐300. NCT00081731 . Benefits of medical therapy plus stenting for renal atherosclerotic lesions. http://clinicaltrials.gov/ct/show/NCT00081731?order=1. [URL: http://clinicaltrials.gov/ct/show/NCT00081731?order=1] ">CORAL</a> trial only reported changes in systolic BP results at the end of follow‐up, where the median follow‐up was 43 months. </p> <p>Only the <a href="./references#CD002944-bbs2-0004" title="PlouinPF , ChatellierG , DarnéB , RaynaudA . Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis. A randomized trial. Essai Multicentrique Medicaments vs Angioplastie (EMMA) Study Group. Hypertension1998;31(3):823‐9. Scottish and Newcastle Renovascular Collaborative Group. Prospective randomized trial of interventional (angioplasty) versus medical therapy in hypertensive patients with atheromatous renal artery stenosis. Journal of Hypertension1994; Vol. 12:1312. ">EMMA</a> and <a href="./references#CD002944-bbs2-0002" title="CooperCJ , MurphyTP , MatsumotoA , SteffesM , CohenDJ , JaffM , et al. Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trial. American Heart Journal2006;152(1):59‐66. CooperCJM , MurphyTP , CutlipDE , JamersonK , HenrichW , ReidDM , et al. Stenting and medical therapy for atherosclerotic renal‐artery stenosis. New England Journal of Medicine2014;370:13‐22. MatsumotoA , H , CooperC , MurphyT , CutlipD , ConawayM , et al. Severity of renal artery lesions in patients enrolled into the CORAL trial. Journal of Vascular and Interventional Radiology2010;21(2 Suppl 1):S19. MatsumotoAH , CooperCJ , MurphyTP , CutlipM , ConawayMR , DworkinL . Severity of renal artery lesions in patients enrolled into the CORAL trial. Cardiovascular and Interventional Radiological Society of Europe Annual Meeting Abstracts; 2008 Sep 13‐17; Copenhagen, Denmark2008:308. MurphyTP , CooperCJ , DworkinLD , HenrichWL , RundbackJH , MatsumotoAH , et al. The Cardiovascular Outcomes with Renal Atherosclerotic Lesions (CORAL) study: rationale and methods. Journal of Vascular and Interventional Radiology2005;16(10):1295‐300. NCT00081731 . Benefits of medical therapy plus stenting for renal atherosclerotic lesions. http://clinicaltrials.gov/ct/show/NCT00081731?order=1. [URL: http://clinicaltrials.gov/ct/show/NCT00081731?order=1] ">CORAL</a> trials reported SDs for change in BP during follow‐up. SDs were therefore imputed for the <a href="./references#CD002944-bbs2-0001" title="ASTRAL Investigators, WheatleyK , IvesN , GrayR , KalraPA , MossJG , et al. Revascularization versus medical therapy for renal‐artery stenosis. New England Journal of Medicine2009;361(20):1953‐62. ISRCTN59586944 . Angioplasty and stent for renal artery lesions. ISRCTN Register2007. [URL: http://www.controlled‐trials.com/ISRCTN59586944/Angioplasty+stent+for+renal+artery+lesions] KalraP , MossJ , IvesN , HandleyK , GrayR , WheatleyK . Outcome of patients with highly significant and clinically relevant RAS within the ASTRAL trial. Renal Week 2008, 41st Annual Meeting &amp; Scientific Exposition; 2008 Nov 4‐9; Pennsylvania,USA2008. KalraPA , MossJ , IvesN , Fitzpatrick EllisK , GrayR , WheatleyK , et al. The impact of renal artery revascularization in atherosclerotic renovascular disease: the angioplasty and stenting for renal artery lesions (ASTRAL) trial [abstract no: 090]. Nephrology2008;13 Suppl 3:A123. MistryS , IvesN , HardingJ , Fitzpatrick‐EllisK , LipkinG , KalraPA , et al. Angioplasty and STent for Renal Artery Lesions (ASTRAL trial): rationale, methods and results so far. Journal of Human Hypertension2007;21(7):511‐5. MossJG . ASTRAL trial initial results. Cardiovascular and Interventional Radiological Society of Europe Annual Meeting Abstracts; 2008 Sep 13‐17; Copenhagen, Denmark2008:309. WheatleyK , KalraPA , MossJ , IvesN , Fitzpatrick‐EllisK , GrayR , et al. Lack of benefit of renal artery revascularization in atherosclerotic renovascular disease (ARVD): results of the ASTRAL trial. Renal Week 2008, 41st Annual Meeting &amp; Scientific Exposition; 2008 Nov 4‐9; Pennsylvania,USA2008. ">ASTRAL</a>, <a href="./references#CD002944-bbs2-0003" title="KrijnenP , vanJaarsveldBC , HuninkMG , HabbemaJD . The effect of treatment on health‐related quality of life in patients with hypertension and renal artery stenosis. Journal of Human Hypertension2005;19(6):467‐70. vanJaarsveldB , KrijnenP , BartelinkA , DeesAd , DerkxFH , Man in't VeldA , et al. The Dutch Renal Artery Stenosis Intervention Cooperative (DRASTIC) Study: rationale and inclusion data. Journal of Hypertension1998;16 Suppl 6:S21‐7. vanJaarsveldB , KrijnenP , BartelinkA , DeesAd , DerkxFH , Man in't VeldA , et al. The Dutch Renal Artery Stenosis Intervention Cooperative (DRASTIC) Study: rationale and inclusion data. Journal of Hypertension1998;16 Suppl 6:S21‐7. vanJaarsveldBC , KrijnenP . Prospective studies of diagnosis and intervention: the Dutch experience. Seminars in Nephrology2000;20(5):463‐73. vanJaarsveldBC , KrijnenP , PietermanH , DerkxF , DeinumJ , PostmaCT , et al. The effect of balloon angioplasty on hypertension in atherosclerotic renal artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group. New England Journal of Medicine2000;342(14):1007‐14. ">DRASTIC</a> and <a href="./references#CD002944-bbs2-0008" title="BaxL , MaliWP , BuskensE , KoomansHA , BeutlerJJ , BraamB , et al. The benefit of STent placement and blood pressure and lipid‐lowering for the prevention of progression of renal dysfunction caused by Atherosclerotic ostial stenosis of the Renal artery. The STAR‐study: rationale and study design. Journal of Nephrology2003;16(6):807‐12. BaxL , WoittiezAJ , KouwenbergHJ , MaliWP , BuskensE , BeekFJ , et al. Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial. Annals of Internal Medicine2009;150(12):840‐8. ">STAR</a> trials using the data available from the <a href="./references#CD002944-bbs2-0004" title="PlouinPF , ChatellierG , DarnéB , RaynaudA . Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis. A randomized trial. Essai Multicentrique Medicaments vs Angioplastie (EMMA) Study Group. Hypertension1998;31(3):823‐9. Scottish and Newcastle Renovascular Collaborative Group. Prospective randomized trial of interventional (angioplasty) versus medical therapy in hypertensive patients with atheromatous renal artery stenosis. Journal of Hypertension1994; Vol. 12:1312. ">EMMA</a> trial to calculate a correlation coefficient, as per the methodology described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD002944-bbs2-0017" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). </p> <p>Data from the <a href="./references#CD002944-bbs2-0007" title="WebsterJ , MarshallF , AbdallaM , DominiczakA , EdwardsR , IslesCG , et al. Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. Scottish and Newcastle Renal Artery Stenosis Collaborative Group. Journal of Human Hypertension1998;12(5):329‐35. ">SNRASCG</a> trial were not pooled as the results were reported separately for participants with unilateral (n = 27) and bilateral renal artery stenosis (n = 28); the authors did not report any significant differences in BP after six months. In the bilateral group, BP decreased by 19/4 (systolic/diastolic) mmHg in the balloon angioplasty group and by 2/2 mmHg in the medical therapy group. In the unilateral group, BP decreased by 9/5 mmHg in the angioplasty group and by 8/6 mmHg in the medical therapy group. No P values or SDs were indicated. Data from the <a href="./references#CD002944-bbs2-0005" title="ScarpioniR , MichielettiE , CristinelliL , UgolottiU , ScolariF , VenturelliC , et al. Atherosclerotic renovascular disease: medical therapy versus medical therapy plus renal artery stenting in preventing renal failure progression: the rationale and study design of a prospective, multicenter and randomized trial (NITER). Journal of Nephrology2005;18(4):423‐8. ScarpioniR , MichielettiE , PavoneL . Atherosclerotic renovascular disease (ARVD): medical therapy plus renal artery stenting (PRTS), compared with medical therapy alone, do not offer more chances in preventing C‐V events or the progression of renal failure. Preliminary results of a prospective, multicenter and randomized trial. Abstract World Congress of Nephrology; May 22, 2009; Milan, Italy2009. ">NITER</a> and <a href="./references#CD002944-bbs2-0006" title="SchwarzwalderU , HaukM , ZellerT . RADAR ‐ A randomised, multi‐centre, prospective study comparing best medical treatment versus best medical treatment plus renal artery stenting in patients with haemodynamically relevant atherosclerotic renal artery stenosis. Trials2009;10:60. [NCT00640406] ZellerT . RADAR ‐ Data of a prematurely terminated randomized, multi‐centre prospective study comparing best medical treatment versus best medical treatment plus renal artery stenting in patients with hemodynamically relevant atherosclerotic renal artery stenosis. VASA. Zeitschrift fur Gefasskrankheiten. Journal for Vascular Diseases2013;42:40. ">RADAR</a> trials were not available. </p> <p>The pooled change in BP in the balloon angioplasty group in comparison to the medical treatment group, from the trials included in the meta‐analysis, showed a non‐significant MD of ‐1.07 mmHg for systolic BP and a significant MD of ‐2.00 mmHg for diastolic BP (95% CI ‐3.45 to 1.30; P = 0.38, I² = 0% (<a href="./references#CD002944-fig-0004" title="">Analysis 1.1</a>); 95% CI ‐3.72 to ‐0.27; P = 0.02, I² = 4% (<a href="./references#CD002944-fig-0005" title="">Analysis 1.2</a>), respectively). </p> </section> <section id="CD002944-sec-0057"> <h4 class="title">Renal function as assessed by serum creatinine, creatinine clearance or estimated glomerular filtration rate (eGFR) </h4> <p>The <a href="./references#CD002944-bbs2-0001" title="ASTRAL Investigators, WheatleyK , IvesN , GrayR , KalraPA , MossJG , et al. Revascularization versus medical therapy for renal‐artery stenosis. New England Journal of Medicine2009;361(20):1953‐62. ISRCTN59586944 . Angioplasty and stent for renal artery lesions. ISRCTN Register2007. [URL: http://www.controlled‐trials.com/ISRCTN59586944/Angioplasty+stent+for+renal+artery+lesions] KalraP , MossJ , IvesN , HandleyK , GrayR , WheatleyK . Outcome of patients with highly significant and clinically relevant RAS within the ASTRAL trial. Renal Week 2008, 41st Annual Meeting &amp; Scientific Exposition; 2008 Nov 4‐9; Pennsylvania,USA2008. KalraPA , MossJ , IvesN , Fitzpatrick EllisK , GrayR , WheatleyK , et al. The impact of renal artery revascularization in atherosclerotic renovascular disease: the angioplasty and stenting for renal artery lesions (ASTRAL) trial [abstract no: 090]. Nephrology2008;13 Suppl 3:A123. MistryS , IvesN , HardingJ , Fitzpatrick‐EllisK , LipkinG , KalraPA , et al. Angioplasty and STent for Renal Artery Lesions (ASTRAL trial): rationale, methods and results so far. Journal of Human Hypertension2007;21(7):511‐5. MossJG . ASTRAL trial initial results. Cardiovascular and Interventional Radiological Society of Europe Annual Meeting Abstracts; 2008 Sep 13‐17; Copenhagen, Denmark2008:309. WheatleyK , KalraPA , MossJ , IvesN , Fitzpatrick‐EllisK , GrayR , et al. Lack of benefit of renal artery revascularization in atherosclerotic renovascular disease (ARVD): results of the ASTRAL trial. Renal Week 2008, 41st Annual Meeting &amp; Scientific Exposition; 2008 Nov 4‐9; Pennsylvania,USA2008. ">ASTRAL</a>, <a href="./references#CD002944-bbs2-0008" title="BaxL , MaliWP , BuskensE , KoomansHA , BeutlerJJ , BraamB , et al. The benefit of STent placement and blood pressure and lipid‐lowering for the prevention of progression of renal dysfunction caused by Atherosclerotic ostial stenosis of the Renal artery. The STAR‐study: rationale and study design. Journal of Nephrology2003;16(6):807‐12. BaxL , WoittiezAJ , KouwenbergHJ , MaliWP , BuskensE , BeekFJ , et al. Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial. Annals of Internal Medicine2009;150(12):840‐8. ">STAR</a> and <a href="./references#CD002944-bbs2-0007" title="WebsterJ , MarshallF , AbdallaM , DominiczakA , EdwardsR , IslesCG , et al. Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. Scottish and Newcastle Renal Artery Stenosis Collaborative Group. Journal of Human Hypertension1998;12(5):329‐35. ">SNRASCG</a> trials all reported serum creatinine as an outcome and the data were pooled from the 725 participants in these three trials. The <a href="./references#CD002944-bbs2-0008" title="BaxL , MaliWP , BuskensE , KoomansHA , BeutlerJJ , BraamB , et al. The benefit of STent placement and blood pressure and lipid‐lowering for the prevention of progression of renal dysfunction caused by Atherosclerotic ostial stenosis of the Renal artery. The STAR‐study: rationale and study design. Journal of Nephrology2003;16(6):807‐12. BaxL , WoittiezAJ , KouwenbergHJ , MaliWP , BuskensE , BeekFJ , et al. Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial. Annals of Internal Medicine2009;150(12):840‐8. ">STAR</a> trial reported serum creatinine at either the end of two‐year follow‐up or when participants reached the primary endpoint (defined as a greater than 20% decline in creatinine clearance). The <a href="./references#CD002944-bbs2-0001" title="ASTRAL Investigators, WheatleyK , IvesN , GrayR , KalraPA , MossJG , et al. Revascularization versus medical therapy for renal‐artery stenosis. New England Journal of Medicine2009;361(20):1953‐62. ISRCTN59586944 . Angioplasty and stent for renal artery lesions. ISRCTN Register2007. [URL: http://www.controlled‐trials.com/ISRCTN59586944/Angioplasty+stent+for+renal+artery+lesions] KalraP , MossJ , IvesN , HandleyK , GrayR , WheatleyK . Outcome of patients with highly significant and clinically relevant RAS within the ASTRAL trial. Renal Week 2008, 41st Annual Meeting &amp; Scientific Exposition; 2008 Nov 4‐9; Pennsylvania,USA2008. KalraPA , MossJ , IvesN , Fitzpatrick EllisK , GrayR , WheatleyK , et al. The impact of renal artery revascularization in atherosclerotic renovascular disease: the angioplasty and stenting for renal artery lesions (ASTRAL) trial [abstract no: 090]. Nephrology2008;13 Suppl 3:A123. MistryS , IvesN , HardingJ , Fitzpatrick‐EllisK , LipkinG , KalraPA , et al. Angioplasty and STent for Renal Artery Lesions (ASTRAL trial): rationale, methods and results so far. Journal of Human Hypertension2007;21(7):511‐5. MossJG . ASTRAL trial initial results. Cardiovascular and Interventional Radiological Society of Europe Annual Meeting Abstracts; 2008 Sep 13‐17; Copenhagen, Denmark2008:309. WheatleyK , KalraPA , MossJ , IvesN , Fitzpatrick‐EllisK , GrayR , et al. Lack of benefit of renal artery revascularization in atherosclerotic renovascular disease (ARVD): results of the ASTRAL trial. Renal Week 2008, 41st Annual Meeting &amp; Scientific Exposition; 2008 Nov 4‐9; Pennsylvania,USA2008. ">ASTRAL</a> trial reported creatinine results for each year during the five‐year follow‐up period; the creatinine results from the end of the second year of follow‐up were selected for inclusion in the meta‐analysis. The <a href="./references#CD002944-bbs2-0007" title="WebsterJ , MarshallF , AbdallaM , DominiczakA , EdwardsR , IslesCG , et al. Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. Scottish and Newcastle Renal Artery Stenosis Collaborative Group. Journal of Human Hypertension1998;12(5):329‐35. ">SNRASCG</a> trial reported creatinine results at the end of the six‐month follow‐up period. </p> <p>The other five trials could not be included in the meta‐analysis as they all reported on different renal outcomes (<a href="./references#CD002944-bbs2-0002" title="CooperCJ , MurphyTP , MatsumotoA , SteffesM , CohenDJ , JaffM , et al. Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trial. American Heart Journal2006;152(1):59‐66. CooperCJM , MurphyTP , CutlipDE , JamersonK , HenrichW , ReidDM , et al. Stenting and medical therapy for atherosclerotic renal‐artery stenosis. New England Journal of Medicine2014;370:13‐22. MatsumotoA , H , CooperC , MurphyT , CutlipD , ConawayM , et al. Severity of renal artery lesions in patients enrolled into the CORAL trial. Journal of Vascular and Interventional Radiology2010;21(2 Suppl 1):S19. MatsumotoAH , CooperCJ , MurphyTP , CutlipM , ConawayMR , DworkinL . Severity of renal artery lesions in patients enrolled into the CORAL trial. Cardiovascular and Interventional Radiological Society of Europe Annual Meeting Abstracts; 2008 Sep 13‐17; Copenhagen, Denmark2008:308. MurphyTP , CooperCJ , DworkinLD , HenrichWL , RundbackJH , MatsumotoAH , et al. The Cardiovascular Outcomes with Renal Atherosclerotic Lesions (CORAL) study: rationale and methods. Journal of Vascular and Interventional Radiology2005;16(10):1295‐300. NCT00081731 . Benefits of medical therapy plus stenting for renal atherosclerotic lesions. http://clinicaltrials.gov/ct/show/NCT00081731?order=1. [URL: http://clinicaltrials.gov/ct/show/NCT00081731?order=1] ">CORAL</a>; <a href="./references#CD002944-bbs2-0003" title="KrijnenP , vanJaarsveldBC , HuninkMG , HabbemaJD . The effect of treatment on health‐related quality of life in patients with hypertension and renal artery stenosis. Journal of Human Hypertension2005;19(6):467‐70. vanJaarsveldB , KrijnenP , BartelinkA , DeesAd , DerkxFH , Man in't VeldA , et al. The Dutch Renal Artery Stenosis Intervention Cooperative (DRASTIC) Study: rationale and inclusion data. Journal of Hypertension1998;16 Suppl 6:S21‐7. vanJaarsveldB , KrijnenP , BartelinkA , DeesAd , DerkxFH , Man in't VeldA , et al. The Dutch Renal Artery Stenosis Intervention Cooperative (DRASTIC) Study: rationale and inclusion data. Journal of Hypertension1998;16 Suppl 6:S21‐7. vanJaarsveldBC , KrijnenP . Prospective studies of diagnosis and intervention: the Dutch experience. Seminars in Nephrology2000;20(5):463‐73. vanJaarsveldBC , KrijnenP , PietermanH , DerkxF , DeinumJ , PostmaCT , et al. The effect of balloon angioplasty on hypertension in atherosclerotic renal artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group. New England Journal of Medicine2000;342(14):1007‐14. ">DRASTIC</a>; <a href="./references#CD002944-bbs2-0004" title="PlouinPF , ChatellierG , DarnéB , RaynaudA . Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis. A randomized trial. Essai Multicentrique Medicaments vs Angioplastie (EMMA) Study Group. Hypertension1998;31(3):823‐9. Scottish and Newcastle Renovascular Collaborative Group. Prospective randomized trial of interventional (angioplasty) versus medical therapy in hypertensive patients with atheromatous renal artery stenosis. Journal of Hypertension1994; Vol. 12:1312. ">EMMA</a>; <a href="./references#CD002944-bbs2-0005" title="ScarpioniR , MichielettiE , CristinelliL , UgolottiU , ScolariF , VenturelliC , et al. Atherosclerotic renovascular disease: medical therapy versus medical therapy plus renal artery stenting in preventing renal failure progression: the rationale and study design of a prospective, multicenter and randomized trial (NITER). Journal of Nephrology2005;18(4):423‐8. ScarpioniR , MichielettiE , PavoneL . Atherosclerotic renovascular disease (ARVD): medical therapy plus renal artery stenting (PRTS), compared with medical therapy alone, do not offer more chances in preventing C‐V events or the progression of renal failure. Preliminary results of a prospective, multicenter and randomized trial. Abstract World Congress of Nephrology; May 22, 2009; Milan, Italy2009. ">NITER</a>; <a href="./references#CD002944-bbs2-0006" title="SchwarzwalderU , HaukM , ZellerT . RADAR ‐ A randomised, multi‐centre, prospective study comparing best medical treatment versus best medical treatment plus renal artery stenting in patients with haemodynamically relevant atherosclerotic renal artery stenosis. Trials2009;10:60. [NCT00640406] ZellerT . RADAR ‐ Data of a prematurely terminated randomized, multi‐centre prospective study comparing best medical treatment versus best medical treatment plus renal artery stenting in patients with hemodynamically relevant atherosclerotic renal artery stenosis. VASA. Zeitschrift fur Gefasskrankheiten. Journal for Vascular Diseases2013;42:40. ">RADAR</a>). The <a href="./references#CD002944-bbs2-0004" title="PlouinPF , ChatellierG , DarnéB , RaynaudA . Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis. A randomized trial. Essai Multicentrique Medicaments vs Angioplastie (EMMA) Study Group. Hypertension1998;31(3):823‐9. Scottish and Newcastle Renovascular Collaborative Group. Prospective randomized trial of interventional (angioplasty) versus medical therapy in hypertensive patients with atheromatous renal artery stenosis. Journal of Hypertension1994; Vol. 12:1312. ">EMMA</a> trial reported creatinine clearance, the <a href="./references#CD002944-bbs2-0003" title="KrijnenP , vanJaarsveldBC , HuninkMG , HabbemaJD . The effect of treatment on health‐related quality of life in patients with hypertension and renal artery stenosis. Journal of Human Hypertension2005;19(6):467‐70. vanJaarsveldB , KrijnenP , BartelinkA , DeesAd , DerkxFH , Man in't VeldA , et al. The Dutch Renal Artery Stenosis Intervention Cooperative (DRASTIC) Study: rationale and inclusion data. Journal of Hypertension1998;16 Suppl 6:S21‐7. vanJaarsveldB , KrijnenP , BartelinkA , DeesAd , DerkxFH , Man in't VeldA , et al. The Dutch Renal Artery Stenosis Intervention Cooperative (DRASTIC) Study: rationale and inclusion data. Journal of Hypertension1998;16 Suppl 6:S21‐7. vanJaarsveldBC , KrijnenP . Prospective studies of diagnosis and intervention: the Dutch experience. Seminars in Nephrology2000;20(5):463‐73. vanJaarsveldBC , KrijnenP , PietermanH , DerkxF , DeinumJ , PostmaCT , et al. The effect of balloon angioplasty on hypertension in atherosclerotic renal artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group. New England Journal of Medicine2000;342(14):1007‐14. ">DRASTIC</a> trial reported median serum creatinine and creatinine clearance, the <a href="./references#CD002944-bbs2-0005" title="ScarpioniR , MichielettiE , CristinelliL , UgolottiU , ScolariF , VenturelliC , et al. Atherosclerotic renovascular disease: medical therapy versus medical therapy plus renal artery stenting in preventing renal failure progression: the rationale and study design of a prospective, multicenter and randomized trial (NITER). Journal of Nephrology2005;18(4):423‐8. ScarpioniR , MichielettiE , PavoneL . Atherosclerotic renovascular disease (ARVD): medical therapy plus renal artery stenting (PRTS), compared with medical therapy alone, do not offer more chances in preventing C‐V events or the progression of renal failure. Preliminary results of a prospective, multicenter and randomized trial. Abstract World Congress of Nephrology; May 22, 2009; Milan, Italy2009. ">NITER</a> trial reported worsening renal failure, the <a href="./references#CD002944-bbs2-0006" title="SchwarzwalderU , HaukM , ZellerT . RADAR ‐ A randomised, multi‐centre, prospective study comparing best medical treatment versus best medical treatment plus renal artery stenting in patients with haemodynamically relevant atherosclerotic renal artery stenosis. Trials2009;10:60. [NCT00640406] ZellerT . RADAR ‐ Data of a prematurely terminated randomized, multi‐centre prospective study comparing best medical treatment versus best medical treatment plus renal artery stenting in patients with hemodynamically relevant atherosclerotic renal artery stenosis. VASA. Zeitschrift fur Gefasskrankheiten. Journal for Vascular Diseases2013;42:40. ">RADAR</a> trial reported change in eGFR after 12 months, and the <a href="./references#CD002944-bbs2-0002" title="CooperCJ , MurphyTP , MatsumotoA , SteffesM , CohenDJ , JaffM , et al. Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trial. American Heart Journal2006;152(1):59‐66. CooperCJM , MurphyTP , CutlipDE , JamersonK , HenrichW , ReidDM , et al. Stenting and medical therapy for atherosclerotic renal‐artery stenosis. New England Journal of Medicine2014;370:13‐22. MatsumotoA , H , CooperC , MurphyT , CutlipD , ConawayM , et al. Severity of renal artery lesions in patients enrolled into the CORAL trial. Journal of Vascular and Interventional Radiology2010;21(2 Suppl 1):S19. MatsumotoAH , CooperCJ , MurphyTP , CutlipM , ConawayMR , DworkinL . Severity of renal artery lesions in patients enrolled into the CORAL trial. Cardiovascular and Interventional Radiological Society of Europe Annual Meeting Abstracts; 2008 Sep 13‐17; Copenhagen, Denmark2008:308. MurphyTP , CooperCJ , DworkinLD , HenrichWL , RundbackJH , MatsumotoAH , et al. The Cardiovascular Outcomes with Renal Atherosclerotic Lesions (CORAL) study: rationale and methods. Journal of Vascular and Interventional Radiology2005;16(10):1295‐300. NCT00081731 . Benefits of medical therapy plus stenting for renal atherosclerotic lesions. http://clinicaltrials.gov/ct/show/NCT00081731?order=1. [URL: http://clinicaltrials.gov/ct/show/NCT00081731?order=1] ">CORAL</a> trial reported progressive renal insufficiency. </p> <p>There was no significant difference in serum creatinine, creatinine clearance, worsening renal failure or progressive renal insufficiency between the angioplasty and medical treatment groups in any of the eight individual trials. </p> <p>The pooled serum creatinine results from the three trials included in the meta‐analysis identified a non‐statistically significant MD of ‐7.99 µmol/L (95% CI ‐22.6 to 6.62; P = 0.28, I² = 12%) in the balloon angioplasty group compared to the medical treatment group (<a href="./references#CD002944-fig-0006" title="">Analysis 1.3</a>). </p> </section> <section id="CD002944-sec-0058"> <h4 class="title">Numbers and defined daily doses of antihypertensive drugs</h4> <p>The <a href="./references#CD002944-bbs2-0002" title="CooperCJ , MurphyTP , MatsumotoA , SteffesM , CohenDJ , JaffM , et al. Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trial. American Heart Journal2006;152(1):59‐66. CooperCJM , MurphyTP , CutlipDE , JamersonK , HenrichW , ReidDM , et al. Stenting and medical therapy for atherosclerotic renal‐artery stenosis. New England Journal of Medicine2014;370:13‐22. MatsumotoA , H , CooperC , MurphyT , CutlipD , ConawayM , et al. Severity of renal artery lesions in patients enrolled into the CORAL trial. Journal of Vascular and Interventional Radiology2010;21(2 Suppl 1):S19. MatsumotoAH , CooperCJ , MurphyTP , CutlipM , ConawayMR , DworkinL . Severity of renal artery lesions in patients enrolled into the CORAL trial. Cardiovascular and Interventional Radiological Society of Europe Annual Meeting Abstracts; 2008 Sep 13‐17; Copenhagen, Denmark2008:308. MurphyTP , CooperCJ , DworkinLD , HenrichWL , RundbackJH , MatsumotoAH , et al. The Cardiovascular Outcomes with Renal Atherosclerotic Lesions (CORAL) study: rationale and methods. Journal of Vascular and Interventional Radiology2005;16(10):1295‐300. NCT00081731 . Benefits of medical therapy plus stenting for renal atherosclerotic lesions. http://clinicaltrials.gov/ct/show/NCT00081731?order=1. [URL: http://clinicaltrials.gov/ct/show/NCT00081731?order=1] ">CORAL</a>, <a href="./references#CD002944-bbs2-0003" title="KrijnenP , vanJaarsveldBC , HuninkMG , HabbemaJD . The effect of treatment on health‐related quality of life in patients with hypertension and renal artery stenosis. Journal of Human Hypertension2005;19(6):467‐70. vanJaarsveldB , KrijnenP , BartelinkA , DeesAd , DerkxFH , Man in't VeldA , et al. The Dutch Renal Artery Stenosis Intervention Cooperative (DRASTIC) Study: rationale and inclusion data. Journal of Hypertension1998;16 Suppl 6:S21‐7. vanJaarsveldB , KrijnenP , BartelinkA , DeesAd , DerkxFH , Man in't VeldA , et al. The Dutch Renal Artery Stenosis Intervention Cooperative (DRASTIC) Study: rationale and inclusion data. Journal of Hypertension1998;16 Suppl 6:S21‐7. vanJaarsveldBC , KrijnenP . Prospective studies of diagnosis and intervention: the Dutch experience. Seminars in Nephrology2000;20(5):463‐73. vanJaarsveldBC , KrijnenP , PietermanH , DerkxF , DeinumJ , PostmaCT , et al. The effect of balloon angioplasty on hypertension in atherosclerotic renal artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group. New England Journal of Medicine2000;342(14):1007‐14. ">DRASTIC</a> and <a href="./references#CD002944-bbs2-0001" title="ASTRAL Investigators, WheatleyK , IvesN , GrayR , KalraPA , MossJG , et al. Revascularization versus medical therapy for renal‐artery stenosis. New England Journal of Medicine2009;361(20):1953‐62. ISRCTN59586944 . Angioplasty and stent for renal artery lesions. ISRCTN Register2007. [URL: http://www.controlled‐trials.com/ISRCTN59586944/Angioplasty+stent+for+renal+artery+lesions] KalraP , MossJ , IvesN , HandleyK , GrayR , WheatleyK . Outcome of patients with highly significant and clinically relevant RAS within the ASTRAL trial. Renal Week 2008, 41st Annual Meeting &amp; Scientific Exposition; 2008 Nov 4‐9; Pennsylvania,USA2008. KalraPA , MossJ , IvesN , Fitzpatrick EllisK , GrayR , WheatleyK , et al. The impact of renal artery revascularization in atherosclerotic renovascular disease: the angioplasty and stenting for renal artery lesions (ASTRAL) trial [abstract no: 090]. Nephrology2008;13 Suppl 3:A123. MistryS , IvesN , HardingJ , Fitzpatrick‐EllisK , LipkinG , KalraPA , et al. Angioplasty and STent for Renal Artery Lesions (ASTRAL trial): rationale, methods and results so far. Journal of Human Hypertension2007;21(7):511‐5. MossJG . ASTRAL trial initial results. Cardiovascular and Interventional Radiological Society of Europe Annual Meeting Abstracts; 2008 Sep 13‐17; Copenhagen, Denmark2008:309. WheatleyK , KalraPA , MossJ , IvesN , Fitzpatrick‐EllisK , GrayR , et al. Lack of benefit of renal artery revascularization in atherosclerotic renovascular disease (ARVD): results of the ASTRAL trial. Renal Week 2008, 41st Annual Meeting &amp; Scientific Exposition; 2008 Nov 4‐9; Pennsylvania,USA2008. ">ASTRAL</a> trials all reported the mean number of antihypertensive drugs as an outcome and data were pooled from the 1717 participants. The <a href="./references#CD002944-bbs2-0003" title="KrijnenP , vanJaarsveldBC , HuninkMG , HabbemaJD . The effect of treatment on health‐related quality of life in patients with hypertension and renal artery stenosis. Journal of Human Hypertension2005;19(6):467‐70. vanJaarsveldB , KrijnenP , BartelinkA , DeesAd , DerkxFH , Man in't VeldA , et al. The Dutch Renal Artery Stenosis Intervention Cooperative (DRASTIC) Study: rationale and inclusion data. Journal of Hypertension1998;16 Suppl 6:S21‐7. vanJaarsveldB , KrijnenP , BartelinkA , DeesAd , DerkxFH , Man in't VeldA , et al. The Dutch Renal Artery Stenosis Intervention Cooperative (DRASTIC) Study: rationale and inclusion data. Journal of Hypertension1998;16 Suppl 6:S21‐7. vanJaarsveldBC , KrijnenP . Prospective studies of diagnosis and intervention: the Dutch experience. Seminars in Nephrology2000;20(5):463‐73. vanJaarsveldBC , KrijnenP , PietermanH , DerkxF , DeinumJ , PostmaCT , et al. The effect of balloon angioplasty on hypertension in atherosclerotic renal artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group. New England Journal of Medicine2000;342(14):1007‐14. ">DRASTIC</a> trial reported the mean number of antihypertensive drugs after one year and the <a href="./references#CD002944-bbs2-0002" title="CooperCJ , MurphyTP , MatsumotoA , SteffesM , CohenDJ , JaffM , et al. Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trial. American Heart Journal2006;152(1):59‐66. CooperCJM , MurphyTP , CutlipDE , JamersonK , HenrichW , ReidDM , et al. Stenting and medical therapy for atherosclerotic renal‐artery stenosis. New England Journal of Medicine2014;370:13‐22. MatsumotoA , H , CooperC , MurphyT , CutlipD , ConawayM , et al. Severity of renal artery lesions in patients enrolled into the CORAL trial. Journal of Vascular and Interventional Radiology2010;21(2 Suppl 1):S19. MatsumotoAH , CooperCJ , MurphyTP , CutlipM , ConawayMR , DworkinL . Severity of renal artery lesions in patients enrolled into the CORAL trial. Cardiovascular and Interventional Radiological Society of Europe Annual Meeting Abstracts; 2008 Sep 13‐17; Copenhagen, Denmark2008:308. MurphyTP , CooperCJ , DworkinLD , HenrichWL , RundbackJH , MatsumotoAH , et al. The Cardiovascular Outcomes with Renal Atherosclerotic Lesions (CORAL) study: rationale and methods. Journal of Vascular and Interventional Radiology2005;16(10):1295‐300. NCT00081731 . Benefits of medical therapy plus stenting for renal atherosclerotic lesions. http://clinicaltrials.gov/ct/show/NCT00081731?order=1. [URL: http://clinicaltrials.gov/ct/show/NCT00081731?order=1] ">CORAL</a> trial at the end of follow‐up. SDs were available for both the <a href="./references#CD002944-bbs2-0002" title="CooperCJ , MurphyTP , MatsumotoA , SteffesM , CohenDJ , JaffM , et al. Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trial. American Heart Journal2006;152(1):59‐66. CooperCJM , MurphyTP , CutlipDE , JamersonK , HenrichW , ReidDM , et al. Stenting and medical therapy for atherosclerotic renal‐artery stenosis. New England Journal of Medicine2014;370:13‐22. MatsumotoA , H , CooperC , MurphyT , CutlipD , ConawayM , et al. Severity of renal artery lesions in patients enrolled into the CORAL trial. Journal of Vascular and Interventional Radiology2010;21(2 Suppl 1):S19. MatsumotoAH , CooperCJ , MurphyTP , CutlipM , ConawayMR , DworkinL . Severity of renal artery lesions in patients enrolled into the CORAL trial. Cardiovascular and Interventional Radiological Society of Europe Annual Meeting Abstracts; 2008 Sep 13‐17; Copenhagen, Denmark2008:308. MurphyTP , CooperCJ , DworkinLD , HenrichWL , RundbackJH , MatsumotoAH , et al. The Cardiovascular Outcomes with Renal Atherosclerotic Lesions (CORAL) study: rationale and methods. Journal of Vascular and Interventional Radiology2005;16(10):1295‐300. NCT00081731 . Benefits of medical therapy plus stenting for renal atherosclerotic lesions. http://clinicaltrials.gov/ct/show/NCT00081731?order=1. [URL: http://clinicaltrials.gov/ct/show/NCT00081731?order=1] ">CORAL</a> and <a href="./references#CD002944-bbs2-0003" title="KrijnenP , vanJaarsveldBC , HuninkMG , HabbemaJD . The effect of treatment on health‐related quality of life in patients with hypertension and renal artery stenosis. Journal of Human Hypertension2005;19(6):467‐70. vanJaarsveldB , KrijnenP , BartelinkA , DeesAd , DerkxFH , Man in't VeldA , et al. The Dutch Renal Artery Stenosis Intervention Cooperative (DRASTIC) Study: rationale and inclusion data. Journal of Hypertension1998;16 Suppl 6:S21‐7. vanJaarsveldB , KrijnenP , BartelinkA , DeesAd , DerkxFH , Man in't VeldA , et al. The Dutch Renal Artery Stenosis Intervention Cooperative (DRASTIC) Study: rationale and inclusion data. Journal of Hypertension1998;16 Suppl 6:S21‐7. vanJaarsveldBC , KrijnenP . Prospective studies of diagnosis and intervention: the Dutch experience. Seminars in Nephrology2000;20(5):463‐73. vanJaarsveldBC , KrijnenP , PietermanH , DerkxF , DeinumJ , PostmaCT , et al. The effect of balloon angioplasty on hypertension in atherosclerotic renal artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group. New England Journal of Medicine2000;342(14):1007‐14. ">DRASTIC</a> trials. The <a href="./references#CD002944-bbs2-0001" title="ASTRAL Investigators, WheatleyK , IvesN , GrayR , KalraPA , MossJG , et al. Revascularization versus medical therapy for renal‐artery stenosis. New England Journal of Medicine2009;361(20):1953‐62. ISRCTN59586944 . Angioplasty and stent for renal artery lesions. ISRCTN Register2007. [URL: http://www.controlled‐trials.com/ISRCTN59586944/Angioplasty+stent+for+renal+artery+lesions] KalraP , MossJ , IvesN , HandleyK , GrayR , WheatleyK . Outcome of patients with highly significant and clinically relevant RAS within the ASTRAL trial. Renal Week 2008, 41st Annual Meeting &amp; Scientific Exposition; 2008 Nov 4‐9; Pennsylvania,USA2008. KalraPA , MossJ , IvesN , Fitzpatrick EllisK , GrayR , WheatleyK , et al. The impact of renal artery revascularization in atherosclerotic renovascular disease: the angioplasty and stenting for renal artery lesions (ASTRAL) trial [abstract no: 090]. Nephrology2008;13 Suppl 3:A123. MistryS , IvesN , HardingJ , Fitzpatrick‐EllisK , LipkinG , KalraPA , et al. Angioplasty and STent for Renal Artery Lesions (ASTRAL trial): rationale, methods and results so far. Journal of Human Hypertension2007;21(7):511‐5. MossJG . ASTRAL trial initial results. Cardiovascular and Interventional Radiological Society of Europe Annual Meeting Abstracts; 2008 Sep 13‐17; Copenhagen, Denmark2008:309. WheatleyK , KalraPA , MossJ , IvesN , Fitzpatrick‐EllisK , GrayR , et al. Lack of benefit of renal artery revascularization in atherosclerotic renovascular disease (ARVD): results of the ASTRAL trial. Renal Week 2008, 41st Annual Meeting &amp; Scientific Exposition; 2008 Nov 4‐9; Pennsylvania,USA2008. ">ASTRAL</a> trial reported the mean number of antihypertensive drugs after one year of follow‐up. SDs were not reported and these were imputed by calculating the mean of the SDs from the <a href="./references#CD002944-bbs2-0002" title="CooperCJ , MurphyTP , MatsumotoA , SteffesM , CohenDJ , JaffM , et al. Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trial. American Heart Journal2006;152(1):59‐66. CooperCJM , MurphyTP , CutlipDE , JamersonK , HenrichW , ReidDM , et al. Stenting and medical therapy for atherosclerotic renal‐artery stenosis. New England Journal of Medicine2014;370:13‐22. MatsumotoA , H , CooperC , MurphyT , CutlipD , ConawayM , et al. Severity of renal artery lesions in patients enrolled into the CORAL trial. Journal of Vascular and Interventional Radiology2010;21(2 Suppl 1):S19. MatsumotoAH , CooperCJ , MurphyTP , CutlipM , ConawayMR , DworkinL . Severity of renal artery lesions in patients enrolled into the CORAL trial. Cardiovascular and Interventional Radiological Society of Europe Annual Meeting Abstracts; 2008 Sep 13‐17; Copenhagen, Denmark2008:308. MurphyTP , CooperCJ , DworkinLD , HenrichWL , RundbackJH , MatsumotoAH , et al. The Cardiovascular Outcomes with Renal Atherosclerotic Lesions (CORAL) study: rationale and methods. Journal of Vascular and Interventional Radiology2005;16(10):1295‐300. NCT00081731 . Benefits of medical therapy plus stenting for renal atherosclerotic lesions. http://clinicaltrials.gov/ct/show/NCT00081731?order=1. [URL: http://clinicaltrials.gov/ct/show/NCT00081731?order=1] ">CORAL</a> and <a href="./references#CD002944-bbs2-0003" title="KrijnenP , vanJaarsveldBC , HuninkMG , HabbemaJD . The effect of treatment on health‐related quality of life in patients with hypertension and renal artery stenosis. Journal of Human Hypertension2005;19(6):467‐70. vanJaarsveldB , KrijnenP , BartelinkA , DeesAd , DerkxFH , Man in't VeldA , et al. The Dutch Renal Artery Stenosis Intervention Cooperative (DRASTIC) Study: rationale and inclusion data. Journal of Hypertension1998;16 Suppl 6:S21‐7. vanJaarsveldB , KrijnenP , BartelinkA , DeesAd , DerkxFH , Man in't VeldA , et al. The Dutch Renal Artery Stenosis Intervention Cooperative (DRASTIC) Study: rationale and inclusion data. Journal of Hypertension1998;16 Suppl 6:S21‐7. vanJaarsveldBC , KrijnenP . Prospective studies of diagnosis and intervention: the Dutch experience. Seminars in Nephrology2000;20(5):463‐73. vanJaarsveldBC , KrijnenP , PietermanH , DerkxF , DeinumJ , PostmaCT , et al. The effect of balloon angioplasty on hypertension in atherosclerotic renal artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group. New England Journal of Medicine2000;342(14):1007‐14. ">DRASTIC</a> trials. The pooled results from the three trials included in the meta‐analysis found that there was a statistically significant MD of ‐0.18 (95% CI ‐0.34 to ‐0.03; P = 0.02, I² = 0%) for the number of antihypertensive drugs in the angioplasty group compared to the medical treatment group (<a href="./references#CD002944-fig-0007" title="">Analysis 1.4</a>). </p> <p>The <a href="./references#CD002944-bbs2-0004" title="PlouinPF , ChatellierG , DarnéB , RaynaudA . Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis. A randomized trial. Essai Multicentrique Medicaments vs Angioplastie (EMMA) Study Group. Hypertension1998;31(3):823‐9. Scottish and Newcastle Renovascular Collaborative Group. Prospective randomized trial of interventional (angioplasty) versus medical therapy in hypertensive patients with atheromatous renal artery stenosis. Journal of Hypertension1994; Vol. 12:1312. ">EMMA</a> trial reported the median defined daily doses (DDD) only, with a significant decrease in median DDD in the balloon angioplasty group. The median DDD at baseline was 1.33 in both groups and decreased to 1.0 (range 0 to 6) in the balloon angioplasty group. In the medical therapy group the median DDD increased to 1.78 (range 0 to 4.3; P = 0.009) for the difference between the two groups. The <a href="./references#CD002944-bbs2-0007" title="WebsterJ , MarshallF , AbdallaM , DominiczakA , EdwardsR , IslesCG , et al. Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. Scottish and Newcastle Renal Artery Stenosis Collaborative Group. Journal of Human Hypertension1998;12(5):329‐35. ">SNRASCG</a> and <a href="./references#CD002944-bbs2-0008" title="BaxL , MaliWP , BuskensE , KoomansHA , BeutlerJJ , BraamB , et al. The benefit of STent placement and blood pressure and lipid‐lowering for the prevention of progression of renal dysfunction caused by Atherosclerotic ostial stenosis of the Renal artery. The STAR‐study: rationale and study design. Journal of Nephrology2003;16(6):807‐12. BaxL , WoittiezAJ , KouwenbergHJ , MaliWP , BuskensE , BeekFJ , et al. Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial. Annals of Internal Medicine2009;150(12):840‐8. ">STAR</a> trials only indicated that there were no statistically significant differences in the number of antihypertensive drugs used at the end of follow‐up without providing more specific information. Data from the <a href="./references#CD002944-bbs2-0005" title="ScarpioniR , MichielettiE , CristinelliL , UgolottiU , ScolariF , VenturelliC , et al. Atherosclerotic renovascular disease: medical therapy versus medical therapy plus renal artery stenting in preventing renal failure progression: the rationale and study design of a prospective, multicenter and randomized trial (NITER). Journal of Nephrology2005;18(4):423‐8. ScarpioniR , MichielettiE , PavoneL . Atherosclerotic renovascular disease (ARVD): medical therapy plus renal artery stenting (PRTS), compared with medical therapy alone, do not offer more chances in preventing C‐V events or the progression of renal failure. Preliminary results of a prospective, multicenter and randomized trial. Abstract World Congress of Nephrology; May 22, 2009; Milan, Italy2009. ">NITER</a> and <a href="./references#CD002944-bbs2-0006" title="SchwarzwalderU , HaukM , ZellerT . RADAR ‐ A randomised, multi‐centre, prospective study comparing best medical treatment versus best medical treatment plus renal artery stenting in patients with haemodynamically relevant atherosclerotic renal artery stenosis. Trials2009;10:60. [NCT00640406] ZellerT . RADAR ‐ Data of a prematurely terminated randomized, multi‐centre prospective study comparing best medical treatment versus best medical treatment plus renal artery stenting in patients with hemodynamically relevant atherosclerotic renal artery stenosis. VASA. Zeitschrift fur Gefasskrankheiten. Journal for Vascular Diseases2013;42:40. ">RADAR</a> trials were not available for this outcome. </p> </section> <section id="CD002944-sec-0059"> <h4 class="title">Presence or absence of restenosis of the renal artery</h4> <p>Restenosis rates could not be assessed in the <a href="./references#CD002944-bbs2-0007" title="WebsterJ , MarshallF , AbdallaM , DominiczakA , EdwardsR , IslesCG , et al. Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. Scottish and Newcastle Renal Artery Stenosis Collaborative Group. Journal of Human Hypertension1998;12(5):329‐35. ">SNRASCG</a> trial because they did not indicate separate restenosis rates for randomised and non‐randomised participants. In the <a href="./references#CD002944-bbs2-0004" title="PlouinPF , ChatellierG , DarnéB , RaynaudA . Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis. A randomized trial. Essai Multicentrique Medicaments vs Angioplastie (EMMA) Study Group. Hypertension1998;31(3):823‐9. Scottish and Newcastle Renovascular Collaborative Group. Prospective randomized trial of interventional (angioplasty) versus medical therapy in hypertensive patients with atheromatous renal artery stenosis. Journal of Hypertension1994; Vol. 12:1312. ">EMMA</a> trial none of the stenotic arteries in either of the two groups were totally occluded on the termination angiogram, but no data on restenosis rates were indicated. In the <a href="./references#CD002944-bbs2-0003" title="KrijnenP , vanJaarsveldBC , HuninkMG , HabbemaJD . The effect of treatment on health‐related quality of life in patients with hypertension and renal artery stenosis. Journal of Human Hypertension2005;19(6):467‐70. vanJaarsveldB , KrijnenP , BartelinkA , DeesAd , DerkxFH , Man in't VeldA , et al. The Dutch Renal Artery Stenosis Intervention Cooperative (DRASTIC) Study: rationale and inclusion data. Journal of Hypertension1998;16 Suppl 6:S21‐7. vanJaarsveldB , KrijnenP , BartelinkA , DeesAd , DerkxFH , Man in't VeldA , et al. The Dutch Renal Artery Stenosis Intervention Cooperative (DRASTIC) Study: rationale and inclusion data. Journal of Hypertension1998;16 Suppl 6:S21‐7. vanJaarsveldBC , KrijnenP . Prospective studies of diagnosis and intervention: the Dutch experience. Seminars in Nephrology2000;20(5):463‐73. vanJaarsveldBC , KrijnenP , PietermanH , DerkxF , DeinumJ , PostmaCT , et al. The effect of balloon angioplasty on hypertension in atherosclerotic renal artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group. New England Journal of Medicine2000;342(14):1007‐14. ">DRASTIC</a> trial angiography was performed in 48 of 56 participants in the angioplasty group, and in 43 of 50 participants in the medical therapy group. Significantly more participants (52%) assigned to balloon angioplasty compared to medical therapy (19%) had a stenosis of less than 50% after 12 months (OR 4.2; 95% CI 1.8 to 9.8). In the <a href="./references#CD002944-bbs2-0008" title="BaxL , MaliWP , BuskensE , KoomansHA , BeutlerJJ , BraamB , et al. The benefit of STent placement and blood pressure and lipid‐lowering for the prevention of progression of renal dysfunction caused by Atherosclerotic ostial stenosis of the Renal artery. The STAR‐study: rationale and study design. Journal of Nephrology2003;16(6):807‐12. BaxL , WoittiezAJ , KouwenbergHJ , MaliWP , BuskensE , BeekFJ , et al. Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial. Annals of Internal Medicine2009;150(12):840‐8. ">STAR</a> trial angiography was repeated in five participants in the intervention group only. This was due to a decline in renal function, and two of the five were found to have restenosis and this was revascularised. Neither of the <a href="./references#CD002944-bbs2-0002" title="CooperCJ , MurphyTP , MatsumotoA , SteffesM , CohenDJ , JaffM , et al. Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trial. American Heart Journal2006;152(1):59‐66. CooperCJM , MurphyTP , CutlipDE , JamersonK , HenrichW , ReidDM , et al. Stenting and medical therapy for atherosclerotic renal‐artery stenosis. New England Journal of Medicine2014;370:13‐22. MatsumotoA , H , CooperC , MurphyT , CutlipD , ConawayM , et al. Severity of renal artery lesions in patients enrolled into the CORAL trial. Journal of Vascular and Interventional Radiology2010;21(2 Suppl 1):S19. MatsumotoAH , CooperCJ , MurphyTP , CutlipM , ConawayMR , DworkinL . Severity of renal artery lesions in patients enrolled into the CORAL trial. Cardiovascular and Interventional Radiological Society of Europe Annual Meeting Abstracts; 2008 Sep 13‐17; Copenhagen, Denmark2008:308. MurphyTP , CooperCJ , DworkinLD , HenrichWL , RundbackJH , MatsumotoAH , et al. The Cardiovascular Outcomes with Renal Atherosclerotic Lesions (CORAL) study: rationale and methods. Journal of Vascular and Interventional Radiology2005;16(10):1295‐300. NCT00081731 . Benefits of medical therapy plus stenting for renal atherosclerotic lesions. http://clinicaltrials.gov/ct/show/NCT00081731?order=1. [URL: http://clinicaltrials.gov/ct/show/NCT00081731?order=1] ">CORAL</a> or <a href="./references#CD002944-bbs2-0001" title="ASTRAL Investigators, WheatleyK , IvesN , GrayR , KalraPA , MossJG , et al. Revascularization versus medical therapy for renal‐artery stenosis. New England Journal of Medicine2009;361(20):1953‐62. ISRCTN59586944 . Angioplasty and stent for renal artery lesions. ISRCTN Register2007. [URL: http://www.controlled‐trials.com/ISRCTN59586944/Angioplasty+stent+for+renal+artery+lesions] KalraP , MossJ , IvesN , HandleyK , GrayR , WheatleyK . Outcome of patients with highly significant and clinically relevant RAS within the ASTRAL trial. Renal Week 2008, 41st Annual Meeting &amp; Scientific Exposition; 2008 Nov 4‐9; Pennsylvania,USA2008. KalraPA , MossJ , IvesN , Fitzpatrick EllisK , GrayR , WheatleyK , et al. The impact of renal artery revascularization in atherosclerotic renovascular disease: the angioplasty and stenting for renal artery lesions (ASTRAL) trial [abstract no: 090]. Nephrology2008;13 Suppl 3:A123. MistryS , IvesN , HardingJ , Fitzpatrick‐EllisK , LipkinG , KalraPA , et al. Angioplasty and STent for Renal Artery Lesions (ASTRAL trial): rationale, methods and results so far. Journal of Human Hypertension2007;21(7):511‐5. MossJG . ASTRAL trial initial results. Cardiovascular and Interventional Radiological Society of Europe Annual Meeting Abstracts; 2008 Sep 13‐17; Copenhagen, Denmark2008:309. WheatleyK , KalraPA , MossJ , IvesN , Fitzpatrick‐EllisK , GrayR , et al. Lack of benefit of renal artery revascularization in atherosclerotic renovascular disease (ARVD): results of the ASTRAL trial. Renal Week 2008, 41st Annual Meeting &amp; Scientific Exposition; 2008 Nov 4‐9; Pennsylvania,USA2008. ">ASTRAL</a> trials performed repeat imaging studies on participants to assess restenosis rates during follow‐up. Data for the <a href="./references#CD002944-bbs2-0005" title="ScarpioniR , MichielettiE , CristinelliL , UgolottiU , ScolariF , VenturelliC , et al. Atherosclerotic renovascular disease: medical therapy versus medical therapy plus renal artery stenting in preventing renal failure progression: the rationale and study design of a prospective, multicenter and randomized trial (NITER). Journal of Nephrology2005;18(4):423‐8. ScarpioniR , MichielettiE , PavoneL . Atherosclerotic renovascular disease (ARVD): medical therapy plus renal artery stenting (PRTS), compared with medical therapy alone, do not offer more chances in preventing C‐V events or the progression of renal failure. Preliminary results of a prospective, multicenter and randomized trial. Abstract World Congress of Nephrology; May 22, 2009; Milan, Italy2009. ">NITER</a> and <a href="./references#CD002944-bbs2-0006" title="SchwarzwalderU , HaukM , ZellerT . RADAR ‐ A randomised, multi‐centre, prospective study comparing best medical treatment versus best medical treatment plus renal artery stenting in patients with haemodynamically relevant atherosclerotic renal artery stenosis. Trials2009;10:60. [NCT00640406] ZellerT . RADAR ‐ Data of a prematurely terminated randomized, multi‐centre prospective study comparing best medical treatment versus best medical treatment plus renal artery stenting in patients with hemodynamically relevant atherosclerotic renal artery stenosis. VASA. Zeitschrift fur Gefasskrankheiten. Journal for Vascular Diseases2013;42:40. ">RADAR</a> trials were not available. </p> </section> <section id="CD002944-sec-0060"> <h4 class="title">Cardiovascular and renal adverse events, procedural complications and side effects of medical therapy </h4> <p>The <a href="./references#CD002944-bbs2-0003" title="KrijnenP , vanJaarsveldBC , HuninkMG , HabbemaJD . The effect of treatment on health‐related quality of life in patients with hypertension and renal artery stenosis. Journal of Human Hypertension2005;19(6):467‐70. vanJaarsveldB , KrijnenP , BartelinkA , DeesAd , DerkxFH , Man in't VeldA , et al. The Dutch Renal Artery Stenosis Intervention Cooperative (DRASTIC) Study: rationale and inclusion data. Journal of Hypertension1998;16 Suppl 6:S21‐7. vanJaarsveldB , KrijnenP , BartelinkA , DeesAd , DerkxFH , Man in't VeldA , et al. The Dutch Renal Artery Stenosis Intervention Cooperative (DRASTIC) Study: rationale and inclusion data. Journal of Hypertension1998;16 Suppl 6:S21‐7. vanJaarsveldBC , KrijnenP . Prospective studies of diagnosis and intervention: the Dutch experience. Seminars in Nephrology2000;20(5):463‐73. vanJaarsveldBC , KrijnenP , PietermanH , DerkxF , DeinumJ , PostmaCT , et al. The effect of balloon angioplasty on hypertension in atherosclerotic renal artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group. New England Journal of Medicine2000;342(14):1007‐14. ">DRASTIC</a> trial reported adverse events during a follow‐up of 12 months. The complication rate in the <a href="./references#CD002944-bbs2-0003" title="KrijnenP , vanJaarsveldBC , HuninkMG , HabbemaJD . The effect of treatment on health‐related quality of life in patients with hypertension and renal artery stenosis. Journal of Human Hypertension2005;19(6):467‐70. vanJaarsveldB , KrijnenP , BartelinkA , DeesAd , DerkxFH , Man in't VeldA , et al. The Dutch Renal Artery Stenosis Intervention Cooperative (DRASTIC) Study: rationale and inclusion data. Journal of Hypertension1998;16 Suppl 6:S21‐7. vanJaarsveldB , KrijnenP , BartelinkA , DeesAd , DerkxFH , Man in't VeldA , et al. The Dutch Renal Artery Stenosis Intervention Cooperative (DRASTIC) Study: rationale and inclusion data. Journal of Hypertension1998;16 Suppl 6:S21‐7. vanJaarsveldBC , KrijnenP . Prospective studies of diagnosis and intervention: the Dutch experience. Seminars in Nephrology2000;20(5):463‐73. vanJaarsveldBC , KrijnenP , PietermanH , DerkxF , DeinumJ , PostmaCT , et al. The effect of balloon angioplasty on hypertension in atherosclerotic renal artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group. New England Journal of Medicine2000;342(14):1007‐14. ">DRASTIC</a> trial (table 2 of their paper) was erroneously reported as number rather than percentage of participants according to the principal author. The <a href="./references#CD002944-bbs2-0004" title="PlouinPF , ChatellierG , DarnéB , RaynaudA . Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis. A randomized trial. Essai Multicentrique Medicaments vs Angioplastie (EMMA) Study Group. Hypertension1998;31(3):823‐9. Scottish and Newcastle Renovascular Collaborative Group. Prospective randomized trial of interventional (angioplasty) versus medical therapy in hypertensive patients with atheromatous renal artery stenosis. Journal of Hypertension1994; Vol. 12:1312. ">EMMA</a> and <a href="./references#CD002944-bbs2-0007" title="WebsterJ , MarshallF , AbdallaM , DominiczakA , EdwardsR , IslesCG , et al. Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. Scottish and Newcastle Renal Artery Stenosis Collaborative Group. Journal of Human Hypertension1998;12(5):329‐35. ">SNRASCG</a> trials reported adverse events during a follow‐up of six months, the <a href="./references#CD002944-bbs2-0008" title="BaxL , MaliWP , BuskensE , KoomansHA , BeutlerJJ , BraamB , et al. The benefit of STent placement and blood pressure and lipid‐lowering for the prevention of progression of renal dysfunction caused by Atherosclerotic ostial stenosis of the Renal artery. The STAR‐study: rationale and study design. Journal of Nephrology2003;16(6):807‐12. BaxL , WoittiezAJ , KouwenbergHJ , MaliWP , BuskensE , BeekFJ , et al. Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial. Annals of Internal Medicine2009;150(12):840‐8. ">STAR</a> trial during a follow‐up of 24 months, the <a href="./references#CD002944-bbs2-0005" title="ScarpioniR , MichielettiE , CristinelliL , UgolottiU , ScolariF , VenturelliC , et al. Atherosclerotic renovascular disease: medical therapy versus medical therapy plus renal artery stenting in preventing renal failure progression: the rationale and study design of a prospective, multicenter and randomized trial (NITER). Journal of Nephrology2005;18(4):423‐8. ScarpioniR , MichielettiE , PavoneL . Atherosclerotic renovascular disease (ARVD): medical therapy plus renal artery stenting (PRTS), compared with medical therapy alone, do not offer more chances in preventing C‐V events or the progression of renal failure. Preliminary results of a prospective, multicenter and randomized trial. Abstract World Congress of Nephrology; May 22, 2009; Milan, Italy2009. ">NITER</a> and <a href="./references#CD002944-bbs2-0002" title="CooperCJ , MurphyTP , MatsumotoA , SteffesM , CohenDJ , JaffM , et al. Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trial. American Heart Journal2006;152(1):59‐66. CooperCJM , MurphyTP , CutlipDE , JamersonK , HenrichW , ReidDM , et al. Stenting and medical therapy for atherosclerotic renal‐artery stenosis. New England Journal of Medicine2014;370:13‐22. MatsumotoA , H , CooperC , MurphyT , CutlipD , ConawayM , et al. Severity of renal artery lesions in patients enrolled into the CORAL trial. Journal of Vascular and Interventional Radiology2010;21(2 Suppl 1):S19. MatsumotoAH , CooperCJ , MurphyTP , CutlipM , ConawayMR , DworkinL . Severity of renal artery lesions in patients enrolled into the CORAL trial. Cardiovascular and Interventional Radiological Society of Europe Annual Meeting Abstracts; 2008 Sep 13‐17; Copenhagen, Denmark2008:308. MurphyTP , CooperCJ , DworkinLD , HenrichWL , RundbackJH , MatsumotoAH , et al. The Cardiovascular Outcomes with Renal Atherosclerotic Lesions (CORAL) study: rationale and methods. Journal of Vascular and Interventional Radiology2005;16(10):1295‐300. NCT00081731 . Benefits of medical therapy plus stenting for renal atherosclerotic lesions. http://clinicaltrials.gov/ct/show/NCT00081731?order=1. [URL: http://clinicaltrials.gov/ct/show/NCT00081731?order=1] ">CORAL</a> trials during a follow‐up of 43 months and the <a href="./references#CD002944-bbs2-0001" title="ASTRAL Investigators, WheatleyK , IvesN , GrayR , KalraPA , MossJG , et al. Revascularization versus medical therapy for renal‐artery stenosis. New England Journal of Medicine2009;361(20):1953‐62. ISRCTN59586944 . Angioplasty and stent for renal artery lesions. ISRCTN Register2007. [URL: http://www.controlled‐trials.com/ISRCTN59586944/Angioplasty+stent+for+renal+artery+lesions] KalraP , MossJ , IvesN , HandleyK , GrayR , WheatleyK . Outcome of patients with highly significant and clinically relevant RAS within the ASTRAL trial. Renal Week 2008, 41st Annual Meeting &amp; Scientific Exposition; 2008 Nov 4‐9; Pennsylvania,USA2008. KalraPA , MossJ , IvesN , Fitzpatrick EllisK , GrayR , WheatleyK , et al. The impact of renal artery revascularization in atherosclerotic renovascular disease: the angioplasty and stenting for renal artery lesions (ASTRAL) trial [abstract no: 090]. Nephrology2008;13 Suppl 3:A123. MistryS , IvesN , HardingJ , Fitzpatrick‐EllisK , LipkinG , KalraPA , et al. Angioplasty and STent for Renal Artery Lesions (ASTRAL trial): rationale, methods and results so far. Journal of Human Hypertension2007;21(7):511‐5. MossJG . ASTRAL trial initial results. Cardiovascular and Interventional Radiological Society of Europe Annual Meeting Abstracts; 2008 Sep 13‐17; Copenhagen, Denmark2008:309. WheatleyK , KalraPA , MossJ , IvesN , Fitzpatrick‐EllisK , GrayR , et al. Lack of benefit of renal artery revascularization in atherosclerotic renovascular disease (ARVD): results of the ASTRAL trial. Renal Week 2008, 41st Annual Meeting &amp; Scientific Exposition; 2008 Nov 4‐9; Pennsylvania,USA2008. ">ASTRAL</a> trial during a follow‐up of five years (<a href="#CD002944-tbl-0001">Table 1</a>; <a href="#CD002944-tbl-0002">Table 2</a>). Data for the <a href="./references#CD002944-bbs2-0006" title="SchwarzwalderU , HaukM , ZellerT . RADAR ‐ A randomised, multi‐centre, prospective study comparing best medical treatment versus best medical treatment plus renal artery stenting in patients with haemodynamically relevant atherosclerotic renal artery stenosis. Trials2009;10:60. [NCT00640406] ZellerT . RADAR ‐ Data of a prematurely terminated randomized, multi‐centre prospective study comparing best medical treatment versus best medical treatment plus renal artery stenting in patients with hemodynamically relevant atherosclerotic renal artery stenosis. VASA. Zeitschrift fur Gefasskrankheiten. Journal for Vascular Diseases2013;42:40. ">RADAR</a> trial were not available. </p> <div class="table" id="CD002944-tbl-0001"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Cardiovascular complications</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Complications</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> ASTRAL</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b> CORAL</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> DRASTIC</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> EMMA</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> NITER</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> SNRASCG</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> STAR</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Angina/myocardial infarction/heart failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>112 in BA, 131 in MT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>40 in BA, 37 in MT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0 in BA, 2 in MT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0 in any group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Data not available</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4 in each group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4 in BA, 6 in MT</p> <p>(defined as</p> <p>CAD + HF)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cholesterol embolisation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 in BA, 0 in MT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 in BA, 0 in MT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0 in BA, 1 in MT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0 in any group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Data not available</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0 in any group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 in BA, 0 in MT</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Non‐procedure‐related symptomatic hypotension</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Data not available</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Data not available</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0 in any group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0 in BA, 1 in MT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Data not available</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0 in any group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Data not available</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Stroke</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24 in BA, 23 in MT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16 in BA, 23 in MT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0 in any group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0 in any group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 in BA, 4 in MT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 in BA, 4 in MT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0 in BA, 1 in MT</p> <p>(defined as cerebro</p> <p>vascular disease)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Death</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>103 in BA, 106 in MT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>63 in BA, 76 in MT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0 in any group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0 in any group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 in BA, 3 in MT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 in BA, 4 in MT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 in MT, 5 in BA</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>BA: balloon angioplasty group<br/> CAD: coronary artery disease<br/> HF: heart failure<br/> MT: medical therapy group </p> </div> </div> <div class="table" id="CD002944-tbl-0002"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Renovascular complications</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Complications</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> ASTRAL</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b> CORAL</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> DRASTIC</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> EMMA</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> NITER</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> SNRASCG</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> STAR</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&gt; 50% increase in serum creatinine</p> <p>or<br/> &gt; 20% decrease in estimated creatinine clearance </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Data not available</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Data not available</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 in BA, 3 in MT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0 in BA, 1 in MT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Data not available</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0 in any group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10 in BA, 16 in MT</p> <p>(data provided for</p> <p>20% fall in CrCl only)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Renal failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>55 in BA, 54 in MT</p> <p>(defined as AKI + dialysis for</p> <p>end stage renal disease)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16 in BA, 8 in MT (defined as permanent RRT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0 in any group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0 in any group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10 in BA, 8 in MT</p> <p>(but unclear how worsening</p> <p>renal failure was defined)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 in each group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Data not available</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Total occlusion of stenotic artery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5 in BA, 4 in MT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Data not available</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0 in BA, 4 in MT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0 in any group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Data not available</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0 in any group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Data not available</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>AKI: acute kidney injury<br/> BA: balloon angioplasty group<br/> CrCl: creatinine clearance<br/> MT: medical therapy group<br/> RRT: renal replacement therapy </p> </div> </div> <p>There were similar numbers of cardiovascular and renal adverse events in participants treated with balloon angioplasty relative to medical therapy. Using the correct values for the <a href="./references#CD002944-bbs2-0003" title="KrijnenP , vanJaarsveldBC , HuninkMG , HabbemaJD . The effect of treatment on health‐related quality of life in patients with hypertension and renal artery stenosis. Journal of Human Hypertension2005;19(6):467‐70. vanJaarsveldB , KrijnenP , BartelinkA , DeesAd , DerkxFH , Man in't VeldA , et al. The Dutch Renal Artery Stenosis Intervention Cooperative (DRASTIC) Study: rationale and inclusion data. Journal of Hypertension1998;16 Suppl 6:S21‐7. vanJaarsveldB , KrijnenP , BartelinkA , DeesAd , DerkxFH , Man in't VeldA , et al. The Dutch Renal Artery Stenosis Intervention Cooperative (DRASTIC) Study: rationale and inclusion data. Journal of Hypertension1998;16 Suppl 6:S21‐7. vanJaarsveldBC , KrijnenP . Prospective studies of diagnosis and intervention: the Dutch experience. Seminars in Nephrology2000;20(5):463‐73. vanJaarsveldBC , KrijnenP , PietermanH , DerkxF , DeinumJ , PostmaCT , et al. The effect of balloon angioplasty on hypertension in atherosclerotic renal artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group. New England Journal of Medicine2000;342(14):1007‐14. ">DRASTIC</a> trial, overall there were 366 out of 1039 (32%) major cardiovascular adverse events and 99 out of 1036 (10%) renal adverse events in participants undergoing balloon angioplasty compared with 395 out of 1071 (37%) and 100 out of 1068 (9%), respectively, in participants treated with medical therapy (OR 0.91; 95% CI 0.75 to 1.11; I² = 0% for cardiovascular adverse events (<a href="./references#CD002944-fig-0008" title="">Analysis 1.5</a>) and OR 1.02; 95% CI 0.75 to 1.38; I² = 42% (<a href="./references#CD002944-fig-0009" title="">Analysis 1.6</a>) for renal adverse events). </p> <p>Of the participants who underwent balloon angioplasty, 64 out of 987 (6.5%) developed a significant haematoma at the site of catheter insertion, using individual trial definitions for this complication, seven out of 987 (0.7%) femoral artery pseudoaneurysm, 25 out of 987 (2.5%) renal artery or kidney perforation or dissection. There were four (0.4%) peri‐procedural deaths (defined as death from procedure‐related causes within 30 days of the procedure): two from the <a href="./references#CD002944-bbs2-0008" title="BaxL , MaliWP , BuskensE , KoomansHA , BeutlerJJ , BraamB , et al. The benefit of STent placement and blood pressure and lipid‐lowering for the prevention of progression of renal dysfunction caused by Atherosclerotic ostial stenosis of the Renal artery. The STAR‐study: rationale and study design. Journal of Nephrology2003;16(6):807‐12. BaxL , WoittiezAJ , KouwenbergHJ , MaliWP , BuskensE , BeekFJ , et al. Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial. Annals of Internal Medicine2009;150(12):840‐8. ">STAR</a> trial following a perforated renal artery, and two from the <a href="./references#CD002944-bbs2-0001" title="ASTRAL Investigators, WheatleyK , IvesN , GrayR , KalraPA , MossJG , et al. Revascularization versus medical therapy for renal‐artery stenosis. New England Journal of Medicine2009;361(20):1953‐62. ISRCTN59586944 . Angioplasty and stent for renal artery lesions. ISRCTN Register2007. [URL: http://www.controlled‐trials.com/ISRCTN59586944/Angioplasty+stent+for+renal+artery+lesions] KalraP , MossJ , IvesN , HandleyK , GrayR , WheatleyK . Outcome of patients with highly significant and clinically relevant RAS within the ASTRAL trial. Renal Week 2008, 41st Annual Meeting &amp; Scientific Exposition; 2008 Nov 4‐9; Pennsylvania,USA2008. KalraPA , MossJ , IvesN , Fitzpatrick EllisK , GrayR , WheatleyK , et al. The impact of renal artery revascularization in atherosclerotic renovascular disease: the angioplasty and stenting for renal artery lesions (ASTRAL) trial [abstract no: 090]. Nephrology2008;13 Suppl 3:A123. MistryS , IvesN , HardingJ , Fitzpatrick‐EllisK , LipkinG , KalraPA , et al. Angioplasty and STent for Renal Artery Lesions (ASTRAL trial): rationale, methods and results so far. Journal of Human Hypertension2007;21(7):511‐5. MossJG . ASTRAL trial initial results. Cardiovascular and Interventional Radiological Society of Europe Annual Meeting Abstracts; 2008 Sep 13‐17; Copenhagen, Denmark2008:309. WheatleyK , KalraPA , MossJ , IvesN , Fitzpatrick‐EllisK , GrayR , et al. Lack of benefit of renal artery revascularization in atherosclerotic renovascular disease (ARVD): results of the ASTRAL trial. Renal Week 2008, 41st Annual Meeting &amp; Scientific Exposition; 2008 Nov 4‐9; Pennsylvania,USA2008. ">ASTRAL</a> trial due to cardiac causes. </p> <p>No trial reported side effects of medical therapy.</p> </section> <section id="CD002944-sec-0061"> <h4 class="title">Subgroup analysis</h4> <p>A subgroup analysis restricting all the meta‐analyses to the five studies that carried out angioplasty with stenting (<a href="./references#CD002944-bbs2-0001" title="ASTRAL Investigators, WheatleyK , IvesN , GrayR , KalraPA , MossJG , et al. Revascularization versus medical therapy for renal‐artery stenosis. New England Journal of Medicine2009;361(20):1953‐62. ISRCTN59586944 . Angioplasty and stent for renal artery lesions. ISRCTN Register2007. [URL: http://www.controlled‐trials.com/ISRCTN59586944/Angioplasty+stent+for+renal+artery+lesions] KalraP , MossJ , IvesN , HandleyK , GrayR , WheatleyK . Outcome of patients with highly significant and clinically relevant RAS within the ASTRAL trial. Renal Week 2008, 41st Annual Meeting &amp; Scientific Exposition; 2008 Nov 4‐9; Pennsylvania,USA2008. KalraPA , MossJ , IvesN , Fitzpatrick EllisK , GrayR , WheatleyK , et al. The impact of renal artery revascularization in atherosclerotic renovascular disease: the angioplasty and stenting for renal artery lesions (ASTRAL) trial [abstract no: 090]. Nephrology2008;13 Suppl 3:A123. MistryS , IvesN , HardingJ , Fitzpatrick‐EllisK , LipkinG , KalraPA , et al. Angioplasty and STent for Renal Artery Lesions (ASTRAL trial): rationale, methods and results so far. Journal of Human Hypertension2007;21(7):511‐5. MossJG . ASTRAL trial initial results. Cardiovascular and Interventional Radiological Society of Europe Annual Meeting Abstracts; 2008 Sep 13‐17; Copenhagen, Denmark2008:309. WheatleyK , KalraPA , MossJ , IvesN , Fitzpatrick‐EllisK , GrayR , et al. Lack of benefit of renal artery revascularization in atherosclerotic renovascular disease (ARVD): results of the ASTRAL trial. Renal Week 2008, 41st Annual Meeting &amp; Scientific Exposition; 2008 Nov 4‐9; Pennsylvania,USA2008. ">ASTRAL</a>; <a href="./references#CD002944-bbs2-0002" title="CooperCJ , MurphyTP , MatsumotoA , SteffesM , CohenDJ , JaffM , et al. Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trial. American Heart Journal2006;152(1):59‐66. CooperCJM , MurphyTP , CutlipDE , JamersonK , HenrichW , ReidDM , et al. Stenting and medical therapy for atherosclerotic renal‐artery stenosis. New England Journal of Medicine2014;370:13‐22. MatsumotoA , H , CooperC , MurphyT , CutlipD , ConawayM , et al. Severity of renal artery lesions in patients enrolled into the CORAL trial. Journal of Vascular and Interventional Radiology2010;21(2 Suppl 1):S19. MatsumotoAH , CooperCJ , MurphyTP , CutlipM , ConawayMR , DworkinL . Severity of renal artery lesions in patients enrolled into the CORAL trial. Cardiovascular and Interventional Radiological Society of Europe Annual Meeting Abstracts; 2008 Sep 13‐17; Copenhagen, Denmark2008:308. MurphyTP , CooperCJ , DworkinLD , HenrichWL , RundbackJH , MatsumotoAH , et al. The Cardiovascular Outcomes with Renal Atherosclerotic Lesions (CORAL) study: rationale and methods. Journal of Vascular and Interventional Radiology2005;16(10):1295‐300. NCT00081731 . Benefits of medical therapy plus stenting for renal atherosclerotic lesions. http://clinicaltrials.gov/ct/show/NCT00081731?order=1. [URL: http://clinicaltrials.gov/ct/show/NCT00081731?order=1] ">CORAL</a>; <a href="./references#CD002944-bbs2-0005" title="ScarpioniR , MichielettiE , CristinelliL , UgolottiU , ScolariF , VenturelliC , et al. Atherosclerotic renovascular disease: medical therapy versus medical therapy plus renal artery stenting in preventing renal failure progression: the rationale and study design of a prospective, multicenter and randomized trial (NITER). Journal of Nephrology2005;18(4):423‐8. ScarpioniR , MichielettiE , PavoneL . Atherosclerotic renovascular disease (ARVD): medical therapy plus renal artery stenting (PRTS), compared with medical therapy alone, do not offer more chances in preventing C‐V events or the progression of renal failure. Preliminary results of a prospective, multicenter and randomized trial. Abstract World Congress of Nephrology; May 22, 2009; Milan, Italy2009. ">NITER</a>; <a href="./references#CD002944-bbs2-0006" title="SchwarzwalderU , HaukM , ZellerT . RADAR ‐ A randomised, multi‐centre, prospective study comparing best medical treatment versus best medical treatment plus renal artery stenting in patients with haemodynamically relevant atherosclerotic renal artery stenosis. Trials2009;10:60. [NCT00640406] ZellerT . RADAR ‐ Data of a prematurely terminated randomized, multi‐centre prospective study comparing best medical treatment versus best medical treatment plus renal artery stenting in patients with hemodynamically relevant atherosclerotic renal artery stenosis. VASA. Zeitschrift fur Gefasskrankheiten. Journal for Vascular Diseases2013;42:40. ">RADAR</a>; <a href="./references#CD002944-bbs2-0008" title="BaxL , MaliWP , BuskensE , KoomansHA , BeutlerJJ , BraamB , et al. The benefit of STent placement and blood pressure and lipid‐lowering for the prevention of progression of renal dysfunction caused by Atherosclerotic ostial stenosis of the Renal artery. The STAR‐study: rationale and study design. Journal of Nephrology2003;16(6):807‐12. BaxL , WoittiezAJ , KouwenbergHJ , MaliWP , BuskensE , BeekFJ , et al. Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial. Annals of Internal Medicine2009;150(12):840‐8. ">STAR</a>) did not significantly alter any of the results apart from the change in diastolic BP, where the MD between the angioplasty and the medical treatment group reduced and became non‐significant (MD ‐1.24 mmHg, 95% CI ‐3.23 to 0.75; P = 0.22, I² = 0%). </p> <p>The available data did not permit the pre‐planned subgroup analyses for patients with ostial versus non‐ostial stenosis, uni‐ versus bilateral stenosis, or trials of high and low risk of bias. </p> </section> <section id="CD002944-sec-0062"> <h4 class="title">Sensitivity analysis</h4> <p>The <a href="./references#CD002944-bbs2-0001" title="ASTRAL Investigators, WheatleyK , IvesN , GrayR , KalraPA , MossJG , et al. Revascularization versus medical therapy for renal‐artery stenosis. New England Journal of Medicine2009;361(20):1953‐62. ISRCTN59586944 . Angioplasty and stent for renal artery lesions. ISRCTN Register2007. [URL: http://www.controlled‐trials.com/ISRCTN59586944/Angioplasty+stent+for+renal+artery+lesions] KalraP , MossJ , IvesN , HandleyK , GrayR , WheatleyK . Outcome of patients with highly significant and clinically relevant RAS within the ASTRAL trial. Renal Week 2008, 41st Annual Meeting &amp; Scientific Exposition; 2008 Nov 4‐9; Pennsylvania,USA2008. KalraPA , MossJ , IvesN , Fitzpatrick EllisK , GrayR , WheatleyK , et al. The impact of renal artery revascularization in atherosclerotic renovascular disease: the angioplasty and stenting for renal artery lesions (ASTRAL) trial [abstract no: 090]. Nephrology2008;13 Suppl 3:A123. MistryS , IvesN , HardingJ , Fitzpatrick‐EllisK , LipkinG , KalraPA , et al. Angioplasty and STent for Renal Artery Lesions (ASTRAL trial): rationale, methods and results so far. Journal of Human Hypertension2007;21(7):511‐5. MossJG . ASTRAL trial initial results. Cardiovascular and Interventional Radiological Society of Europe Annual Meeting Abstracts; 2008 Sep 13‐17; Copenhagen, Denmark2008:309. WheatleyK , KalraPA , MossJ , IvesN , Fitzpatrick‐EllisK , GrayR , et al. Lack of benefit of renal artery revascularization in atherosclerotic renovascular disease (ARVD): results of the ASTRAL trial. Renal Week 2008, 41st Annual Meeting &amp; Scientific Exposition; 2008 Nov 4‐9; Pennsylvania,USA2008. ">ASTRAL</a> trial had 806 participants and the <a href="./references#CD002944-bbs2-0002" title="CooperCJ , MurphyTP , MatsumotoA , SteffesM , CohenDJ , JaffM , et al. Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trial. American Heart Journal2006;152(1):59‐66. CooperCJM , MurphyTP , CutlipDE , JamersonK , HenrichW , ReidDM , et al. Stenting and medical therapy for atherosclerotic renal‐artery stenosis. New England Journal of Medicine2014;370:13‐22. MatsumotoA , H , CooperC , MurphyT , CutlipD , ConawayM , et al. Severity of renal artery lesions in patients enrolled into the CORAL trial. Journal of Vascular and Interventional Radiology2010;21(2 Suppl 1):S19. MatsumotoAH , CooperCJ , MurphyTP , CutlipM , ConawayMR , DworkinL . Severity of renal artery lesions in patients enrolled into the CORAL trial. Cardiovascular and Interventional Radiological Society of Europe Annual Meeting Abstracts; 2008 Sep 13‐17; Copenhagen, Denmark2008:308. MurphyTP , CooperCJ , DworkinLD , HenrichWL , RundbackJH , MatsumotoAH , et al. The Cardiovascular Outcomes with Renal Atherosclerotic Lesions (CORAL) study: rationale and methods. Journal of Vascular and Interventional Radiology2005;16(10):1295‐300. NCT00081731 . Benefits of medical therapy plus stenting for renal atherosclerotic lesions. http://clinicaltrials.gov/ct/show/NCT00081731?order=1. [URL: http://clinicaltrials.gov/ct/show/NCT00081731?order=1] ">CORAL</a> trial had 947 participants; these trials therefore accounted for the majority of the participants included in the meta‐analysis. A sensitivity analysis was carried out and this showed that these studies did not heavily influence any of the meta‐analysis results with the exception of the meta‐analysis of the number of antihypertensive drugs. If either the <a href="./references#CD002944-bbs2-0002" title="CooperCJ , MurphyTP , MatsumotoA , SteffesM , CohenDJ , JaffM , et al. Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trial. American Heart Journal2006;152(1):59‐66. CooperCJM , MurphyTP , CutlipDE , JamersonK , HenrichW , ReidDM , et al. Stenting and medical therapy for atherosclerotic renal‐artery stenosis. New England Journal of Medicine2014;370:13‐22. MatsumotoA , H , CooperC , MurphyT , CutlipD , ConawayM , et al. Severity of renal artery lesions in patients enrolled into the CORAL trial. Journal of Vascular and Interventional Radiology2010;21(2 Suppl 1):S19. MatsumotoAH , CooperCJ , MurphyTP , CutlipM , ConawayMR , DworkinL . Severity of renal artery lesions in patients enrolled into the CORAL trial. Cardiovascular and Interventional Radiological Society of Europe Annual Meeting Abstracts; 2008 Sep 13‐17; Copenhagen, Denmark2008:308. MurphyTP , CooperCJ , DworkinLD , HenrichWL , RundbackJH , MatsumotoAH , et al. The Cardiovascular Outcomes with Renal Atherosclerotic Lesions (CORAL) study: rationale and methods. Journal of Vascular and Interventional Radiology2005;16(10):1295‐300. NCT00081731 . Benefits of medical therapy plus stenting for renal atherosclerotic lesions. http://clinicaltrials.gov/ct/show/NCT00081731?order=1. [URL: http://clinicaltrials.gov/ct/show/NCT00081731?order=1] ">CORAL</a> or <a href="./references#CD002944-bbs2-0001" title="ASTRAL Investigators, WheatleyK , IvesN , GrayR , KalraPA , MossJG , et al. Revascularization versus medical therapy for renal‐artery stenosis. New England Journal of Medicine2009;361(20):1953‐62. ISRCTN59586944 . Angioplasty and stent for renal artery lesions. ISRCTN Register2007. [URL: http://www.controlled‐trials.com/ISRCTN59586944/Angioplasty+stent+for+renal+artery+lesions] KalraP , MossJ , IvesN , HandleyK , GrayR , WheatleyK . Outcome of patients with highly significant and clinically relevant RAS within the ASTRAL trial. Renal Week 2008, 41st Annual Meeting &amp; Scientific Exposition; 2008 Nov 4‐9; Pennsylvania,USA2008. KalraPA , MossJ , IvesN , Fitzpatrick EllisK , GrayR , WheatleyK , et al. The impact of renal artery revascularization in atherosclerotic renovascular disease: the angioplasty and stenting for renal artery lesions (ASTRAL) trial [abstract no: 090]. Nephrology2008;13 Suppl 3:A123. MistryS , IvesN , HardingJ , Fitzpatrick‐EllisK , LipkinG , KalraPA , et al. Angioplasty and STent for Renal Artery Lesions (ASTRAL trial): rationale, methods and results so far. Journal of Human Hypertension2007;21(7):511‐5. MossJG . ASTRAL trial initial results. Cardiovascular and Interventional Radiological Society of Europe Annual Meeting Abstracts; 2008 Sep 13‐17; Copenhagen, Denmark2008:309. WheatleyK , KalraPA , MossJ , IvesN , Fitzpatrick‐EllisK , GrayR , et al. Lack of benefit of renal artery revascularization in atherosclerotic renovascular disease (ARVD): results of the ASTRAL trial. Renal Week 2008, 41st Annual Meeting &amp; Scientific Exposition; 2008 Nov 4‐9; Pennsylvania,USA2008. ">ASTRAL</a> trial was excluded from this meta‐analysis then the MD between antihypertensive drug requirements in the angioplasty group relative to the medical treatment group reduced and became non‐significant (MD ‐0.15; 95% CI ‐0.43 to 0.12; P = 0.27, I² = 10% and MD ‐0.18; 95% CI ‐0.36 to 0.00; P = 0.05, I² = 14%, respectively). </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD002944-sec-0063" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD002944-sec-0063"></div> <p>We reviewed eight randomised controlled trials comparing medical treatment to balloon angioplasty, with or without stenting, in hypertensive patients with atherosclerotic renal artery stenosis. </p> <section id="CD002944-sec-0064"> <h3 class="title" id="CD002944-sec-0064">Summary of main results</h3> <p>Our meta‐analysis did not identify any statistically significant difference in serum creatinine or in cardiovascular or renal adverse events between the balloon angioplasty and medical treatment arms. There was a small improvement in diastolic BP and a small reduction in the number of antihypertensive drugs required in the angioplasty group relative to the medical treatment group. However, the quality and methodology of the studies is variable and not all the available data from all eight studies could be combined as part of a pooled analysis. </p> <p>There is a non‐significant trend towards a reduction in cardiovascular and renal adverse events in the angioplasty group relative to the medical treatment group. A type beta error with false acceptance of the null hypothesis is therefore a possibility and larger trials with increased power are required to address this issue. </p> <p>A small number of procedural complications of balloon angioplasty were reported (haematoma at the site of catheter insertion (6.5%), femoral artery pseudoaneurysm (0.7%), renal artery or kidney perforation or dissection (2.5%) as well as peri‐procedural deaths (0.4%)). No side effects of medical therapy were reported. </p> <p>Overall, the available evidence suggests that the benefits of balloon angioplasty for patients with renal artery stenosis are at best limited to a small improvement in diastolic blood pressure (BP) and a small reduction in antihypertensive medication. </p> </section> <section id="CD002944-sec-0065"> <h3 class="title" id="CD002944-sec-0065">Overall completeness and applicability of evidence</h3> <p>The quality of the included studies is variable and overall there is insufficient evidence to determine whether or not patients with renal artery stenosis benefit clinically from balloon angioplasty. None of the studies presented data separately according to the severity of the renal artery stenosis, and only one trial (<a href="./references#CD002944-bbs2-0007" title="WebsterJ , MarshallF , AbdallaM , DominiczakA , EdwardsR , IslesCG , et al. Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. Scottish and Newcastle Renal Artery Stenosis Collaborative Group. Journal of Human Hypertension1998;12(5):329‐35. ">SNRASCG</a>) analysed results separately for participants with unilateral and bilateral stenosis. We were therefore unable to carry out any subgroup analyses to try and identify groups of patients who may potentially have a greater clinical benefit from angioplasty. </p> <p>An additional limitation to the analysis was the fact that only two studies (<a href="./references#CD002944-bbs2-0002" title="CooperCJ , MurphyTP , MatsumotoA , SteffesM , CohenDJ , JaffM , et al. Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trial. American Heart Journal2006;152(1):59‐66. CooperCJM , MurphyTP , CutlipDE , JamersonK , HenrichW , ReidDM , et al. Stenting and medical therapy for atherosclerotic renal‐artery stenosis. New England Journal of Medicine2014;370:13‐22. MatsumotoA , H , CooperC , MurphyT , CutlipD , ConawayM , et al. Severity of renal artery lesions in patients enrolled into the CORAL trial. Journal of Vascular and Interventional Radiology2010;21(2 Suppl 1):S19. MatsumotoAH , CooperCJ , MurphyTP , CutlipM , ConawayMR , DworkinL . Severity of renal artery lesions in patients enrolled into the CORAL trial. Cardiovascular and Interventional Radiological Society of Europe Annual Meeting Abstracts; 2008 Sep 13‐17; Copenhagen, Denmark2008:308. MurphyTP , CooperCJ , DworkinLD , HenrichWL , RundbackJH , MatsumotoAH , et al. The Cardiovascular Outcomes with Renal Atherosclerotic Lesions (CORAL) study: rationale and methods. Journal of Vascular and Interventional Radiology2005;16(10):1295‐300. NCT00081731 . Benefits of medical therapy plus stenting for renal atherosclerotic lesions. http://clinicaltrials.gov/ct/show/NCT00081731?order=1. [URL: http://clinicaltrials.gov/ct/show/NCT00081731?order=1] ">CORAL</a>; <a href="./references#CD002944-bbs2-0004" title="PlouinPF , ChatellierG , DarnéB , RaynaudA . Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis. A randomized trial. Essai Multicentrique Medicaments vs Angioplastie (EMMA) Study Group. Hypertension1998;31(3):823‐9. Scottish and Newcastle Renovascular Collaborative Group. Prospective randomized trial of interventional (angioplasty) versus medical therapy in hypertensive patients with atheromatous renal artery stenosis. Journal of Hypertension1994; Vol. 12:1312. ">EMMA</a>) reported SDs for changes in systolic BP and only one study (<a href="./references#CD002944-bbs2-0004" title="PlouinPF , ChatellierG , DarnéB , RaynaudA . Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis. A randomized trial. Essai Multicentrique Medicaments vs Angioplastie (EMMA) Study Group. Hypertension1998;31(3):823‐9. Scottish and Newcastle Renovascular Collaborative Group. Prospective randomized trial of interventional (angioplasty) versus medical therapy in hypertensive patients with atheromatous renal artery stenosis. Journal of Hypertension1994; Vol. 12:1312. ">EMMA</a>) for the change in diastolic BP during follow‐up. SDs were therefore imputed for the five other studies included in the meta‐analysis (<a href="./references#CD002944-bbs2-0001" title="ASTRAL Investigators, WheatleyK , IvesN , GrayR , KalraPA , MossJG , et al. Revascularization versus medical therapy for renal‐artery stenosis. New England Journal of Medicine2009;361(20):1953‐62. ISRCTN59586944 . Angioplasty and stent for renal artery lesions. ISRCTN Register2007. [URL: http://www.controlled‐trials.com/ISRCTN59586944/Angioplasty+stent+for+renal+artery+lesions] KalraP , MossJ , IvesN , HandleyK , GrayR , WheatleyK . Outcome of patients with highly significant and clinically relevant RAS within the ASTRAL trial. Renal Week 2008, 41st Annual Meeting &amp; Scientific Exposition; 2008 Nov 4‐9; Pennsylvania,USA2008. KalraPA , MossJ , IvesN , Fitzpatrick EllisK , GrayR , WheatleyK , et al. The impact of renal artery revascularization in atherosclerotic renovascular disease: the angioplasty and stenting for renal artery lesions (ASTRAL) trial [abstract no: 090]. Nephrology2008;13 Suppl 3:A123. MistryS , IvesN , HardingJ , Fitzpatrick‐EllisK , LipkinG , KalraPA , et al. Angioplasty and STent for Renal Artery Lesions (ASTRAL trial): rationale, methods and results so far. Journal of Human Hypertension2007;21(7):511‐5. MossJG . ASTRAL trial initial results. Cardiovascular and Interventional Radiological Society of Europe Annual Meeting Abstracts; 2008 Sep 13‐17; Copenhagen, Denmark2008:309. WheatleyK , KalraPA , MossJ , IvesN , Fitzpatrick‐EllisK , GrayR , et al. Lack of benefit of renal artery revascularization in atherosclerotic renovascular disease (ARVD): results of the ASTRAL trial. Renal Week 2008, 41st Annual Meeting &amp; Scientific Exposition; 2008 Nov 4‐9; Pennsylvania,USA2008. ">ASTRAL</a>; <a href="./references#CD002944-bbs2-0003" title="KrijnenP , vanJaarsveldBC , HuninkMG , HabbemaJD . The effect of treatment on health‐related quality of life in patients with hypertension and renal artery stenosis. Journal of Human Hypertension2005;19(6):467‐70. vanJaarsveldB , KrijnenP , BartelinkA , DeesAd , DerkxFH , Man in't VeldA , et al. The Dutch Renal Artery Stenosis Intervention Cooperative (DRASTIC) Study: rationale and inclusion data. Journal of Hypertension1998;16 Suppl 6:S21‐7. vanJaarsveldB , KrijnenP , BartelinkA , DeesAd , DerkxFH , Man in't VeldA , et al. The Dutch Renal Artery Stenosis Intervention Cooperative (DRASTIC) Study: rationale and inclusion data. Journal of Hypertension1998;16 Suppl 6:S21‐7. vanJaarsveldBC , KrijnenP . Prospective studies of diagnosis and intervention: the Dutch experience. Seminars in Nephrology2000;20(5):463‐73. vanJaarsveldBC , KrijnenP , PietermanH , DerkxF , DeinumJ , PostmaCT , et al. The effect of balloon angioplasty on hypertension in atherosclerotic renal artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group. New England Journal of Medicine2000;342(14):1007‐14. ">DRASTIC</a>; <a href="./references#CD002944-bbs2-0005" title="ScarpioniR , MichielettiE , CristinelliL , UgolottiU , ScolariF , VenturelliC , et al. Atherosclerotic renovascular disease: medical therapy versus medical therapy plus renal artery stenting in preventing renal failure progression: the rationale and study design of a prospective, multicenter and randomized trial (NITER). Journal of Nephrology2005;18(4):423‐8. ScarpioniR , MichielettiE , PavoneL . Atherosclerotic renovascular disease (ARVD): medical therapy plus renal artery stenting (PRTS), compared with medical therapy alone, do not offer more chances in preventing C‐V events or the progression of renal failure. Preliminary results of a prospective, multicenter and randomized trial. Abstract World Congress of Nephrology; May 22, 2009; Milan, Italy2009. ">NITER</a>; <a href="./references#CD002944-bbs2-0007" title="WebsterJ , MarshallF , AbdallaM , DominiczakA , EdwardsR , IslesCG , et al. Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. Scottish and Newcastle Renal Artery Stenosis Collaborative Group. Journal of Human Hypertension1998;12(5):329‐35. ">SNRASCG</a>; <a href="./references#CD002944-bbs2-0008" title="BaxL , MaliWP , BuskensE , KoomansHA , BeutlerJJ , BraamB , et al. The benefit of STent placement and blood pressure and lipid‐lowering for the prevention of progression of renal dysfunction caused by Atherosclerotic ostial stenosis of the Renal artery. The STAR‐study: rationale and study design. Journal of Nephrology2003;16(6):807‐12. BaxL , WoittiezAJ , KouwenbergHJ , MaliWP , BuskensE , BeekFJ , et al. Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial. Annals of Internal Medicine2009;150(12):840‐8. ">STAR</a>) using the available data from the <a href="./references#CD002944-bbs2-0004" title="PlouinPF , ChatellierG , DarnéB , RaynaudA . Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis. A randomized trial. Essai Multicentrique Medicaments vs Angioplastie (EMMA) Study Group. Hypertension1998;31(3):823‐9. Scottish and Newcastle Renovascular Collaborative Group. Prospective randomized trial of interventional (angioplasty) versus medical therapy in hypertensive patients with atheromatous renal artery stenosis. Journal of Hypertension1994; Vol. 12:1312. ">EMMA</a> trial. Additionally, one study (<a href="./references#CD002944-bbs2-0001" title="ASTRAL Investigators, WheatleyK , IvesN , GrayR , KalraPA , MossJG , et al. Revascularization versus medical therapy for renal‐artery stenosis. New England Journal of Medicine2009;361(20):1953‐62. ISRCTN59586944 . Angioplasty and stent for renal artery lesions. ISRCTN Register2007. [URL: http://www.controlled‐trials.com/ISRCTN59586944/Angioplasty+stent+for+renal+artery+lesions] KalraP , MossJ , IvesN , HandleyK , GrayR , WheatleyK . Outcome of patients with highly significant and clinically relevant RAS within the ASTRAL trial. Renal Week 2008, 41st Annual Meeting &amp; Scientific Exposition; 2008 Nov 4‐9; Pennsylvania,USA2008. KalraPA , MossJ , IvesN , Fitzpatrick EllisK , GrayR , WheatleyK , et al. The impact of renal artery revascularization in atherosclerotic renovascular disease: the angioplasty and stenting for renal artery lesions (ASTRAL) trial [abstract no: 090]. Nephrology2008;13 Suppl 3:A123. MistryS , IvesN , HardingJ , Fitzpatrick‐EllisK , LipkinG , KalraPA , et al. Angioplasty and STent for Renal Artery Lesions (ASTRAL trial): rationale, methods and results so far. Journal of Human Hypertension2007;21(7):511‐5. MossJG . ASTRAL trial initial results. Cardiovascular and Interventional Radiological Society of Europe Annual Meeting Abstracts; 2008 Sep 13‐17; Copenhagen, Denmark2008:309. WheatleyK , KalraPA , MossJ , IvesN , Fitzpatrick‐EllisK , GrayR , et al. Lack of benefit of renal artery revascularization in atherosclerotic renovascular disease (ARVD): results of the ASTRAL trial. Renal Week 2008, 41st Annual Meeting &amp; Scientific Exposition; 2008 Nov 4‐9; Pennsylvania,USA2008. ">ASTRAL</a>) did not report SDs for the mean number of antihypertensive drugs and these were imputed using the SD data available for the other two included studies (<a href="./references#CD002944-bbs2-0002" title="CooperCJ , MurphyTP , MatsumotoA , SteffesM , CohenDJ , JaffM , et al. Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trial. American Heart Journal2006;152(1):59‐66. CooperCJM , MurphyTP , CutlipDE , JamersonK , HenrichW , ReidDM , et al. Stenting and medical therapy for atherosclerotic renal‐artery stenosis. New England Journal of Medicine2014;370:13‐22. MatsumotoA , H , CooperC , MurphyT , CutlipD , ConawayM , et al. Severity of renal artery lesions in patients enrolled into the CORAL trial. Journal of Vascular and Interventional Radiology2010;21(2 Suppl 1):S19. MatsumotoAH , CooperCJ , MurphyTP , CutlipM , ConawayMR , DworkinL . Severity of renal artery lesions in patients enrolled into the CORAL trial. Cardiovascular and Interventional Radiological Society of Europe Annual Meeting Abstracts; 2008 Sep 13‐17; Copenhagen, Denmark2008:308. MurphyTP , CooperCJ , DworkinLD , HenrichWL , RundbackJH , MatsumotoAH , et al. The Cardiovascular Outcomes with Renal Atherosclerotic Lesions (CORAL) study: rationale and methods. Journal of Vascular and Interventional Radiology2005;16(10):1295‐300. NCT00081731 . Benefits of medical therapy plus stenting for renal atherosclerotic lesions. http://clinicaltrials.gov/ct/show/NCT00081731?order=1. [URL: http://clinicaltrials.gov/ct/show/NCT00081731?order=1] ">CORAL</a>; <a href="./references#CD002944-bbs2-0003" title="KrijnenP , vanJaarsveldBC , HuninkMG , HabbemaJD . The effect of treatment on health‐related quality of life in patients with hypertension and renal artery stenosis. Journal of Human Hypertension2005;19(6):467‐70. vanJaarsveldB , KrijnenP , BartelinkA , DeesAd , DerkxFH , Man in't VeldA , et al. The Dutch Renal Artery Stenosis Intervention Cooperative (DRASTIC) Study: rationale and inclusion data. Journal of Hypertension1998;16 Suppl 6:S21‐7. vanJaarsveldB , KrijnenP , BartelinkA , DeesAd , DerkxFH , Man in't VeldA , et al. The Dutch Renal Artery Stenosis Intervention Cooperative (DRASTIC) Study: rationale and inclusion data. Journal of Hypertension1998;16 Suppl 6:S21‐7. vanJaarsveldBC , KrijnenP . Prospective studies of diagnosis and intervention: the Dutch experience. Seminars in Nephrology2000;20(5):463‐73. vanJaarsveldBC , KrijnenP , PietermanH , DerkxF , DeinumJ , PostmaCT , et al. The effect of balloon angioplasty on hypertension in atherosclerotic renal artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group. New England Journal of Medicine2000;342(14):1007‐14. ">DRASTIC</a>). The imputation of SDs, particularly in the changes in systolic and diastolic BP meta‐analyses where three out of five and four out of five studies, respectively, were missing SDs, may reduce the validity of the meta‐analysis results. </p> <p>It should also be noted that angiographic techniques are constantly improving, with the five more recent trials (<a href="./references#CD002944-bbs2-0001" title="ASTRAL Investigators, WheatleyK , IvesN , GrayR , KalraPA , MossJG , et al. Revascularization versus medical therapy for renal‐artery stenosis. New England Journal of Medicine2009;361(20):1953‐62. ISRCTN59586944 . Angioplasty and stent for renal artery lesions. ISRCTN Register2007. [URL: http://www.controlled‐trials.com/ISRCTN59586944/Angioplasty+stent+for+renal+artery+lesions] KalraP , MossJ , IvesN , HandleyK , GrayR , WheatleyK . Outcome of patients with highly significant and clinically relevant RAS within the ASTRAL trial. Renal Week 2008, 41st Annual Meeting &amp; Scientific Exposition; 2008 Nov 4‐9; Pennsylvania,USA2008. KalraPA , MossJ , IvesN , Fitzpatrick EllisK , GrayR , WheatleyK , et al. The impact of renal artery revascularization in atherosclerotic renovascular disease: the angioplasty and stenting for renal artery lesions (ASTRAL) trial [abstract no: 090]. Nephrology2008;13 Suppl 3:A123. MistryS , IvesN , HardingJ , Fitzpatrick‐EllisK , LipkinG , KalraPA , et al. Angioplasty and STent for Renal Artery Lesions (ASTRAL trial): rationale, methods and results so far. Journal of Human Hypertension2007;21(7):511‐5. MossJG . ASTRAL trial initial results. Cardiovascular and Interventional Radiological Society of Europe Annual Meeting Abstracts; 2008 Sep 13‐17; Copenhagen, Denmark2008:309. WheatleyK , KalraPA , MossJ , IvesN , Fitzpatrick‐EllisK , GrayR , et al. Lack of benefit of renal artery revascularization in atherosclerotic renovascular disease (ARVD): results of the ASTRAL trial. Renal Week 2008, 41st Annual Meeting &amp; Scientific Exposition; 2008 Nov 4‐9; Pennsylvania,USA2008. ">ASTRAL</a>; <a href="./references#CD002944-bbs2-0002" title="CooperCJ , MurphyTP , MatsumotoA , SteffesM , CohenDJ , JaffM , et al. Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trial. American Heart Journal2006;152(1):59‐66. CooperCJM , MurphyTP , CutlipDE , JamersonK , HenrichW , ReidDM , et al. Stenting and medical therapy for atherosclerotic renal‐artery stenosis. New England Journal of Medicine2014;370:13‐22. MatsumotoA , H , CooperC , MurphyT , CutlipD , ConawayM , et al. Severity of renal artery lesions in patients enrolled into the CORAL trial. Journal of Vascular and Interventional Radiology2010;21(2 Suppl 1):S19. MatsumotoAH , CooperCJ , MurphyTP , CutlipM , ConawayMR , DworkinL . Severity of renal artery lesions in patients enrolled into the CORAL trial. Cardiovascular and Interventional Radiological Society of Europe Annual Meeting Abstracts; 2008 Sep 13‐17; Copenhagen, Denmark2008:308. MurphyTP , CooperCJ , DworkinLD , HenrichWL , RundbackJH , MatsumotoAH , et al. The Cardiovascular Outcomes with Renal Atherosclerotic Lesions (CORAL) study: rationale and methods. Journal of Vascular and Interventional Radiology2005;16(10):1295‐300. NCT00081731 . Benefits of medical therapy plus stenting for renal atherosclerotic lesions. http://clinicaltrials.gov/ct/show/NCT00081731?order=1. [URL: http://clinicaltrials.gov/ct/show/NCT00081731?order=1] ">CORAL</a>; <a href="./references#CD002944-bbs2-0005" title="ScarpioniR , MichielettiE , CristinelliL , UgolottiU , ScolariF , VenturelliC , et al. Atherosclerotic renovascular disease: medical therapy versus medical therapy plus renal artery stenting in preventing renal failure progression: the rationale and study design of a prospective, multicenter and randomized trial (NITER). Journal of Nephrology2005;18(4):423‐8. ScarpioniR , MichielettiE , PavoneL . Atherosclerotic renovascular disease (ARVD): medical therapy plus renal artery stenting (PRTS), compared with medical therapy alone, do not offer more chances in preventing C‐V events or the progression of renal failure. Preliminary results of a prospective, multicenter and randomized trial. Abstract World Congress of Nephrology; May 22, 2009; Milan, Italy2009. ">NITER</a>; <a href="./references#CD002944-bbs2-0006" title="SchwarzwalderU , HaukM , ZellerT . RADAR ‐ A randomised, multi‐centre, prospective study comparing best medical treatment versus best medical treatment plus renal artery stenting in patients with haemodynamically relevant atherosclerotic renal artery stenosis. Trials2009;10:60. [NCT00640406] ZellerT . RADAR ‐ Data of a prematurely terminated randomized, multi‐centre prospective study comparing best medical treatment versus best medical treatment plus renal artery stenting in patients with hemodynamically relevant atherosclerotic renal artery stenosis. VASA. Zeitschrift fur Gefasskrankheiten. Journal for Vascular Diseases2013;42:40. ">RADAR</a>; <a href="./references#CD002944-bbs2-0008" title="BaxL , MaliWP , BuskensE , KoomansHA , BeutlerJJ , BraamB , et al. The benefit of STent placement and blood pressure and lipid‐lowering for the prevention of progression of renal dysfunction caused by Atherosclerotic ostial stenosis of the Renal artery. The STAR‐study: rationale and study design. Journal of Nephrology2003;16(6):807‐12. BaxL , WoittiezAJ , KouwenbergHJ , MaliWP , BuskensE , BeekFJ , et al. Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial. Annals of Internal Medicine2009;150(12):840‐8. ">STAR</a>) all comparing angioplasty with stent insertion to medical treatment rather than angioplasty alone.The most recently published trial (<a href="./references#CD002944-bbs2-0002" title="CooperCJ , MurphyTP , MatsumotoA , SteffesM , CohenDJ , JaffM , et al. Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trial. American Heart Journal2006;152(1):59‐66. CooperCJM , MurphyTP , CutlipDE , JamersonK , HenrichW , ReidDM , et al. Stenting and medical therapy for atherosclerotic renal‐artery stenosis. New England Journal of Medicine2014;370:13‐22. MatsumotoA , H , CooperC , MurphyT , CutlipD , ConawayM , et al. Severity of renal artery lesions in patients enrolled into the CORAL trial. Journal of Vascular and Interventional Radiology2010;21(2 Suppl 1):S19. MatsumotoAH , CooperCJ , MurphyTP , CutlipM , ConawayMR , DworkinL . Severity of renal artery lesions in patients enrolled into the CORAL trial. Cardiovascular and Interventional Radiological Society of Europe Annual Meeting Abstracts; 2008 Sep 13‐17; Copenhagen, Denmark2008:308. MurphyTP , CooperCJ , DworkinLD , HenrichWL , RundbackJH , MatsumotoAH , et al. The Cardiovascular Outcomes with Renal Atherosclerotic Lesions (CORAL) study: rationale and methods. Journal of Vascular and Interventional Radiology2005;16(10):1295‐300. NCT00081731 . Benefits of medical therapy plus stenting for renal atherosclerotic lesions. http://clinicaltrials.gov/ct/show/NCT00081731?order=1. [URL: http://clinicaltrials.gov/ct/show/NCT00081731?order=1] ">CORAL</a>) also included the use of distal protection devices. As yet, these technological advances do not appear to have translated into improved patient outcomes. A subgroup analysis restricting all the meta‐analyses to the five studies that carried out angioplasty with stenting (<a href="./references#CD002944-bbs2-0001" title="ASTRAL Investigators, WheatleyK , IvesN , GrayR , KalraPA , MossJG , et al. Revascularization versus medical therapy for renal‐artery stenosis. New England Journal of Medicine2009;361(20):1953‐62. ISRCTN59586944 . Angioplasty and stent for renal artery lesions. ISRCTN Register2007. [URL: http://www.controlled‐trials.com/ISRCTN59586944/Angioplasty+stent+for+renal+artery+lesions] KalraP , MossJ , IvesN , HandleyK , GrayR , WheatleyK . Outcome of patients with highly significant and clinically relevant RAS within the ASTRAL trial. Renal Week 2008, 41st Annual Meeting &amp; Scientific Exposition; 2008 Nov 4‐9; Pennsylvania,USA2008. KalraPA , MossJ , IvesN , Fitzpatrick EllisK , GrayR , WheatleyK , et al. The impact of renal artery revascularization in atherosclerotic renovascular disease: the angioplasty and stenting for renal artery lesions (ASTRAL) trial [abstract no: 090]. Nephrology2008;13 Suppl 3:A123. MistryS , IvesN , HardingJ , Fitzpatrick‐EllisK , LipkinG , KalraPA , et al. Angioplasty and STent for Renal Artery Lesions (ASTRAL trial): rationale, methods and results so far. Journal of Human Hypertension2007;21(7):511‐5. MossJG . ASTRAL trial initial results. Cardiovascular and Interventional Radiological Society of Europe Annual Meeting Abstracts; 2008 Sep 13‐17; Copenhagen, Denmark2008:309. WheatleyK , KalraPA , MossJ , IvesN , Fitzpatrick‐EllisK , GrayR , et al. Lack of benefit of renal artery revascularization in atherosclerotic renovascular disease (ARVD): results of the ASTRAL trial. Renal Week 2008, 41st Annual Meeting &amp; Scientific Exposition; 2008 Nov 4‐9; Pennsylvania,USA2008. ">ASTRAL</a>; <a href="./references#CD002944-bbs2-0002" title="CooperCJ , MurphyTP , MatsumotoA , SteffesM , CohenDJ , JaffM , et al. Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trial. American Heart Journal2006;152(1):59‐66. CooperCJM , MurphyTP , CutlipDE , JamersonK , HenrichW , ReidDM , et al. Stenting and medical therapy for atherosclerotic renal‐artery stenosis. New England Journal of Medicine2014;370:13‐22. MatsumotoA , H , CooperC , MurphyT , CutlipD , ConawayM , et al. Severity of renal artery lesions in patients enrolled into the CORAL trial. Journal of Vascular and Interventional Radiology2010;21(2 Suppl 1):S19. MatsumotoAH , CooperCJ , MurphyTP , CutlipM , ConawayMR , DworkinL . Severity of renal artery lesions in patients enrolled into the CORAL trial. Cardiovascular and Interventional Radiological Society of Europe Annual Meeting Abstracts; 2008 Sep 13‐17; Copenhagen, Denmark2008:308. MurphyTP , CooperCJ , DworkinLD , HenrichWL , RundbackJH , MatsumotoAH , et al. The Cardiovascular Outcomes with Renal Atherosclerotic Lesions (CORAL) study: rationale and methods. Journal of Vascular and Interventional Radiology2005;16(10):1295‐300. NCT00081731 . Benefits of medical therapy plus stenting for renal atherosclerotic lesions. http://clinicaltrials.gov/ct/show/NCT00081731?order=1. [URL: http://clinicaltrials.gov/ct/show/NCT00081731?order=1] ">CORAL</a>; <a href="./references#CD002944-bbs2-0005" title="ScarpioniR , MichielettiE , CristinelliL , UgolottiU , ScolariF , VenturelliC , et al. Atherosclerotic renovascular disease: medical therapy versus medical therapy plus renal artery stenting in preventing renal failure progression: the rationale and study design of a prospective, multicenter and randomized trial (NITER). Journal of Nephrology2005;18(4):423‐8. ScarpioniR , MichielettiE , PavoneL . Atherosclerotic renovascular disease (ARVD): medical therapy plus renal artery stenting (PRTS), compared with medical therapy alone, do not offer more chances in preventing C‐V events or the progression of renal failure. Preliminary results of a prospective, multicenter and randomized trial. Abstract World Congress of Nephrology; May 22, 2009; Milan, Italy2009. ">NITER</a>; <a href="./references#CD002944-bbs2-0006" title="SchwarzwalderU , HaukM , ZellerT . RADAR ‐ A randomised, multi‐centre, prospective study comparing best medical treatment versus best medical treatment plus renal artery stenting in patients with haemodynamically relevant atherosclerotic renal artery stenosis. Trials2009;10:60. [NCT00640406] ZellerT . RADAR ‐ Data of a prematurely terminated randomized, multi‐centre prospective study comparing best medical treatment versus best medical treatment plus renal artery stenting in patients with hemodynamically relevant atherosclerotic renal artery stenosis. VASA. Zeitschrift fur Gefasskrankheiten. Journal for Vascular Diseases2013;42:40. ">RADAR</a>; <a href="./references#CD002944-bbs2-0008" title="BaxL , MaliWP , BuskensE , KoomansHA , BeutlerJJ , BraamB , et al. The benefit of STent placement and blood pressure and lipid‐lowering for the prevention of progression of renal dysfunction caused by Atherosclerotic ostial stenosis of the Renal artery. The STAR‐study: rationale and study design. Journal of Nephrology2003;16(6):807‐12. BaxL , WoittiezAJ , KouwenbergHJ , MaliWP , BuskensE , BeekFJ , et al. Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial. Annals of Internal Medicine2009;150(12):840‐8. ">STAR</a>) did not significantly alter any of the results apart from the change in diastolic BP, where the mean difference (MD) between the angioplasty and the medical treatment group reduced and became non‐significant (MD ‐1.24 mmHg; 95% CI ‐3.23 to 0.75; P = 0.22, I² = 0%). </p> </section> <section id="CD002944-sec-0066"> <h3 class="title" id="CD002944-sec-0066">Quality of the evidence</h3> <p>A significant limitation of this review is that several of the studies did not provide enough information to accurately judge the risk of bias, and the majority of studies were considered to be at high risk of bias in at least two areas. Selection bias could not be determined in half of studies as authors failed to report the methods used for random number generation and concealing allocation. Due to the nature of the trials, allocation concealment was not possible. Detection bias could not be assessed for the majority of the trials as insufficient information was provided with regards to the blinding of personnel. The majority of studies were low risk for attrition and reporting bias as they had reported on all pre‐specified study outcomes and accounted for all participants. </p> <p>Four of the studies were considered to be high risk for other sources of bias, which was largely due to either significant numbers of participants crossing over from medical treatment to balloon angioplasty or not all participants allocated to angioplasty undergoing revascularisation. This may have reduced any benefits of angioplasty relative to medical treatment. One trial enrolled participants only if their clinician was uncertain as to whether revascularisation would be of clinical benefit (<a href="./references#CD002944-bbs2-0001" title="ASTRAL Investigators, WheatleyK , IvesN , GrayR , KalraPA , MossJG , et al. Revascularization versus medical therapy for renal‐artery stenosis. New England Journal of Medicine2009;361(20):1953‐62. ISRCTN59586944 . Angioplasty and stent for renal artery lesions. ISRCTN Register2007. [URL: http://www.controlled‐trials.com/ISRCTN59586944/Angioplasty+stent+for+renal+artery+lesions] KalraP , MossJ , IvesN , HandleyK , GrayR , WheatleyK . Outcome of patients with highly significant and clinically relevant RAS within the ASTRAL trial. Renal Week 2008, 41st Annual Meeting &amp; Scientific Exposition; 2008 Nov 4‐9; Pennsylvania,USA2008. KalraPA , MossJ , IvesN , Fitzpatrick EllisK , GrayR , WheatleyK , et al. The impact of renal artery revascularization in atherosclerotic renovascular disease: the angioplasty and stenting for renal artery lesions (ASTRAL) trial [abstract no: 090]. Nephrology2008;13 Suppl 3:A123. MistryS , IvesN , HardingJ , Fitzpatrick‐EllisK , LipkinG , KalraPA , et al. Angioplasty and STent for Renal Artery Lesions (ASTRAL trial): rationale, methods and results so far. Journal of Human Hypertension2007;21(7):511‐5. MossJG . ASTRAL trial initial results. Cardiovascular and Interventional Radiological Society of Europe Annual Meeting Abstracts; 2008 Sep 13‐17; Copenhagen, Denmark2008:309. WheatleyK , KalraPA , MossJ , IvesN , Fitzpatrick‐EllisK , GrayR , et al. Lack of benefit of renal artery revascularization in atherosclerotic renovascular disease (ARVD): results of the ASTRAL trial. Renal Week 2008, 41st Annual Meeting &amp; Scientific Exposition; 2008 Nov 4‐9; Pennsylvania,USA2008. ">ASTRAL</a>). Therefore, patients who otherwise met the study inclusion criteria but were felt to be likely to benefit from angioplasty were excluded from the study, and this may have resulted in the potential benefits of angioplasty being underestimated. </p> <p>A further source of heterogeneity is the different BP regimes employed in the different studies. In some of the studies specific antihypertensive treatment protocols were provided (<a href="./references#CD002944-bbs2-0002" title="CooperCJ , MurphyTP , MatsumotoA , SteffesM , CohenDJ , JaffM , et al. Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trial. American Heart Journal2006;152(1):59‐66. CooperCJM , MurphyTP , CutlipDE , JamersonK , HenrichW , ReidDM , et al. Stenting and medical therapy for atherosclerotic renal‐artery stenosis. New England Journal of Medicine2014;370:13‐22. MatsumotoA , H , CooperC , MurphyT , CutlipD , ConawayM , et al. Severity of renal artery lesions in patients enrolled into the CORAL trial. Journal of Vascular and Interventional Radiology2010;21(2 Suppl 1):S19. MatsumotoAH , CooperCJ , MurphyTP , CutlipM , ConawayMR , DworkinL . Severity of renal artery lesions in patients enrolled into the CORAL trial. Cardiovascular and Interventional Radiological Society of Europe Annual Meeting Abstracts; 2008 Sep 13‐17; Copenhagen, Denmark2008:308. MurphyTP , CooperCJ , DworkinLD , HenrichWL , RundbackJH , MatsumotoAH , et al. The Cardiovascular Outcomes with Renal Atherosclerotic Lesions (CORAL) study: rationale and methods. Journal of Vascular and Interventional Radiology2005;16(10):1295‐300. NCT00081731 . Benefits of medical therapy plus stenting for renal atherosclerotic lesions. http://clinicaltrials.gov/ct/show/NCT00081731?order=1. [URL: http://clinicaltrials.gov/ct/show/NCT00081731?order=1] ">CORAL</a>; <a href="./references#CD002944-bbs2-0004" title="PlouinPF , ChatellierG , DarnéB , RaynaudA . Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis. A randomized trial. Essai Multicentrique Medicaments vs Angioplastie (EMMA) Study Group. Hypertension1998;31(3):823‐9. Scottish and Newcastle Renovascular Collaborative Group. Prospective randomized trial of interventional (angioplasty) versus medical therapy in hypertensive patients with atheromatous renal artery stenosis. Journal of Hypertension1994; Vol. 12:1312. ">EMMA</a>; <a href="./references#CD002944-bbs2-0008" title="BaxL , MaliWP , BuskensE , KoomansHA , BeutlerJJ , BraamB , et al. The benefit of STent placement and blood pressure and lipid‐lowering for the prevention of progression of renal dysfunction caused by Atherosclerotic ostial stenosis of the Renal artery. The STAR‐study: rationale and study design. Journal of Nephrology2003;16(6):807‐12. BaxL , WoittiezAJ , KouwenbergHJ , MaliWP , BuskensE , BeekFJ , et al. Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial. Annals of Internal Medicine2009;150(12):840‐8. ">STAR</a>) whilst in other studies (<a href="./references#CD002944-bbs2-0001" title="ASTRAL Investigators, WheatleyK , IvesN , GrayR , KalraPA , MossJG , et al. Revascularization versus medical therapy for renal‐artery stenosis. New England Journal of Medicine2009;361(20):1953‐62. ISRCTN59586944 . Angioplasty and stent for renal artery lesions. ISRCTN Register2007. [URL: http://www.controlled‐trials.com/ISRCTN59586944/Angioplasty+stent+for+renal+artery+lesions] KalraP , MossJ , IvesN , HandleyK , GrayR , WheatleyK . Outcome of patients with highly significant and clinically relevant RAS within the ASTRAL trial. Renal Week 2008, 41st Annual Meeting &amp; Scientific Exposition; 2008 Nov 4‐9; Pennsylvania,USA2008. KalraPA , MossJ , IvesN , Fitzpatrick EllisK , GrayR , WheatleyK , et al. The impact of renal artery revascularization in atherosclerotic renovascular disease: the angioplasty and stenting for renal artery lesions (ASTRAL) trial [abstract no: 090]. Nephrology2008;13 Suppl 3:A123. MistryS , IvesN , HardingJ , Fitzpatrick‐EllisK , LipkinG , KalraPA , et al. Angioplasty and STent for Renal Artery Lesions (ASTRAL trial): rationale, methods and results so far. Journal of Human Hypertension2007;21(7):511‐5. MossJG . ASTRAL trial initial results. Cardiovascular and Interventional Radiological Society of Europe Annual Meeting Abstracts; 2008 Sep 13‐17; Copenhagen, Denmark2008:309. WheatleyK , KalraPA , MossJ , IvesN , Fitzpatrick‐EllisK , GrayR , et al. Lack of benefit of renal artery revascularization in atherosclerotic renovascular disease (ARVD): results of the ASTRAL trial. Renal Week 2008, 41st Annual Meeting &amp; Scientific Exposition; 2008 Nov 4‐9; Pennsylvania,USA2008. ">ASTRAL</a>) local centres used their own treatment protocols. </p> <p>The ASTRAL trial had 806 participants and the CORAL trial had 947 participants, and these trials therefore accounted for the majority of the participants included in the meta‐analysis. A sensitivity analysis was carried out and this showed that these studies did not heavily influence any of the meta‐analysis results, with the exception of the meta‐analysis of the number of antihypertensive drugs. If either the CORAL or ASTRAL trial was excluded from this meta‐analysis then the MD between antihypertensive drug requirements in the angioplasty group relative to the medial treatment group reduced and became non‐significant (MD‐0.15; 95% CI ‐0.43 to 0.12; P = 0.27, I² = 10% and MD ‐0.18; 95% CI ‐0.36 to 0.00; P = 0.05, I² = 14%, respectively). </p> <p>The overall quality of the evidence was considered to be moderate because the methodological quality of the studies varied substantially and two of the studies had not provided sufficient data to be able to assess their risk of bias. </p> </section> <section id="CD002944-sec-0067"> <h3 class="title" id="CD002944-sec-0067">Potential biases in the review process</h3> <p>In this systematic review we identified all the randomised controlled trials that compared angioplasty to medical therapy in hypertensive patients with haemodynamically significant renal artery stenosis. We believe our search for randomised controlled trials has been inclusive and that our standardised methods of study selection and data extraction should not have introduced bias. We were not always able to pool the available data due to the variable presentation of some of the trial outcomes. </p> <p>Serum creatinine at two years or end of follow‐up was selected as an outcome as SD data were not available for change in creatinine during follow‐up. The main limitation of presenting final serum creatinine levels as an outcome is that the final value does not take into account the change from baseline. </p> <p>Only the <a href="./references#CD002944-bbs2-0004" title="PlouinPF , ChatellierG , DarnéB , RaynaudA . Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis. A randomized trial. Essai Multicentrique Medicaments vs Angioplastie (EMMA) Study Group. Hypertension1998;31(3):823‐9. Scottish and Newcastle Renovascular Collaborative Group. Prospective randomized trial of interventional (angioplasty) versus medical therapy in hypertensive patients with atheromatous renal artery stenosis. Journal of Hypertension1994; Vol. 12:1312. ">EMMA</a> and <a href="./references#CD002944-bbs2-0002" title="CooperCJ , MurphyTP , MatsumotoA , SteffesM , CohenDJ , JaffM , et al. Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trial. American Heart Journal2006;152(1):59‐66. CooperCJM , MurphyTP , CutlipDE , JamersonK , HenrichW , ReidDM , et al. Stenting and medical therapy for atherosclerotic renal‐artery stenosis. New England Journal of Medicine2014;370:13‐22. MatsumotoA , H , CooperC , MurphyT , CutlipD , ConawayM , et al. Severity of renal artery lesions in patients enrolled into the CORAL trial. Journal of Vascular and Interventional Radiology2010;21(2 Suppl 1):S19. MatsumotoAH , CooperCJ , MurphyTP , CutlipM , ConawayMR , DworkinL . Severity of renal artery lesions in patients enrolled into the CORAL trial. Cardiovascular and Interventional Radiological Society of Europe Annual Meeting Abstracts; 2008 Sep 13‐17; Copenhagen, Denmark2008:308. MurphyTP , CooperCJ , DworkinLD , HenrichWL , RundbackJH , MatsumotoAH , et al. The Cardiovascular Outcomes with Renal Atherosclerotic Lesions (CORAL) study: rationale and methods. Journal of Vascular and Interventional Radiology2005;16(10):1295‐300. NCT00081731 . Benefits of medical therapy plus stenting for renal atherosclerotic lesions. http://clinicaltrials.gov/ct/show/NCT00081731?order=1. [URL: http://clinicaltrials.gov/ct/show/NCT00081731?order=1] ">CORAL</a> trials reported SDs for change in BP during follow‐up. SDs were therefore imputed for the <a href="./references#CD002944-bbs2-0001" title="ASTRAL Investigators, WheatleyK , IvesN , GrayR , KalraPA , MossJG , et al. Revascularization versus medical therapy for renal‐artery stenosis. New England Journal of Medicine2009;361(20):1953‐62. ISRCTN59586944 . Angioplasty and stent for renal artery lesions. ISRCTN Register2007. [URL: http://www.controlled‐trials.com/ISRCTN59586944/Angioplasty+stent+for+renal+artery+lesions] KalraP , MossJ , IvesN , HandleyK , GrayR , WheatleyK . Outcome of patients with highly significant and clinically relevant RAS within the ASTRAL trial. Renal Week 2008, 41st Annual Meeting &amp; Scientific Exposition; 2008 Nov 4‐9; Pennsylvania,USA2008. KalraPA , MossJ , IvesN , Fitzpatrick EllisK , GrayR , WheatleyK , et al. The impact of renal artery revascularization in atherosclerotic renovascular disease: the angioplasty and stenting for renal artery lesions (ASTRAL) trial [abstract no: 090]. Nephrology2008;13 Suppl 3:A123. MistryS , IvesN , HardingJ , Fitzpatrick‐EllisK , LipkinG , KalraPA , et al. Angioplasty and STent for Renal Artery Lesions (ASTRAL trial): rationale, methods and results so far. Journal of Human Hypertension2007;21(7):511‐5. MossJG . ASTRAL trial initial results. Cardiovascular and Interventional Radiological Society of Europe Annual Meeting Abstracts; 2008 Sep 13‐17; Copenhagen, Denmark2008:309. WheatleyK , KalraPA , MossJ , IvesN , Fitzpatrick‐EllisK , GrayR , et al. Lack of benefit of renal artery revascularization in atherosclerotic renovascular disease (ARVD): results of the ASTRAL trial. Renal Week 2008, 41st Annual Meeting &amp; Scientific Exposition; 2008 Nov 4‐9; Pennsylvania,USA2008. ">ASTRAL</a>, <a href="./references#CD002944-bbs2-0003" title="KrijnenP , vanJaarsveldBC , HuninkMG , HabbemaJD . The effect of treatment on health‐related quality of life in patients with hypertension and renal artery stenosis. Journal of Human Hypertension2005;19(6):467‐70. vanJaarsveldB , KrijnenP , BartelinkA , DeesAd , DerkxFH , Man in't VeldA , et al. The Dutch Renal Artery Stenosis Intervention Cooperative (DRASTIC) Study: rationale and inclusion data. Journal of Hypertension1998;16 Suppl 6:S21‐7. vanJaarsveldB , KrijnenP , BartelinkA , DeesAd , DerkxFH , Man in't VeldA , et al. The Dutch Renal Artery Stenosis Intervention Cooperative (DRASTIC) Study: rationale and inclusion data. Journal of Hypertension1998;16 Suppl 6:S21‐7. vanJaarsveldBC , KrijnenP . Prospective studies of diagnosis and intervention: the Dutch experience. Seminars in Nephrology2000;20(5):463‐73. vanJaarsveldBC , KrijnenP , PietermanH , DerkxF , DeinumJ , PostmaCT , et al. The effect of balloon angioplasty on hypertension in atherosclerotic renal artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group. New England Journal of Medicine2000;342(14):1007‐14. ">DRASTIC</a> and <a href="./references#CD002944-bbs2-0008" title="BaxL , MaliWP , BuskensE , KoomansHA , BeutlerJJ , BraamB , et al. The benefit of STent placement and blood pressure and lipid‐lowering for the prevention of progression of renal dysfunction caused by Atherosclerotic ostial stenosis of the Renal artery. The STAR‐study: rationale and study design. Journal of Nephrology2003;16(6):807‐12. BaxL , WoittiezAJ , KouwenbergHJ , MaliWP , BuskensE , BeekFJ , et al. Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial. Annals of Internal Medicine2009;150(12):840‐8. ">STAR</a> trials from the available data using methodology described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD002944-bbs2-0017" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). Similarly, only the <a href="./references#CD002944-bbs2-0003" title="KrijnenP , vanJaarsveldBC , HuninkMG , HabbemaJD . The effect of treatment on health‐related quality of life in patients with hypertension and renal artery stenosis. Journal of Human Hypertension2005;19(6):467‐70. vanJaarsveldB , KrijnenP , BartelinkA , DeesAd , DerkxFH , Man in't VeldA , et al. The Dutch Renal Artery Stenosis Intervention Cooperative (DRASTIC) Study: rationale and inclusion data. Journal of Hypertension1998;16 Suppl 6:S21‐7. vanJaarsveldB , KrijnenP , BartelinkA , DeesAd , DerkxFH , Man in't VeldA , et al. The Dutch Renal Artery Stenosis Intervention Cooperative (DRASTIC) Study: rationale and inclusion data. Journal of Hypertension1998;16 Suppl 6:S21‐7. vanJaarsveldBC , KrijnenP . Prospective studies of diagnosis and intervention: the Dutch experience. Seminars in Nephrology2000;20(5):463‐73. vanJaarsveldBC , KrijnenP , PietermanH , DerkxF , DeinumJ , PostmaCT , et al. The effect of balloon angioplasty on hypertension in atherosclerotic renal artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group. New England Journal of Medicine2000;342(14):1007‐14. ">DRASTIC</a> and <a href="./references#CD002944-bbs2-0002" title="CooperCJ , MurphyTP , MatsumotoA , SteffesM , CohenDJ , JaffM , et al. Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trial. American Heart Journal2006;152(1):59‐66. CooperCJM , MurphyTP , CutlipDE , JamersonK , HenrichW , ReidDM , et al. Stenting and medical therapy for atherosclerotic renal‐artery stenosis. New England Journal of Medicine2014;370:13‐22. MatsumotoA , H , CooperC , MurphyT , CutlipD , ConawayM , et al. Severity of renal artery lesions in patients enrolled into the CORAL trial. Journal of Vascular and Interventional Radiology2010;21(2 Suppl 1):S19. MatsumotoAH , CooperCJ , MurphyTP , CutlipM , ConawayMR , DworkinL . Severity of renal artery lesions in patients enrolled into the CORAL trial. Cardiovascular and Interventional Radiological Society of Europe Annual Meeting Abstracts; 2008 Sep 13‐17; Copenhagen, Denmark2008:308. MurphyTP , CooperCJ , DworkinLD , HenrichWL , RundbackJH , MatsumotoAH , et al. The Cardiovascular Outcomes with Renal Atherosclerotic Lesions (CORAL) study: rationale and methods. Journal of Vascular and Interventional Radiology2005;16(10):1295‐300. NCT00081731 . Benefits of medical therapy plus stenting for renal atherosclerotic lesions. http://clinicaltrials.gov/ct/show/NCT00081731?order=1. [URL: http://clinicaltrials.gov/ct/show/NCT00081731?order=1] ">CORAL</a> trials reported SDs for the mean number of antihypertensive drugs and SDs were therefore imputed for the <a href="./references#CD002944-bbs2-0001" title="ASTRAL Investigators, WheatleyK , IvesN , GrayR , KalraPA , MossJG , et al. Revascularization versus medical therapy for renal‐artery stenosis. New England Journal of Medicine2009;361(20):1953‐62. ISRCTN59586944 . Angioplasty and stent for renal artery lesions. ISRCTN Register2007. [URL: http://www.controlled‐trials.com/ISRCTN59586944/Angioplasty+stent+for+renal+artery+lesions] KalraP , MossJ , IvesN , HandleyK , GrayR , WheatleyK . Outcome of patients with highly significant and clinically relevant RAS within the ASTRAL trial. Renal Week 2008, 41st Annual Meeting &amp; Scientific Exposition; 2008 Nov 4‐9; Pennsylvania,USA2008. KalraPA , MossJ , IvesN , Fitzpatrick EllisK , GrayR , WheatleyK , et al. The impact of renal artery revascularization in atherosclerotic renovascular disease: the angioplasty and stenting for renal artery lesions (ASTRAL) trial [abstract no: 090]. Nephrology2008;13 Suppl 3:A123. MistryS , IvesN , HardingJ , Fitzpatrick‐EllisK , LipkinG , KalraPA , et al. Angioplasty and STent for Renal Artery Lesions (ASTRAL trial): rationale, methods and results so far. Journal of Human Hypertension2007;21(7):511‐5. MossJG . ASTRAL trial initial results. Cardiovascular and Interventional Radiological Society of Europe Annual Meeting Abstracts; 2008 Sep 13‐17; Copenhagen, Denmark2008:309. WheatleyK , KalraPA , MossJ , IvesN , Fitzpatrick‐EllisK , GrayR , et al. Lack of benefit of renal artery revascularization in atherosclerotic renovascular disease (ARVD): results of the ASTRAL trial. Renal Week 2008, 41st Annual Meeting &amp; Scientific Exposition; 2008 Nov 4‐9; Pennsylvania,USA2008. ">ASTRAL</a> trial. </p> </section> <section id="CD002944-sec-0068"> <h3 class="title" id="CD002944-sec-0068">Agreements and disagreements with other studies or reviews</h3> <p>To date, one other meta‐analysis has examined the effect of angioplasty on atherosclerotic renal artery stenosis (<a href="./references#CD002944-bbs2-0018" title="KumbhaniDJ , BavryAA , HarveyJE , deSouzaR , ScarpioniR , BhattDL , et al. Clinical outcomes after percutaneous revascularization versus medical management in patients with significant renal artery stenosis: a meta‐analysis of randomized controlled trials. American Heart Journal2011;161(3):622‐30. ">Kumbhani 2011</a>). The findings of this meta‐analysis were similar, with the authors concluding that although there may be a small reduction in the use of antihypertensive medications there was no evidence that angioplasty improved serum creatinine or clinical outcomes when compared to optimal medical treatment. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD002944-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002944.pub2/media/CDSR/CD002944/urn:x-wiley:14651858:media:CD002944:CD002944-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002944.pub2/media/CDSR/CD002944/image_t/tCD002944-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD002944-fig-0001" src="/cdsr/doi/10.1002/14651858.CD002944.pub2/media/CDSR/CD002944/image_n/nCD002944-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002944.pub2/full#CD002944-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002944.pub2/media/CDSR/CD002944/image_n/nCD002944-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002944-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002944.pub2/media/CDSR/CD002944/urn:x-wiley:14651858:media:CD002944:CD002944-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002944.pub2/media/CDSR/CD002944/image_t/tCD002944-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD002944-fig-0002" src="/cdsr/doi/10.1002/14651858.CD002944.pub2/media/CDSR/CD002944/image_n/nCD002944-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002944.pub2/full#CD002944-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002944.pub2/media/CDSR/CD002944/image_n/nCD002944-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002944-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002944.pub2/media/CDSR/CD002944/urn:x-wiley:14651858:media:CD002944:CD002944-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002944.pub2/media/CDSR/CD002944/image_t/tCD002944-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD002944-fig-0003" src="/cdsr/doi/10.1002/14651858.CD002944.pub2/media/CDSR/CD002944/image_n/nCD002944-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002944.pub2/full#CD002944-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002944.pub2/media/CDSR/CD002944/image_n/nCD002944-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002944-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002944.pub2/media/CDSR/CD002944/urn:x-wiley:14651858:media:CD002944:CD002944-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002944.pub2/media/CDSR/CD002944/image_t/tCD002944-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Balloon angioplasty versus medical therapy, Outcome 1 Change in systolic BP at 2 years or end of follow‐up." data-id="CD002944-fig-0004" src="/cdsr/doi/10.1002/14651858.CD002944.pub2/media/CDSR/CD002944/image_n/nCD002944-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Balloon angioplasty versus medical therapy, Outcome 1 Change in systolic BP at 2 years or end of follow‐up. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002944.pub2/references#CD002944-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002944.pub2/media/CDSR/CD002944/image_n/nCD002944-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002944-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002944.pub2/media/CDSR/CD002944/urn:x-wiley:14651858:media:CD002944:CD002944-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002944.pub2/media/CDSR/CD002944/image_t/tCD002944-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Balloon angioplasty versus medical therapy, Outcome 2 Change in diastolic BP at 2 years or end of follow‐up." data-id="CD002944-fig-0005" src="/cdsr/doi/10.1002/14651858.CD002944.pub2/media/CDSR/CD002944/image_n/nCD002944-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Balloon angioplasty versus medical therapy, Outcome 2 Change in diastolic BP at 2 years or end of follow‐up. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002944.pub2/references#CD002944-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002944.pub2/media/CDSR/CD002944/image_n/nCD002944-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002944-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002944.pub2/media/CDSR/CD002944/urn:x-wiley:14651858:media:CD002944:CD002944-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002944.pub2/media/CDSR/CD002944/image_t/tCD002944-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Balloon angioplasty versus medical therapy, Outcome 3 Serum creatinine at 2 years or end of follow up." data-id="CD002944-fig-0006" src="/cdsr/doi/10.1002/14651858.CD002944.pub2/media/CDSR/CD002944/image_n/nCD002944-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Balloon angioplasty versus medical therapy, Outcome 3 Serum creatinine at 2 years or end of follow up. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002944.pub2/references#CD002944-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002944.pub2/media/CDSR/CD002944/image_n/nCD002944-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002944-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002944.pub2/media/CDSR/CD002944/urn:x-wiley:14651858:media:CD002944:CD002944-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002944.pub2/media/CDSR/CD002944/image_t/tCD002944-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Balloon angioplasty versus medical therapy, Outcome 4 Number of antihypertensive drugs." data-id="CD002944-fig-0007" src="/cdsr/doi/10.1002/14651858.CD002944.pub2/media/CDSR/CD002944/image_n/nCD002944-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Balloon angioplasty versus medical therapy, Outcome 4 Number of antihypertensive drugs. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002944.pub2/references#CD002944-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002944.pub2/media/CDSR/CD002944/image_n/nCD002944-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002944-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002944.pub2/media/CDSR/CD002944/urn:x-wiley:14651858:media:CD002944:CD002944-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002944.pub2/media/CDSR/CD002944/image_t/tCD002944-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Balloon angioplasty versus medical therapy, Outcome 5 Cardiovascular adverse events." data-id="CD002944-fig-0008" src="/cdsr/doi/10.1002/14651858.CD002944.pub2/media/CDSR/CD002944/image_n/nCD002944-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Balloon angioplasty versus medical therapy, Outcome 5 Cardiovascular adverse events. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002944.pub2/references#CD002944-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002944.pub2/media/CDSR/CD002944/image_n/nCD002944-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002944-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002944.pub2/media/CDSR/CD002944/urn:x-wiley:14651858:media:CD002944:CD002944-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002944.pub2/media/CDSR/CD002944/image_t/tCD002944-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Balloon angioplasty versus medical therapy, Outcome 6 Renal adverse events." data-id="CD002944-fig-0009" src="/cdsr/doi/10.1002/14651858.CD002944.pub2/media/CDSR/CD002944/image_n/nCD002944-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Balloon angioplasty versus medical therapy, Outcome 6 Renal adverse events.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002944.pub2/references#CD002944-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002944.pub2/media/CDSR/CD002944/image_n/nCD002944-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table data-id="CD002944-tbl-0001"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Cardiovascular complications</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Complications</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> ASTRAL</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b> CORAL</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> DRASTIC</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> EMMA</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> NITER</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> SNRASCG</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> STAR</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Angina/myocardial infarction/heart failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>112 in BA, 131 in MT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>40 in BA, 37 in MT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0 in BA, 2 in MT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0 in any group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Data not available</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4 in each group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4 in BA, 6 in MT</p> <p>(defined as</p> <p>CAD + HF)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cholesterol embolisation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 in BA, 0 in MT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 in BA, 0 in MT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0 in BA, 1 in MT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0 in any group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Data not available</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0 in any group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 in BA, 0 in MT</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Non‐procedure‐related symptomatic hypotension</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Data not available</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Data not available</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0 in any group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0 in BA, 1 in MT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Data not available</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0 in any group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Data not available</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Stroke</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24 in BA, 23 in MT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16 in BA, 23 in MT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0 in any group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0 in any group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 in BA, 4 in MT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 in BA, 4 in MT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0 in BA, 1 in MT</p> <p>(defined as cerebro</p> <p>vascular disease)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Death</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>103 in BA, 106 in MT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>63 in BA, 76 in MT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0 in any group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0 in any group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 in BA, 3 in MT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 in BA, 4 in MT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 in MT, 5 in BA</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="8"> <div class="table-footnote"> <p>BA: balloon angioplasty group<br/> CAD: coronary artery disease<br/> HF: heart failure<br/> MT: medical therapy group </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Cardiovascular complications</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD002944.pub2/full#CD002944-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD002944-tbl-0002"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Renovascular complications</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Complications</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> ASTRAL</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b> CORAL</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> DRASTIC</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> EMMA</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> NITER</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> SNRASCG</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> STAR</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&gt; 50% increase in serum creatinine</p> <p>or<br/> &gt; 20% decrease in estimated creatinine clearance </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Data not available</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Data not available</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 in BA, 3 in MT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0 in BA, 1 in MT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Data not available</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0 in any group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10 in BA, 16 in MT</p> <p>(data provided for</p> <p>20% fall in CrCl only)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Renal failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>55 in BA, 54 in MT</p> <p>(defined as AKI + dialysis for</p> <p>end stage renal disease)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16 in BA, 8 in MT (defined as permanent RRT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0 in any group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0 in any group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10 in BA, 8 in MT</p> <p>(but unclear how worsening</p> <p>renal failure was defined)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 in each group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Data not available</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Total occlusion of stenotic artery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5 in BA, 4 in MT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Data not available</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0 in BA, 4 in MT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0 in any group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Data not available</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0 in any group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Data not available</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="8"> <div class="table-footnote"> <p>AKI: acute kidney injury<br/> BA: balloon angioplasty group<br/> CrCl: creatinine clearance<br/> MT: medical therapy group<br/> RRT: renal replacement therapy </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Renovascular complications</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD002944.pub2/full#CD002944-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD002944-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Balloon angioplasty versus medical therapy</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Change in systolic BP at 2 years or end of follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1743</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.07 [‐3.45, 1.30]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Change in diastolic BP at 2 years or end of follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>809</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.00 [‐3.72, ‐0.27]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Serum creatinine at 2 years or end of follow up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>725</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐7.99 [‐22.60, 6.62]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Number of antihypertensive drugs <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1717</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.18 [‐0.34, ‐0.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Cardiovascular adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2110</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.75, 1.11]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Renal adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2104</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.75, 1.38]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Balloon angioplasty versus medical therapy</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD002944.pub2/references#CD002944-tbl-0003">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD002944.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD002944-note-0003">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD002944-note-0008">فارسی</a> </li> <li class="section-language"> <a class="" href="hr#CD002944-note-0002">Hrvatski</a> </li> <li class="section-language"> <a class="" href="ru#CD002944-note-0001">Русский</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD002944\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD002944\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD002944\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD002944\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD002944\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD002944\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD002944\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD002944\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD002944\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD002944\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD002944\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD002944\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD002944\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD002944\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD002944\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD002944\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD002944\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD002944\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=BqmVIxTs&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD002944.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD002944.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD002944.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD002944.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD002944.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740725170417"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD002944.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740725170421"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD002944.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918e74b5bc071be5',t:'MTc0MDcyNTE3MC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 